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PREFACE 
The complex formation between divalent metal 
ions and amino acids at 37 °C and ionic strength 
O. lSM (KN0 3) was studied by potentiometric 
ti ration ~ The titration data were analysed 
using the non-linear least-squares programme 
SCOGS. The results indicated that it was important 
to consider protonated and hydrolysed species as 
well as the usual stepwise complexes . The mixed-
l ' gand complex formation of nickel(II) with various 
amino acids was studied. 
The compound N-(2-mercaptopropionyl)glycine 
was selected as a model for a thiol-containing 
dipeptide and its stability constants with various 
meta ions were determined. With the aid of the 
computer programme SCOGS, it was possible to compute 
stab ' lity cons ants for eight zinc(II) and seven 
cadmium(II) complexes of the tripeptide glutathione. 
Pr otonated species were shown to be important as 
well as simple ML and ML 2 complexes. Structures 
are proposed for the complexes. In both glutathione 
and N-(2-mercaptopropionyl)glycine, it is suggested 
that ionisat ' on of the peptide, or amide, linkage 
can occur on complex formation. 
Us ' ng he programme COMICS, the equilibrium 
distribution of copper(II), zinc(II), and 
manganese(II) ions among a mixture of seventeen 
amino acids was computed from stability constant 
data (from this thesis and from previous work by 
members of this Department) and blood plasma 
composition data. At pH 7.4, 98% of the copper(II) 
in the simulated plasma solution is coordinated 
to hi s tidine and cystine, predominantly as the 
mixed-ligand complexes [Cu.His.Cystine] and 
[Cu.H.His.Cys tine], and approximately half the 
zinc(II) i s coordinated to cysteine and histidine 
although appreciable complex formation occurs with 
most of the o ther amino acids. 98% of the 
manganese(II) is present as the free metal ion. 
Taking the coppe -zinc-manganese-amino acids 
system as a model for blood plasma, the effect of 
adventitious cations such as Pb 2+ , Ni 2+, Cd2+, and 
co
2 
on the equilibrium concentrations of the metal 
ions and complex species present was computed. The 
effect of the addition of D-penicillamine to a 
t t . . th . . ' b 2+ sys em con aining e extrinsic cation P was 
computed and the results indicated that zinc, as 
well as lead, was readily complexed and removed by 
D-penicillamine. Similar calculations using 
N-(2-mercaptopropionyl)glycine indicated that the 
zinc depletion, previously observed during the 
treatment of lead poisoning by D-penicillamine, 
might be diminished by the use of N-(2-mercapto-
propionyl)glycine instead of D-penicillamine. 
Publications based on the present work: 
1) "Complex Formation of Zinc and Cadmium with 
Glutathione", D. D. Perrin and Ann E. Watt, 
Biochim. et Biophys. Acta, accepted for publication. 
2) "The Computed Distribution of Copper(II) and 
Zinc(II) Ions Among Seventeen Amino Acids Present 
in Human Blood Plasma", P. s. Hallman, D. D. Perrin 
and Ann E. Watt, Biochem. J., accepted for publication. 
CHAPTER 1 
INTRODUCTION 
Biological systems contain several kinds of metal 
ions and many different complexing species. The purpose 
of the present work was to study quantitatively the 
multiple equilibr}a which are set up by the competition 
of the complexing species for the metal ions. 
Metal ions are essential to the functioning of all 
living tissue, and they exert important effects, not 
only in the maintenance of osmotic balance, but also in 
ways that are specific to the ions themselves and the 
complexes they form with a wide range of naturally 
occuring components of biological systems. In addition 
to the four principal metal ions, sodium, potassium, 
calcium, and magnesium, at least six cations have been 
shown to be required in trace amounts by the mammalian 
body. These are iron, copper, manganese , cobalt, zinc, 
and molybdenum . This list will undoubtedly be lengthened 
in future as the roles of metal ions in metabolism become 
better understood. On the other hand, metal ions are 
frequently present adventitiously. For example, cadmium 
is often present in tissues but no particular function 
has been ascribed to it, and it is doubtful that it is 
essential. 1 
1 
Animal and plant tissues contain many different kinds 
of complexing species, such as amino acids, peptides, 
proteins, carboxylic acids, and phosphates. For present 
purposes, a complex is defined as a species formed by the 
association of two or more simpler species, each capable 
d . t 2 of indepen ent exis ence. Thus the species BA is a 
complex whether there is inner-sphere interaction or only 
outer-sphere interaction between A and B. In each tissue, 
the amino acids, peptides, proteins, carboxylic acids, 
and phosphates compete with each other for the various 
metal ions hat are present. The barrier surrounding the 
tissue can be penetrated with varying ease, depending 
upon the nature of the molecule or ion. For example, a 
neutral molecule such as 2,3-dimercaptopropanol passes 
more easily through a layer of fatlike molecules than 
does a highly ionized species such as an EDTA anion. 
The laws of chemistry may be assumed to apply to 
such systems and the equilibria involving metal complexes 
within any phase are expressed quantitatively by the 
appropriate stability constant determined under the same 
conditions of ionic strength and temperature. 
2 
A quantitative approach to metal-binding in biological 
systems would provide a background against which to view 
the reactions and equ ' libria in the living cell. It would 
also yield information on the equilibrium concentrations 
of free metal ions, the concentrations of all species 
containing metal ions or complexing species, and hence 
information on how each metal ion distributes itself 
among the various complexing species. The effect of pH 
on the distribution of metal ions, and the effect of 
metal ion deficiencies or excesses on the distribution 
of these and other metal ions among complexing species, 
could be estimated. The effect of variations in 
concentrations of the complex-forming species could be 
calculated. The use of metal-chelating agents, such as 
penicillamine or 2,3-dimercaptopropanol, which are 
intended to remove or lower the concentrations of 
undesirable cations, can be examined. It should be 
pointed out, however, that true equilibrium in a 
biological system occurs only at death although pseudo-
equilibria exist so that the most efficient conversion 
of food into energy may be obtained. The calculation 
of equilibrium concentrations in a model for biological 
systems is thus a valid approximation. 
The aims of the present study were twofold; 
(1) The stability constant values of biologically 
impo tan metals and ligands were determined under 
conditions prevailing in blood plasma. 
3 
(2) These stability constants were used to make a 
quantitative study of the dynamic equilibria that exist 
in multi-metal - multi-ligand mixtures considered as 
models for biological systems. A computer programme 
COMICS 3 developed in this laboratory was used for this 
purpose . 
1.1 Previous studies of multiple equilibria in chemical 
and biological systemse 
There has been much discussion about the stability 
of individual metal complexes and stability constant 
sequences such as that of Irving and Williams 4 , 5 are 
well known . Until recently, however, there has been 
little progress in the quantitative treatment of multiple 
equilibria involving metal complex formation. 
6 Orgel made an essentially "informed guess" about 
the binding of metal ions in protein-containing solutions . 
He suggested that magnesium(II) prefers carboxylate 
whereas zinc(II) has a fairly high affinity for amine and 
-SH groups Williams 7 has also discussed, qualitatively ~, 
the "most likely coordination partner for a given cation 
at pH 7 . 3" in a system in which there is an excess of 
every type of organic ligand competing for a limited 
concentration of cations . 
4 
The competit'on of amino acids fo r copper(II) . ions 
in human serum was studied recently by Neumann and 
Sass-Kortsak. 8 Histidine competed most effectively for 
the b inding of copper(II), followed by glutamine, 
threonine, cystine, and the other amino acids. 
Attempts to interpret multiple equilibria had to 
await the advent of electronic computers with sufficient 
"memory" and able to be programmed to solve many 
simu taneous equations. The earliest computer applications 
to equilibrium studies were concerned with gas mixtures . 9 
Villars lO described a method of successive approximations 
for comput_ing combustion equilibria in which only one 
reaction at a time was considered. The free energy of a 
system (obtained by using chemical potentials) has been 
used to determine equilibrium compositions in complex 
. 11,12 d 13 h d h h 'l'b . mixtures . An eregg s owe ow t e equi i rium 
concentrations of all species in a mixture of one metal 
ion and one ligand could be computed from the total 
metal ion and total ligand concentrations, pH, pK, and 
stability constan values. An iterative process was 
used. The spec·es can include protonated, hydrolysed 
or polynuclear metal complexes, hydrolysed metal ions, 
and protonated ligands. The programme described by 
Ropars and Viovy 14 extended the possible range of systems 
5 
to include one kind of metal ion and two different 
complexing agents able to form mixed complexes. It was 
based on the Newton-Raphson 15 method of successive 
approximat ' ons to solve the mathematical equations 
obtained from material-balance sums, electroneutrality, 
and the equilibrium constant relationships. Supplementary 
information enabled the stability constant of a mixed-
ligand complex to be computed. 16 
Bard and King 17 published a programme which they 
applied to the ionisation of a polybasic acid and to 
equilibria in a system of one metal ion and two kinds of 
ligands ~ The programme was used to solve n algebraic 
equations inn unknowns by first guessing values for two 
of the variables and then using them to evaluate the 
others, in turn, from n-2 equations. All but one of the 
constants were used in the last two equations to evaluate 
the remaining constant and, if the two estimates did not 
agree, the first constant was increased or decreased . 
The process was continued until adequate agreement was 
reached. Improvements to this programme were subsequently 
18 
suggested. 
6 
Botts, Chashin and Schmidt 19 described a programme 
which computed equilibrium concentrations in systems 
containing two kinds of metal ions and two kinds of ligands. 
A more general programme had been developed by this 
time in this laboratory in which multi-metal - multi-ligand 
mixtures of simple complexes of the type MLn were 
'd d 20 consi ere. This programme was later modified to give 
an entir ely general treatment of equilibria in a single 
phase, such as a solution or a gas, and the system can 
contain such species as mixed-ligand, hydrolysed, 
protonated, polynuclear or mononuclear metal complexes, 
protonated ligands, and hydrolysed metal ions. 3 The 
programme, COMICS, required the total concentration of 
each metal and each complexing agent, the relevant 
equilibrium constants (pKa values and stability constants), 
and the pH of the solution. It then calculates the free 
ligand and the free metal concentrations by an iterative 
method which begins by assuming that complex formation 
is negligible. The iteration ceases when the calculated 
total metal ion and calculated total ligand concentrations 
differ from actual concentrations by less than a specified 
quantity. The equilibrium concentrations of all species 
a e then calculated and p inted in tabular form. 
21 The programme HALTAFALL extends the possibilities 
to systems containing more than one phase. It calculates 
equilibrium concentrations of all species in mixtures of 
any number of components, which can include solid phases, 
provided equilibrium constants and gross composition are 
7 
known. The form t he progranune takes depends on the nature 
of the input, but examples have been described for one 
fluid phase, two fluid phases (two liquids or a gas and a 
liquid), and fluids with solid phases present. 21 
1.2 The use of COMICS 
COMICS is an acronym for Concentrations of Metal 
Ions and Complexing Species, and is the name of a 
computer programme which calculates equilibrium 
concentrations of all species in a multi-metal - multi-
ligand mixture. 3 It was used in the present work to 
study equilibria in systems considered as models for 
blood plasma. The composition of the blood is variable 
and reflects changes in diet, time since ingestion of 
food, stress, age, and other factors. Average values 
have, however, been determined and some typical plasma 
composition data are given in Table 1 . 01. 
The stability constants and ionisation constants 
used in COMICS must be those measured under conditions 
prevai l ing in blood plasma in vivo (37 ° C and 0.15M in 
NaCl). A great many constants have been determined 
previously 22 but conditions and methods have varied 
and thus all the constants have been re-determined at 
37 °C and O. lSM. The background salt used i n each case 
8 
Table 1.01 
Typical Plasma Composition Data. 
L-alanine 
L-arginine 
Chloride ion 
Citric acid · 
L-cysteine 
L-cystine 
Glucose 
L-glutamic acid 
L-glutamine 
Glycine 
L-histidine 
L-isoleucine 
L- leucine 
L-Methionine 
L-ornithine 
Phosphate 
L-proline 
L-serine 
L-threonine 
L-tryptophan 
L-valine 
Copper 
Iron 
Manganese 
Potassium 
Sodium 
Zinc 
-4 Cone . (M) xl 0 
3.83 
0.93 
1010.00 
1.30 
0.33 
0.42 
54.00 
0.48 
5.68 
2.05 
0.74 
0.68 
1.29 
0.26 
0.55 
10.70 
2.05 
1.07 
1.17 
0.54 
2.46 
0.011 
0.23 
0.007 
41.00 
1410.00 
0.46 
Albumin 
Globulin 
3.5-4.9g/100ml. 
2.6g/100ml. 
Ref. 
123 
124 
124 
124 
125 
125 
124 
123 
126 
123 
123,124 
123 
123 
123 
123 
124 
123 
123 
123 
127 
123 
128 
124 
124 
124 
124 
129 
124 
124 
9 
was potassium nitrate although sodium chloride 
predominates in human plasma. This simplification 
was made to avoid possible competitive complex 
formation between Cl and the amino acids for the 
metal ions. A suitable correction can be made when 
reliable data for metal ion-chloride complex formation 
are available. This correction is expected to be 
small and probably negligible. 
The pH of blood plasma was taken to be 7.4. 
1.3 Factors affecting the stability of a complex. 
It is worthwhile discussing at this point the 
factors which affect the stability of metal complexes. 
Metal classification. 
Ahrland, Chatt, and Davies 23 have divided metals 
into two broad classes, class (a) and class (b). 
Those metals which form their most stable complexes 
with ligands of the first row of the Periodic Table 
(N,O,F) are placed in class (a), and those which form 
stronger complexes with ligands in the second (P,S,Cl) 
or a subsequent row, are termed class (b). Their 
classification is shown in Fig. 1.01. Class (b) metals 
form a roughly triangular group at the centre of the 
Table, and the boundary between the classes is diffuse. 
10 
Class {a) 
1 Lanthanides 
2 Actinides 
~ Class {b) ~ 
Figure 1.01 
Border region 
Classification of acceptor ions in the Periodic Table. 
He 
Kr 
Xe 
Rn 
~ 
f,-1 
f,-1 
Metals at the centre of the group show (b) character 
only in their lower oxidation states, while metals to 
the right of the group show some (b) character even 
in their higher oxidation states. 
Pearson 24 has extended the classification of 
Ahrland et al., pointing out that metals and ligands 
could be regarded as Lewis acids and bases. Class (a) 
metals may be regarded as "hard" (i.e. non-polarisable), 
and prefer to bind to hard bases. Class (b) metals are 
"soft" and prefer to bind to soft bases. These 
observations may be explained in terms of the theories 
of ionic and covalent bonding, n-bonding, electron 
correlation effects, and the nature of the solvent 
(if any). These various factors contribute to different 
extents, depending on the example considered. Williams 
and Hale 25 felt that use of the terms "hard" and "soft" 
might be confusing as class (a) and class (b) behaviour 
cannot be fully explained on this basis. 
26 Craig and Nyholm discussed the formation of 
metal halide complexes in terms of the ionisation 
potential of the metal, the electron affinity of the 
anion, the loss of hydration energy of the two ions, and 
the energy involved in bringing together the two ions 
from infinity. They found that the division into class (a) 
or class (b) depended largely on the ionisation potential 
I 
12 
of the metal, the high ionisation potent ial o f the 
class (b) metals reflecting the high polarising power 
of these acceptors, and their ability to fo r m c ovalent 
bonds. This model, however, takes no account of the 
ability of many metals of pronounced (b) c harac ter to 
donate electrons back to the ligand in the for matio n 
of a TI bond (as is found in the coordination o f c 2H4 , 
CO etc.). This factor was regarded as being very 
important by Ahrland et al. 
Thus, class (a) metal ions, for example ma nganese 
and calcium, form their most stable compl e xes with 
ligands such as polycarboxylic acids, whereas clas s (b) 
metal ions, for example mercury, favour compl e x f o rmation 
with sulphur containing ligands, rather than oxygen 
containing ligands. 
Irving-Williams order. 
The complex-forming abilities of t he transition 
metal ions are frequently characterised by s tability 
orders. The stability order established by Irving and 
Williams 4 , 5 is important because it i s valid for most 
nitrogen and oxygen donor ligands, irrespec t ive of the 
nature of the ligand. The order 
Mn 2+ < Fe 2+ < co 2+ < Ni 2+ < cu 2+ > zn 2+ 
was rationalized on the basis of the i onic r a dius and 
13 
the second ionisation potential of the metal ion. 
According to the crystal field theory, the Irving-
Williams order is a consequence of crystal field 
t b 'l' t' 27,28 s a i isa ion. For all config_urations other then 
the splitting of the d electron levels by the electrical 
field of the ligand lowers the total energy of the 
system. This decrease in energy is termed the crystal 
field stabilisation energy (CFSE). No stabilisation 
occurs in the case of Mn 2+ (in the absence of spin-
· · ) d 2+ 1 d pairing an Zn comp exes an 
maximum value for Ni 2+ and cu2+ 
the stabilisation has a 
complexes. An estimate 
of the crystal field stabilisation energy can be obtained 
from spectroscopic data. For many systems, these values 
are in good agreement with the energy values derived 
from the deviation of the experimentally found stability 
constants from the values obtained by linear interpolation 
2+ 2+ between the Mn and Zn complexes. 
The Irving-Williams series is valid for comparisons 
only of high-spin complexes. In strong ligand fields, 
for example CN and SCN, spin pairing occurs with the 
formation of low-spin complexes. An example of this is 
the tris o-phenanthroline complex of iron(II) which is 
low-spin and has an anomalously high stability and does 
not, therefore, conform to the Irving-Williams order. 
14 
Stereochemistry. 
The number of groups disposed around a metal ion 
and the stereochemistry of the resulting complexes are 
important factors in determining the stability and 
reactivity of metal complexes. The common 
stereochemistries of metal ions are established. 29 
For example, cobalt(II) favours tetrahedral, and 
nickel(II) square planar, configuration when they are 
four coordinate but they can also form octahedral 
complexes. Copper(II) shows four coordination, forming 
square planar complexes, but it can also form distorted 
octahedral structures with four short bonds and two 
long (weaker) bonds, which, in the limit, pass into 
square planar. 
The additional stability conferred on metal 
complexes by chelate ring formation is well known. For 
Cu(NH 3 )~+ the overall stability constant is 10
12
·
6
, 
whereas for the corresponding bisethylenediamine 
copper(II) species, the constant is 10 20 · 0 . 
With ter- and multidentate ligands, steric 
considerations, as well as chelation, are of major 
importance. The more bonding sites available from the 
ligand, and the closer they can accommodate themselves 
to the preferred stereochemistry of the metal ion, the 
15 
• 
stronger will be the resulting complex. This is 
demonstrated by the fact that the copper complex 
with triethylenetetramine(I) 
NH 2CH 2CH 2~ CH2CH 2NH 2 
CH2CH2NH 2 
. . . • . . • . • • . . • . I 
............. II 
16 
has a higher stability constant than the copper complex 
with triaminotriethylamine(II), whereas for the cobalt(II) 
complexes the reverse is true. The amino groups of 
triethylenetetramine fit readily into a planar arrangement, 
but triaminotriethylamine is better suited to tetrahedral 
or octahedral complex formation. 
In the extreme case of an ion like Ag+ that usually 
forms linear complexes, its complexes with multidentate 
ligands such as EDTA are relatively much less stable than 
the complexes of most other metal ions which commonly 
have coordination numbers of four to six. 
1.4 Essential metal ions in the mammalian body. 
In seeking to apply the COMICS approach to a 
biological system for the first time, it is important 
to consider the nature and functions of the metal ions 
in the system and also the factors that govern the 
stability of their complexes (discussed above). 
The major functions of sodium and potassium in the 
body are the maintenance of the osmotic pressure of the 
body fluid and the regulation of acid-base equilibria. 
Sodium is the main cation in the extracellular fluid 
whereas potassium, although found in the extracellular 
fluid, is the main cation in the intracellular fluid. 30 
Calcium and magnesium are mainly found in bone but the 
small concentration of calcium in the body fluid is 
important in blood coagulation, in the function of the 
heart, muscles and nerves, and in the permeability of 
the membranes. 30 
The less abundant metal ions, on the other hand, 
are concerned almost entirely at the metabolic level 
and exert little, if any, effect as purely ionic species. 
Thus iron in the body exerts its effect almost entirely 
in processes of cellular respiration. It is present 
as an essential component of haemoglobin, myoglobin, 
t h d h 1 d 'd 30 cy oc rome, an t e enzymes cata ase an peroxi ase. 
Iron is bound to protein in its storage and transport 
forms. Inadequate intake or absorption of iron can lead 
to iron deficiency and anaemia, whereas excessive 
accumulation can also occur, leading to haemochromatosis, 
in which the skin and viscera become bronzed with 
haemosiderin and haemofusein. (This occurs, for example, 
17 
among the Bantu of Africa who have a low phosphate diet 
30 
and a high iron intake from iron cooking pots.) Iron 
is rapidly bound in blood and relatively little is 
readily exchangeable. 
Blood serum contains about 114µg/100ml copper, 31 
which is present in two different fractions, a "direct-
reacting" component that is readily removed by dialysis 
against solutions of complexing agents, and the greater 
fraction in which the copper is bound in the protein 
caeruloplasmin, an alpha globulin of molecular weight 
around 151,000 containing perhaps 8 atoms of copper 
per molecule. Similarly, copper-containing proteins 
haemocuprein (erythrocuprein) and cerebrocuprein are 
present in red blood cells and human brain, 32 
respectively, whilst haemocyanin is a copper-protein 
complex in the blood of certain invertebrates where 
it functions as an oxygen carrier like haemoglobin. 
Copper is necessary for the synthesis of haemoglobin 
and for the activity of a number of enzymes including 
cytochrome oxidase, catalase, tyrosinase, monoamine 
oxidase, ascorbic acid oxidase, and uricase. 30 
The functions of manganese are not known but, . ~n 
vitro, manganese activates several enzymes including 
blood- and bone-phosphatases, yeast-, intestine- and 
liver- phosphatases, arginase, carboxylase, cozymase, 
18 
• 
and cholinesterase. The intracellular respiratory 
enzyme systems are associated with the mitochondria 
and a correlation was found 33 between the 
mitochrondrial content of a given organ and its 
ability to concentrate manganese. Manganese may, 
therefore, be a co-enzyme for the intracellular 
respiratory enzymes. 
Manganese deficiency in experimental animals 
mainly affects three systems: bone, reproduction, 
d b . 34-36 h t. . t f . . d d . an rain. Te ac ivi yo arginase is re uce in 
the livers of manganese deficient mammals and the 
activity of blood- and bone- phosphatase is depressed 
in chicks with perosis (slipped tendon). Since 
manganese is a cofactor in these enzymes, these 
results could have been predicted. Manganese deficiency 
has not been demonstrated in man. 37 
Cobalt is a constituent of vitamin B12 and is 
implicated in blood formation. Vitamin B12 is 
synthesised by microorganisms but not by higher plants 
38 
or animals. It has been suggested that disorders 
in man may occur due to defective transport mechanisms 
of cobalt but the idea is unproven. Cobalt is a 
necessary supplement to the milk diet of anaemic dogs. 39 
Deficiency diseases (characterised by poor growth, 
emaciation, and anaemia) of cattle and sheep in cobalt 
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deficient areas are well known. 36 Cobalt salts have 
caused goitre in children (although not in adults) 
and vasodilation, with flushing, has been described 
after injecting cobalt salts. 40 The latter effect 
has been used to reduce blood pressure in hypertensive 
t . t 41 pa ien s. 
Zinc is a structural and functional component of 
the enzyme carboxypeptidase, and it participates 
42 directly in the catalytic action of the enzyme. 
It is also closely associated with several other 
enzymes, including carbonic anhydrase and alcohol 
dehydrogenase. Chronic zinc deficiency has been 
reported in subjects exhibiting dwarfism and 
. 43 44 hypogonadism ' and was associated with depressed 
levels of zinc in plasma, red blood cells, hair, and 
sweat. 44145 These clinical findings have, however, 
b t . d 46 een ques ione. Conditioned zinc deficiency has been 
d . b d4 7 '48 . t. . h . h . f escri e in pa ients wit severe cirr osis o 
the liver and the condition was improved with the 
administration of zinc. 
The enzymes xanthine oxidase and liver aldehyde 
oxidase are flavoproteins and both contain molybdenum. 
Interrelationships exist between metal ions in 
the body. For example, copper facilitates the absorption 
of iron from the gastrointestinal tract and copper 
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deficiency may result in hypoferraemia. Molybdenum 
deficiency may promote copper toxicity in multigastric 
animals. On the other hand, excess molybdenum or 
sulphate in the diet may produce a copper deficiency, 
characterised by depigmentation and abnormal growth 
of hair, anaemia, depressed growth, bone disorders, 
gastrointestinal disorders, and impaired reproduction. 
It is suggested that the excess molybdenum may inhibit 
absorption of copper from the intestine. 
1.5 Abnormal trace metals and toxicity. 
A cadmium-containing protein has been isolated 
from equine renal cortex 49 and is known as 
metallothionein. Cadmium is almost invariably found 
naturally with zinc although it is considered a 
non-essential trace metal at present. 1 Cadmium 
toxicity to mammals is well established 50, 5l and it 
produces renal tubular damage, proteinur i a, low 
alkaline phosphatase activity, and excretion of 
muramidase and ribonuclease in man and rabbits. In 
Japan, the disease Itai Itai is the result of cadmium 
poisoning and the victims' bones become weak and 
brittle. 120 lives have been claimed by this disease 
. t 52 . . in twen y years. Acute "zinc" intoxication has been 
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repeatedly described in humans ingesting acidic fluids 
stored in galvanised iron containers, but the symptoms 
are identical with those of cadmium poisoning. Zinc 
53 
used in galvanised pails contains 1% cadmium or more 
and it is suggested that the so-called "zinc" toxicity 
. f t d . t . ' t 54 A 1 t' f is, in ac , ca mium oxici y. ccumu a ion o 
cadmium in the human kidney is a cause of arterial 
h · 55 H t . b . d d . t ypertension. yper ension can e in uce in ra s 
b h . . t. 56 t . . t . 57 f y c ronic inges ion or acu e inJec ion o 
small amounts of cadmium acetate and it can be cured 
chemically by replacing some of the cadmium by zinc. 58 
Excessive doses of zinc retard the growth of rats 
and caused hypochromic anaemia. 36 
Nickel is present in the intestine, lung, and 
some metabolically active tissues and there has been 
some discussion 59 as to whether it may have a 
physiological role, possibly connected with 
pigmentation. 60 The toxicity of nickel for mammals 
is low, ranking with the essential metals and with 
h . t' b . d ·1 61 c romiurn, in, arium, an si ver. Nickel salts 
exert their action mainly by gastrointestinal 
. . t t. d t b . h t t . ' t 36 ' 62 I irri a ion an no yin eren oxici y. n 
nickel refineries, respiratory tract neoplasia is 
fairly common among exposed workers and nickel 
59 dermatitis is common. Nickel carbonyl has been 
22 
implicated but toxicity of the carbonyl does not 
indicate toxicity of the metal ion. 63 A recent report 
on nickel toxicity in young mice showed that addition 
of nickel to the diet caused reduction in body weight 
and a reduction in the activity of liver cytochrome 
oxidase, isocitric dehydrogenase, kidney malic 
dehydrogenase, heart cytochrome oxidase, and malic 
dehydrogenase. 
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Copper toxicity in sheep and cattle is well known 36 , 64 
but monogastric animals appear to have a higher 
· t 6 5 C t · · t 1 · humans 6 6 resis ance. opper oxici y rare y occurs in 
and only one hereditary abnormality, hepatolenticular 
degeneration (Wilson's disease), is known. 67 The 
total serum copper in patients with Wilson's disease 
may appear normal or only slightly reduced but the 
level of caeruloplasmin is low. As a result, there 
is a quantity of "unattached" copper which is free 
to combine in an abnormal manner with the proteins 
of the brain or liver. Excessive excretion of copper 
in the urine also occurs. The formation of 
erythrocuprein in Wilson's disease appears to be 
d 1 d 68,69 e aye. 
Lead is a cumulative poison so that its toxicity 
is a function of both the magnitude of the dose and 
its rate of administration. Lead poisoning is most 
apparent in children, the commonest source of lead 
being the flaking paint in old, poorly maintained 
properties . 70171 Atmospheric pollution by lead is 
caused by lead tetraethyl in petrol, 72 and lead 
smelting. 73 Water can be contaminated by standing 
in pipes or tanks made of lead or of copper with 
lead solder. 74 Radioactive lead is continuously 
deposited at the earth's surface as part of the 
natural fallout although it is increased after 
atmospheric nuclear detonations. 75 Because the 
body does not distinguish between radioactive and 
stable lead, radioactive lead tends to accumulate 
in the bones. 76 
In normal humans exposed to normal concentrations 
of lead, at least 90% of the ingested lead is not 
absorbed and the faecal lead is an index of ingested 
lead. Lead from the gut enters the circulation and 
95% passes into the erythrocytes. In vitro studies 
with radioactive lead have shown that lead is not 
absorbed onto the cell membrane but that equilibrium 
between the p l asma and erythrocyte lead is attained 
within fifteen minutes. Potassium leakage has been 
77 demonstrated from erythrocytes exposed to lead. 
Subsequently, lead is deposited in certain tissues, 
the liver and kidneys initially and the bone finally . 
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Brain and skeletal muscle show minimal lead-binding 
. 70 properties. 
Mercury is extremely toxic because it forms ver y 
stable complexes with thiol groups which occur in 
cysteine, glutathione, and many sulphur-containing 
enzymes. It affects the central nervous system so 
that sufferers become paralysed, mentally deranged, 
or develop speech defects. . . Mercury poisoning, 
causing 42 deaths in 1953 and 12 in 1965, was reported 
52 in Japan and the origin of the pollution was traced 
to the abnormal presence of mercury alkyls in the 
untreated effluents of the chemical industry. Workers 
exposed to mercury showed degrees of tolerance 
dependent on their exposure, no correlation being 
found between symptoms of mercury poisoning and 
78 
urinary mercury level. A great deal of work has 
been carried out to test the effect of various 
. 79-82 
mercury compounds on animals. Alkyl mercury 
compounds were excreted more slowly and were retained 
in higher concentrations for a longer time i n the 
body than were mercury(II) chloride and phenylmercury 
chloride. The metabolic behaviour of some mercury 
compounds depended on the carbon chain length of the 
81 
alkyl group. 
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The effect of mercury on the red blood cells has 
been investigated in detail 83 - 86 and, like lead, it 
affects the sodium-potassium balance in the cell. It 
+ 
causes a considerable prehaemolytic loss of K from 
the red cell, the net efflux proceeding rapidly to 
'l'b . 1 t' h' 83 an equi i rium re a ions ip. 
1.6 Chelation therapy. 
Metal ions are thus important in biological 
systems and the disorders caused by their excesses 
may sometimes be treated with specially designed 
87 
chelating agents. Ligands which are highly specific 
under biological conditions have not been developed but 
several useful compounds are available. Some drugs, 
not used intentionally as metal-binding agents, may 
actually exert their fundamental effect through an 
tt h t t t 1 . . 88 a ac men o a me a ~n v ~vo. Conversely, 
pharmacological effects of metal-binding drugs occur 
which are not necessarily attributable to metal-
binding. 
The most common chelating agents used are 
2,3-dimercaptopropanol (British anti-Lewisite), sodium 
and calcium salts of ethylenediamine tetraacetic acid 
(EDTA), D-penicillamine, and desferrioxamine-B. 
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2,3-Dimercaptopropanol (dimercaprol) 
. d . . 89-91 treat arsenic an mercury poisoning. 
is used to 
It has some 
undesirable side effects and administration must begin 
within 18 hours of poisoning if maximum prevention of 
neuropathology is to be obtained. 92 The heavy metal 
chelates of dimercaprol are stored or excreted as 
such without influence on electrolyte or trace metal 
balance. Dimercaprol is not effective in the treatment 
of lead, cadmium, and thallium poisoning and its use 
may be hazardous because it shifts these metals about 
in the body. 93 - 95 Unithiol (sodium 2,3-dimercapto-
propane-l-sulphonate) has also been used in the 
t t t f . d . . t . t. 96 rea men o arsenic an mercury in oxica ion. 
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EDTA has been widely used in medicine and the 
toxicities of various metal ions and their EDTA chelates 
have been studied in mice. 97 The chelates of nickel(II), 
cobalt(II), lead(II), manganese(II), zinc(II), chromium(II), 
calcium(II), and cadmium(II) are less toxic than the 
ions themselves, whereas the chelates of iron(II) and 
iron(III) have the same toxicity and those of copper(II), 
mercury(II), and aluminium(II) are more toxic than the 
ions alone. EDTA is well established in its use for the 
t t t f 1 d . . 98 rea men o ea poisoning. Experiments with 210 Pb 
have shown that the lead withdrawn by EDTA comes mainly 
from the bone. 99 The soft-tissue lead declines as it 
is redistributed to the bone. EDTA is not metabolised 
by the body and the EDTA chelate of the toxic metal 
is excreted, mixed with the calcium, magnesium, or 
zinc complexes of EDTA. 
When intravenous infusion of an EDTA salt is used 
to treat a number of diseases, pyridoxine deficiency 
commonly develops. This may be related to zinc 
depletion. 100 Oral administration of the calcium salt 
of EDTA can be catastrophic because the iron chelate 
(which is formed in large quantities) appears to 
overwhelm the intestinal barrier to iron absorption 
and more iron reaches the liver than would have been 
the case in the absence of the EDTA. 101 Oral calcium 
EDTA has, however, been reported to be effective in 
the treatment of lead-induced porphyria. 102 
Diethylenetriamine pentaacetic acid was found 
ff t . . 1 d . . 103 d 1 d . . . e ec ive in ea poisoning an ora a ministration 
of the drug augments the faecal excretion of copper 
patients with Wilson's disease over that caused by 
penicillamine alone. 104 · 
Only the D-isomer of penicillamine is used for 
therapeutic purposes because the L- or the DL-isomer 
can produce serious effects, mainly due to the anti-
vitamin B6 properties of the L-isomer.
105 The primary 
use of the drug is for the removal of copper from 
28 
patients suffering from Wilson's disease. 106 Although 
copper is removed at 100 times the normal rate by 
· · 11 . l O 7 1 f th b 11 D-penici amine, on y some o ea norma y 
deposited copper is lost because plasma caeruloplasmin 
formation is unaffected 108 as is the copper used 
. h. f t' 109 in air orma ion. No significant change in iron 
balance was found in 10 patients with Wilson's disease 
who were treated with D-penicillamine. It sometimes, 
however, causes side effects such as fever, urticarial 
reactions, and abdominal pain, and alternatives such 
as 2,3-dimercaptopropanol must then be used for the 
treatment of Wilson's disease. 106 Recently, 
triethylenetetramine dihydrochloride llO and L-dopa 111 
(S-(3,4-dihydroxyphenyl)-L-alanine) have been applied 
to treat patients with Wilson's disease who did not 
continue to improve with D-penicillamine therapy. 
Both treatments were reasonably successful. 
D-penicillamine is also the recommended treatment 
for lead poisoning. 112 The metabolically active lead 
is rapidly chelated and the urinary delta-aminolaevulinic 
acid output is reduced to normal within a few days. 
Oral penicillamine is slightly less effective than 
penicillamine given intravenously which in turn is only 
slightly less effective than the calcium sodium salt of 
EDTA, if both drugs are given in the same dosage, while 
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at the same time avoiding the undesirable mineral 
depletion effects associated with the latter. It is 
not known whether the two drugs act on different lead 
pools in the body. 
In the body, D-penicillamine can be metabolised 
to tetramethylcystine(oxidised penicillamine) which is 
still a powerful chelating agent. It has been 
suggested 113 that the use of D-penicillamine in the 
treatment of cystinuria (in which urinary tract stones 
of cystine are formed) depends upon its oxidation to 
form the mixed cysteine-penicillamine disulphide 
(3,3-dimethylcystine). 
Desferrioxamine B. Iron chelating agents occur 
naturally in certain microorganisms, and an iron 
chelate, ferrioxamine B, was isolated in 1960 from 
St t · ~ 114 d b tl th . d 115 rep omyces p~vosus , an su sequen y syn esize . 
Other ferrioxamines, or sideramines, are a l so known, 
occuring only i n bacteria, where it is thoughtthat they 
play a fundamental role in the enzymic incorporation 
of iron into the porphyrin skeleton. All of the 
sideramines have three hydroxamic acid groups as iron-
binding centres, so that the central ion is held in a 
six-coordinate structure . The desferrioxamines derived 
from them when the iron is removed by acid treatment 
have a powerful chelating ability for iron(III) but 
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only a relatively weak affinity for most other cations, 
including iron(II). Despite its avidity for iron(III), 
desferrioxamine cannot withdraw the porphyrin iron. 
In idiopathic haemochromatosis, excessive amounts 
of iron are absorbed and stored in the liver, spleen, 
and other organs. Attempts to maintain a low-iron 
diet, for example by the use of EDTA, can lead to 
deficiencies of other cations. Desferrioxamine 
however, when taken orally, largely blocks the 
b t . f . f th l' t 1 116 F a sorp ion o iron rom ea imen ary cana. or 
the depletion of iron deposits within the body, 
desferrioxamine is given by intramuscular injection 
b . t d . 116 or yin ravenous rip. Slow addition of 
desferrioxamine to the bloodstream is desirable if 
the formation of toxic concentrations of ferrioxamine 
is t b . d d 117 '118 t . b . . d f . t o e avoi e, ime eing require or i 
to be excreted through the kidney. 
A similar therapy is applied to the treatment of 
acute iron poisoning, namely dosage with desferrioxamine, 
orally, to prevent further uptake of iron, coupled with 
intravenous injection to mask iron already absorbed. 
Some recent examples of the use of desferrioxamine in the 
31 
t t t f . . . . . h f 119-122 rea men o iron poisoning are given int ere erences. 
CHAPTER II 
CHEMICAL ASPECTS OF THE MODEL SYSTEMS 
2.1 Ligands and metal ions studied. 
The stability constants of some amino acids with 
copper(II) and zinc(II) had already been determined 
in this department. 130 - 132 With this in mind, 
copper(II) and zinc(II) with L-leucine, L-isoleucine, 
L-ornithine hydrochloride, and L-arginine were 
studied. In addition, as a start to toxicity studies, 
complex formation between manganese(II), cobalt(II), 
nickel(II), cadmium(II), lead(Il), and mercury(II) 
with some of the amino acids, glycine, L-leucine, 
L-isoleucine, L-ornithine hydrochloride, L-arginine, 
L-methionine, and L-cysteine, was examined. The 
therapeutic effect of D-penicillamine is well 
established 87 and its stability constants with 
lead(II), mercury(II), and cadmium(II) were determined. 
The study of the complex formation between glutathione 
and N-(2-mercaptopropionyl)glycine with zinc(II), 
cadmiurn(II), lead(II), and mercury(II) was the 
beginning of the next stage in the COMICS approach, 
the consideration of peptide interactions with metal 
ions. 
32 
The mixed-ligand complex formation between 
nickel(II) and L-cystine and glycine (or L-leucine), 
and L-cysteine and glycine (or L-leucine), was examined. 
The formulae of the ligands are shown in 
Figure 2.01. 
FIGURE 2. 01 
Formulae of ligands studied 
glycine leucine 
isoleucine ornithine 
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-
HS.CH 2 .CH.COO I 
+NH3 
cysteine 
H C +NH3 
3 \ I 
;f·CH.COO 
H3C SH 
penicillamine 
arginine 
-fS.CH 2 .IH.COO ) 2 
+NH3 
cystine 
methionine 
N-(2-mercaptopropionyl)glycine 
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glutathione (H3L) 
2.2 Historical review. 
a) Introduction. 
Previous results for the systems discussed in 
section 2.1 are summarised in Tables 2.01-2.09. 
The notation and conventions are those used in the 
22 Stability Constant Tables (paper electrophoresis 
is abbreviated to p.e). 
Many methods have been used for the determination 
of stability constants. Initially, it was customary 
to assume that stepwise complex formation of ML, ML 2 , 
and perhaps ML 3 , provided adequate representation. 
On a relatively unsophisticated basis, relationships 
were readily devised between the observed properties 
of solutions, such as spectral shifts, proton 
displacement, or movement of polarographic steps, 
that enabled these constants to be obtained. In 
particular, Bjerrum deduced certain simple relationships 
involving the formation function, n, and the stepwise 
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formation constants, K1 and K2 , on the assumption t hat 
K >>K 201 Subsequently, it has become obvious that 
-1 -2· 
these treatments are frequently gross over-
simplifications and some early stability constant 
determinations are of little value. 
b) Previous work on ligands bonding through nitrogen 
and oxygen. 
Chelation of amino acids with metal ions was 
usually assumed to take place through the amino 
143,158,168-9,190 
nitrogen and the carboxyl oxygen. 
In some cases, for example, nickel(II) and 
L-ornithine, it was suggested that chelation occured 
via the two nitrogen atoms giving a seven-membered 
Chelate rl.'ng.168,171 Th ·t· 1 h d t . 1 e pos1. 1.ve y-c arge erm1.na 
groups of lysine, arginine, and ornithine reduced 
the stability constants of their metal complexes 
because of the electrostatic interactions between 
the cation and the terminal groups. 143 , 168 - 9 
There have been few attempts to determine the 
effect of temperature on pK sand stability constants. 
-a 
Exceptions include studies on glycine stability 
Constants 137, 146-7, 152, 155-6 d th d ' · t ' an on e 1.ssoc1.a 1.on 
172 
constants of arginine and its metal complexes. 
These values were useful for comparison with the present 
work. 
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Variations in the reported stability constant 
values are often large, possibly casting doubt on 
the methods used. For example, the electrophoretic 
method for the determination of the stability 
constants of glycine and leucine complexes yielded 
consistently higher results. 140 
Recently, Clarke and Martell 171 published the 
stability constants of divalent calcium, cobalt, 
copper, mercury, magnesium, manganese, nickel, and 
zinc with arginine, ornithine, and citrulline. They 
distinguished, for the first time, between the fully 
dissociated ligand and the monoprotonated ligand 
which is responsible for most of the complex 
formation. Clarke and Martell assigned the highest 
pK of arginine to the guanidine group, but suggested 
-a 
that the high pK of the ornithine could be attributed 
-a 
to either the alpha-amino nitrogen or the terminal 
amino group, the latter being more likely. 
Chelation by methionine normally occurs via the 
amino nitrogen and the carboxyl oxygen but a recent 
· t· 202 d f 1 d ' h conununica ion suggeste rom H nmr stu 1es tat 
mercury(II) formed stable labile complexes in which 
mercury(II)-thio-ether bonding occured. The complex 
I was present in lM HN0 3 whereas the expected chelate II 
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I 
II 
occured when the carboxyl and the amino groups 
ionised. The binding of Hg 2+ to an isolated thio-
ether group could be of importance in suggesting 
an additional manner in which mercury(II) could 
bind in a protein chain. 
Although the structures of complexes in the 
solid state and in solution are not necessarily 
similar, X-ray structure determinations may be used 
to support stability constant determinations. 
Freeman 203 summarised the structures of the glycine 
complexes of nickel(II), copper(II), cadmium(II), 
and zinc(II). The bis-glycinato-copper(II) complex 
38 
was a distorted octahedron with the fifth position 
occupied by a water molecule and the sixth by the 
b 1 f d . l . 204 h car oxy oxygen o an a Jacent g ycine . Te 
1:2 cadmium(II)-glycine was stacked in the crystal 
so that the uncoordinated carboxyl oxygen of each 
glycine was in the octahedral coordination position 
of an adjacent cadmium atom. The structure of the 
zinc(II) complex was similar. Nickel(II) complexes 
of amino acids and peptides had octahedral symmetry 
at low pH whereas, at high pH, the complexes of the 
glycyl peptides with three or more residues had 
1 d . . ·20s square p anar coor ination. 
The absorption spectra and circular dichroism 
of nickel(II) complexes with alanine, serine, 
valine, arginine, ornithine, and glutamic acid 
were consistent with the formation of the 1:1, 1:2 
but not the 1:3 chelates. 206 Contrary to the 
207 
suggestion by Brubaker and Busch, no evidence was 
obtained for the participation of the terminal ami no 
group in chelation . 
c) Previous work on ligands bonding through sulphur . 
Most of the previous work on ligands bondi ng 
through sulphur, for example, cysteine and 
penicillamine, has tacitly assumed that onl y complexes 
39 
178 185 ML, ML 2 , and perhaps ML 3 , have been formed. ' 
The log K2 values reported by Kuchinskas and 
18 S f · · 11 . . th f Rosen or DL-pen1c1 amine wi a range o 
divalent metal ions were disputed by Lenz and 
Martell. 181 The latter claimed that the second 
buffer region of the titration curve corresponded 
to a composite of the free ligand and the 1:1 metal 
complex curves and not to the formation of the 1:2 
complex. From an examination of the formation curves, 
Lenz and Martell reported that whereas in complexes 
with cadmium(II), mercury(II), and lead(II), cysteine 
and penicillamine both appeared to be tridentate, the 
nickel(II), zinc(II), and cobalt(II) chelates appeared 
to be bidentate. 
The formation of the 1:3 complexes of nickel(II), 
183 
zinc(II), and lead(II) with L-cysteine was reported 
and this appears to be the only report of stability 
constants for these ML 3 complexes. However, 1:3 
nickel(Il)-cysteine complexes were known and it was 
161 
suggested that a 2:3 complex was formed. The 
latter conclusion is consistent with observations by 
182 Perrin and Sayce. From a study of the kinetics 
of the complexation of L-cysteine with cobalt(II) 
and nickel(II), it has been suggested that the complexes 
of cobalt are probably octahedral whereas those of 
40 
208 
nickel are square planar. 
Recently, Sugiura et al. studied the complex 
formation of cobalt(II), zinc(II), nickel(II), 
m~rcury(II), cadmium(II), and lead(II) with 
· · 11 · 186 d . d 1 · d 1 penici amine, an mixe - igan comp ex 
formation of metal ions and penicillamine with 
other sulphur containing ligands. 209 They reported 
two "macroscopic" pK values for penicillamine but 
pointed out that these cannot be simply assigned 
to the dissociation of the amino and the thiol 
groups. A scheme of ionisation equilibria involving 
microscopic constants was suggested, similar to 
that postulated for glutathione, and this concept 
is discussed below. The chelates of cobalt(II), 
nickel(II), and zinc(II) with penicillamine were 
bonded through the sulphur and nitrogen atoms and 
the carboxyl group did not take part in coordination. 
In the mercury(II), cadmium(II), and lead(II) 
chelates of penicillamine, bonding occured through 
sulphur, nitrogen, and oxygen atoms. 
Ligands of the type RS readily form polynuclear 
. 210-214 
complexes in aqueous solution. Examples 
include the complexes of mercaptoacetic acid with 
nickel and zinc, 2111212 2-mercaptoethylamine with 
. k l 215 d . . th . 216 nice, an cysteine wi zinc. Protonated 
41 
species could be predicted for cysteine and 
penicillamine and hydrolysed species may be important 
in lead and mercury systems. It was clearly desirable 
that some of the systems discussed above should be 
re-examined for the formation of polynuclear, 
protonated, and hydrolysed species. 
The quantitative study of metal-complex formation 
by glutathione (H 3L) presents difficulties because 
of the multiplicity of sites at which binding of the 
metal ion is possible. These comprise the thiol 
group, the two carboxyls, the amino group, and the 
two peptide linkages. Few stability constants have 
been reported for metal-glutathione complexes, and 
these have been obtained by making simplifying 
assumptions. 198 Li, Gawron, and Bascuas assumed 
that only two complexes, ML and ML 2 , were formed 
with divalent metal ions and suggested that in these 
complexes the metal ion was bonded to the ionised 
sulphur atom and the amino group. On this basis 
the value of log K1 for zinc~glutathione, obtained 
from pH titration measurements at 25°C and 
I= 0.15 (KN0 3), varied from 8.55 to 8.07 as n 
increased from 0.3 to 0.8. Log K2 was not calculated 
because values ranged from 5.13 to 3.04 as n varied 
f 1 1 t 1 4 . · 1 1 . d . 178 f d rom . o .. Simi ar y, Li an Manning oun 
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log K1 = 10.5 for cadmium-glutathione and 10.6 for 
lead-glutathione. 
Martin and Edsall 199 considered that divalent 
metal ions could be bound to glutathione either 
through the amino and carboxyl groups of the glutamyl 
residue or to the sulphydryl group of the cysteinyl 
residue with, possible, chelate formation through 
a peptide bond. They assumed that sulphur-bonding 
could be excluded in S-methylglutathione and that 
the bondi~g to the y~glutamyl residue would be 
equivalent in glutathione and in S-methylglutathione. 
On the basis of this assumption, stability constant 
values were assigned to the two types of complexes 
of zinc, nickel, cobalt, and manganese. 
From polarographic measurements, Stricks and 
184 Kolthoff concluded that mercury and glutathione 
form at least three types of compounds, HgL 2 , 
Hg 2L2 , and Hg 3L2 , in which the mercury is bound 
firmly as the mercaptide. In these complexes the 
amino group of the glutamyl residue can be protonated. 
Hence, five constants were needed for the species 
HgL 2 , namely log s2 values for the complexes in 
which neither, one, nor both of the amino groups 
were protonated and pK 
-a 
di-protonated complexes. 
values for the mono- and 
217 Kapoor, Doughty, and Gorin 
43 
studied competitive complex formation of glutathione 
and chloride ions with mercury, and estimated the 
pK values for the amino groups in the complex 
-a 
2-Hg(HL)2 and also the equilibrium constant for the 
2- 2-formation of Hg 2L2 from HgC1 2 and HgL 2 . 
200 Recently, Zegzhda, Zegzhda, and Shul'man 
prepared a series of silver-glutathione complexes, 
AgH 2L, Ag 2HL, and Ag 2H2L+, and determined their 
K 1 d t b ·1· t t t Ceci'l 218 had p va ues an s a ii y cons ans. 
-a 
earlier shown by potentiometric titration that 
glutathione forms a 1:1 silver mercaptide and also 
a soluble silver complex containing two equivalents 
of silver. 
A complication in these studies is the uncertainty 
as to the assignment of the two pK values which relate 
-a 
to the amino and the thiol groups. This is a general 
problem for aminothiols. 219 The numerically greater 
pK value has been assigned to the thiol group, 196 , 198 , 220 
-a 
221 222 180 to the amino group, ' and to a mixture of both ' 
1991223
-
6 
on the basis that the thiol and the protonated 
amino groups are acids of comparable strengths. This 
would make it necessary to formulate the ionisation 
of an aminothiol in terms of four microscopic constants. 
, 
44 
At 25°C and I= 0.15 (KN0 3 ), pK values for 
-a 
glutathione have been reported 198 as 3.59, 8.75 ±0.01 
( 8 . 7 4 ± 0 . 0 1 ) 19 9 and 9 . 6 5 ± 0 . 0 l ( 9 . 6 2 ± 0 . 0 2 ) . 19 9 (The 
value of pK = 9.12 given in reference 197 appears 
-al 
to be in error.) Martin and Edsall 199 believe that 
the equilibria in alkaline glutathione solutions 
are best represented by the four microconstants 
pkv - 8.92, pkx = 9.16, pky = 9.20, and pk
2 
= 9.44, 
where the subscripts are as shown in the scheme. 
These constants have been obtained from pKal and p~2 
of glutathione on the basis of the pK value of 
-a 
S-methylglutathione (9.20±0.02 at 25°C and I= 0.16) 199 
by assuming that the inductive effects of a methylthio 
and a thiol group are the same. These microconstants 
are reasonable. Thus, pk is close to the value 
-y 
(9.13, 227 9.28 228 ) t d f th 1 . repor e or e ana ogous amino 
group in glutamine. 
SH+ 
NH 3 
s 
NH+ 
3 
, 
45 
46 
Table 2.01 
Stability constants of complexes of glycine HL 
Metal Method Temp. ( 0 c) Medium Log of equilibrium constant Ref. 
Cd 2+ gl 25 +O Kl 4. 80, K2 4 .03 133 
gl 20 . 5 KN0 3 Kl 3.88, K2 3. 18, K3 1.92 
134 
gl 25 . 01 Kl 4 . 74, K2 3.86 135 
gl 20 . 01 Kl 4.5, 82 8.10 136, 190 
pol 25 . 15 83 9.94 137 
gl 25 . 1 KN0 3 Kl 4. 27, K2 4.46 
138 
pol 25 . 1 KN0 3 Kl 4. 65, K2 3.36 
138 
pol 30 1 82 = 9.80 139 
p.e 20 . 1 KN0 3 Kl 6.0, K2 3 . 9, K3 2. 6 
140 
pol 30 1.0 KN0 3 82 8.08, 83 9.78 
141 
K(Cd 2+ + 2L + OH - ~ CdL 20H-) 9 .2 7 
Co 2+ gl 25 +Q Kl 5 . 23, K2 4.02 142 
gl 20 . 5 KN0 3 Kl 4.61, K2 3. 75, K3 
2.56 134 
gl 25.15 . 15 KN0 3 Kl 4 . 65, K2 3 . 78, K3 2.38 
143 
gl 25 . 01 Kl 4.95, K2 3.99 144, 135 
H 25 +Q Kl 5. 02, K2 3. 9 7 133 
gl 26 . 15 Kl 4. 65, K2 3.78, K3 2.33 145 
gl 20 . 01 Kl 5.1, 82 8.9 136, 190 
H 0-:45 +() Kl (0) 5. 28, ( 15) 5. 14, (25) 5. 07, 146 
(35) 5 . 01, (45) 4 . 95 
K2 ( 0) 4. 23, (15) 4 .07 , (25) 4.97, 
( 35) 4. 90, (45) 4.82 
p.e 20 . 1 KN0 3 Kl 5. 5, K2 3. 5, K3 2 . 3 
140 
gl 15, 40 . 2 KCl Kl ( 15) 4.76, (40) 4.64 147 
K2 ( 15) 3. 56, (40) 3.34 
Ni 2+ gl 25 . 15 Kl 5.97, K2 4.95 148 
gl 25-40 . 15 Kl ( 25) 5 . 9 7, ( 30) 5.88, ( 40) 5. 72 137 
K2 ( 2 5) 4. 95, (30) 4 . 86, ( 40) 4.70 
gl 25-40 45 % Kl ( 2 5) 7. 16, (30) 7. 09, ( 40) 6.96 137 
dioxan K2 ( 25) 6. 06, ( 30) 5.97, (40) 5 . 77 
.004 
gl 25-30 70 % dioxan Kl ( 2 5) 8. 51 , ( 30) 8 . 45 137 
. 001 K2 ( 25) 7.24, ( 30) 7.22 
gl 25 +Q Kl 6. 18, K2 4.96 142 
gl 20 . 5 KN0 3 Kl 5. 77, K2 4 . 80, K3 3.61 
134 
gl 20 "' . 0 1 Kl 6. 1, 82 11. 0 136, 190 
gl 25 . 01 Kl 6. 12 , K2 5 . 0 3 
135 
... 
Metal 
gl 
gl 
gl 
H 
p. e 
gl 
gl 
gl 
gl 
gl 
gl 
gl 
20 
25 
30 
0-45 
20 
10, 25 
25 
15-40 
25 
10-40 
20- 30 
25 
. 1 KC 1 
.1 NaC10 4 
75% dioxan 
-+O 
.1 KN0 3 
. 6 5 KC 1 
1 NaCl0 4 
. 2 KC 1 
. 5 KC 1 
0 corr. 
. 5 KC 1 
K1 5.73, K2 4.76 
K1 5.86, K2 4.78 
K1 9.0, K3 4.8 
K1 (0) 6.47, (15) 6.29, (25) 6.18, 
(35) 6.08, (45) 6.00 
K2 (0) 5.29, (15) 5.08, (25) 5.95, 
(35) 5.84, (45) 5.75 
Kl 6.4, K2 4 . 4, K3 3.0 
K1 (10) 5 . 73, (25) ' 5.66 
6 2 ( 1 o ) 1 o . 80 , ( 2 5 ) 1 o . 5 1 
63 (10) 14.4, (25) 14.0 
Table 2.02 
K1 5 . 70, 62 10.50, 63 13.96 
K1 (15) 6.04, (25) 5 . 94, (40) 5 . 78 
K2 (15) 4.98, (25) 4.84, (40) 4 . 71 
K1 5 . 65, 62 10 . 51, 63 13.95 
K1 (10) 6.36, (25) 6 . 18, (40) 6.09 
K2 (10) 5.29, (25) 5.07, (40) 4.92 
Kl (20) 5.80, (25) 5.73, (30) 5,70 
62 (20) 10.70, (25) 10 . 56, (30) 10.47 
K1 5.63, 62 10.48, 63 14.0 
Stability constants of complexes of leucine HL 
Method Temp.( 0 c) 
gl 
gl 
gl 
gl 
g 1 
gl 
gl 
gl 
gl 
gl 
p.e 
20 
25 
25 
20 
20 
25 
25 
1-50 
25 
20 
20 
Medi um 
. 0 1 
. 01 
1 NaCl 04 
'\, . 1 
'\, . 1 
KCl 
.02 -.07 
. 0 1 
Log of equilibrium constant 
K1 9.92 
K1 9.60, K12 2.36 
K1 9.7 7, K12 2.36 
K1 9.62, K12 2.37 
K1 9.62 
Kl 9. 71, K2 2. 39 
K1 9.69, K2 2 . 36 
K1 (1) l~.45, (12.~) 10.10, 
(25) 9. 74, (37.5) 9.43, (50) 9 .1 4 
K2 (1) 2.38 , ( 12.5) 2.35, 
(25) 2.33 , (37.5) 2 .33, (50) 2.33 
K1 3.99, K2 3.38 
6 2 7 . 8 
K1 5.8, K2 3.6, K3 2. 4 
149 
150 
151 
146 
140 
152 
153 
147 
154 
155 
156 
15 7 
Ref . 
158 
135 
159 
160 
161 
162 
16 2 * 
16 3 
159 
158 
140 
47 
.... 
48 
Co 2+ g 1 25 . 01 Kl 4.49, K2 3.58 159 
gl 25 . 01 Kl 4. 55, K2 3. 71 135 
p.e 20 . 1 KN0 3 Kl 5.2, K2 3.2, K3 2. 3 140 
Cu 2+ gl 25 . 01 Kl 8.35, K2 7.00 159 
spJ 25 3 Kl 7. 55, 132 14.98 164 
gl 25 . 01 Kl 7. 89, K2 6.45 135 
Cu 25 .10 Kl 8. 11, 132 15.84 164 
pol 25 .40 Kl 7.78 165 
po 1 25 1. 50 Kl 7. 77 165 
E 25 3 Kl 7. 55, 132 15.00 165 
sp 25 3 132 14.97 165 
p.e 20 . 1 KN0 3 Kl 8. 6, K2 7.0 140 
Mn 2+ gl 25 . 01 Kl 2.78, K2 2.67 135 
gl 25 . 1 Kl 2. 15 166 
p.e 20 . 1 KN0 3 Kl 3. 9, K2 1. 8 140 
Ni 2+ gl 25 . 01 Kl 5.58, K2 4.56 159 
p.e 20 . 1 KN0 3 Kl 6. 3, K2 4 .0, K3 2. 5 140 
gl 25 '\, . 1 Kl 5. 71, 13 2 10.26, 133 14.97 16 2 
gl 25 '\, . 1 Kl 5. 53, 132 9.46, 133 14.38 162* 
Zn 2+ gl 25 . 01 Kl 4.83, K2 4.26 159 
g 1 25 . 01 Kl 4.92, K2 4.01 135 
gl 20 13 2 9 .1 158 
p . e 20 . 1 KN0 3 Kl 5. 8, K2 4.2, K3 3.3 
140 
* Denotes L (- )- leucine 
Table 2.03 
Stability cons tan ts of complexes of isoleucine HL 
Me ta 1 Method Temp.(°C) Medium Log of equilibrium constant Ref. 
H+ gl 20 Kl 9 . 86 158 
gl 25 .5 KCl Kl 9. 70, K2 2.66 154 
gl 25 '\, . 1 Kl 9 . 76, K2 2.38 162 
g 1 25 '\, . 1 Kl 9. 69, K2 2.31 162* 
gl 1-50 .02- , 09 Kl ( 1) 10. 46, (12.5) 10. 10, 163 
( 2 5) 9. 76, ( 37. 5) 9. 44, ( 50) 9 . 16 
K2 ( 1) 2 . 37, (12.5) 2. 33, 
( 2 5) 2. 32, ( 37. 5) 2 . 32, (50) 2.33 
49 
Cd 2+ gl 20 a2 6.6 158 
N1 2+ gl 25 . 5 KCl Kl 5. 22, a2 9.45 154 
gl 25 "' . 1 Kl 5.28, a2 9.56, a3 12.40 162 
gl 25 "' . 1 Kl 5. 52, a2 9.83,a 3 12.58 162* 
zn 2+ gl 20 a2 8.2 158 
gl 25 . 5 KC l Kl 4.49, a2 8 . 49, a3 10.9 154 
* Denotes L(+)-isoleucine 
Table 2.04 
Stability constants of complexes of ornithine HL 
Metal Method Temp.{°C) Medium Log of equilibrium constant Ref. 
H+ gl 25 "' . 02 Kl 10. 6 7, K2 8.65, K3 1. 98 16 7 
gl 20 1 NaCl0 4 Kl 10.59, K12 8.93, K13 2.11 160 
gl 20 1 KCl K12 8.93 161 
gl 20 "' . 01 Kl 10.73, K12 8:62, K13 1.94 168 
gl 20 "'o Kl 10 . 73, Kl2 8.75 169 
gl 25 •0 Kl 10 . 76, K2 8.69 170 
gl 25 .10 KN0 3 Kl 10.73, K2 8.98 171 
gl 25 1. 0 KN0 3 Kl 10. 46, K2 8. 58 171 
ci• gl 25 "'0.02 Kl 3. 70, K2 2.70 16 7 
pol 25 "' l. 0 Kl 3. 41, K2 2.41 16 7 
gl 20 .005 CdS0 4 a2 6. 1 169 
Co 2+ gl 25 "' . 02 Kl 4.02, K2 2.90 16 7 
gl 20 "' . 01 a2 6.3 16 8 
gl 25 .10 KN0 3 Kl 3. 54, K2 3.33 171 
gl 25 1. 0 KN0 3 Kl 3. 52, K2 2. 80 171 
cu 2• gl 25 
"' 
.02 Kl 6.90, K2 5. 55 16 7 
sp 25 K2 4. 57 16 7 
gl 20 "' . 0 1 a2 13. 0 168 
gl 25 .10 KN0 3 Kl 7. 87, K2 6. 18 171 
gl 25 1. 0 KN0 3 Kl 7. 17, K2 6. 14 171 
Mn 2+ gl 20 "' . 01 Kl <2 168 
gl 25 .10 KN0 3 Kl 1. 60 171 
50 
N1 2+ gl 25 "' . 02 Kl 4.85, K2 3. 89 16 7 
gl 20 "' . 01 62 8.3 168 
gl 25 . 10 KN0 3 Kl 4. 72, K2 4.34 171 
gl 25 1. 0 KN0 3 Kl 4.44, K2 3. 68 171 
zn 2+ gl 25 "' . 02 Kl 4 .10, K2 3. 20 16 7 
gl 20 "' . 01 62 6.9 168 
gl 20 .005 ZnS0 4 62 7.6 169 
gl 25 .10 KN0 3 Kl 3. 77, K2 2.67 171 
gl 25 1. 0 KN0 3 Kl 3.60 171 
Table 2.05 
Stabil 1ty constants of complexes of arginine HL 
Me ta 1 Method Temp.{ 0 c) Medium Log of equilibrium constant Ref. 
H+ gl 20 1 NaCl0 4 Kl 9. 21, K12 2.19 160 
gl 25.15 .15 KN0 3 Kl 9. 11 143 
gl 20 . 01 Kl 12.48, Kl2 9.08, K13 2.17 168 
gl 17-40 Kl 9.27 { 17) • 9.05 { 2 5) , 8. 9 2 { 30·) 172 
8. 80 { 3 5) , 8.67 (40) 
Kl2 1. 98 { 17). 1. 98 { 2 5) , 1. 9 7 { 30) , 
1. 97 { 35) , 1. 97 (40) 
E 25 Kl2 9.04 173 
gl 0-50 .023 Kl2 9.74 (0). 9.41 (10), 9.13 (20) 174 
8.87 { 30) , 8. 6 5 { 40) , 8. 46 { 50) 
25 -.o Kl 12.48, K12 9.04 175 
23 -.o Kl 13. 2, Kl2 9.09 176 
gl 25 . 10 KN0 3 Kl 11. 5, Kl2 9.36 171 
Cd 2+ gl 17-40 Kl 3.31 (17). 3.27 ( 2 5) , 3.25 (30), 172 
3.22 ( 35) , 3.19 (40) 
K2 3.30 ( 17). 3.18 ( 2 5) , 3. 11 ( 30) , 
3.03 ( 3 5) , 2.96 ( 40) 
gl 19 .005 CdS0 4 62 6. 7 169 
Co 2+ gl 17-40 Kl 3 . 79 ( 17). 3 . 73 ( 30) , 172 
3. 70 ( 35) , 3. 68 (40) 
K2 3. 10 ( 17). 2.95 ( 40) ; 
K3 2.10 ( 17). 2.00 (40) 
gl 2 5. 15 . 15 KN0 3 Kl 3. 87, K2 3.20, K3 2.08 143 
gl 20 . 01 62 7.40 168 
gl 25 . 10 KN0 3 Kl 4 . 02, K2 3.22 171 
51 
cu 2+ g 1 17-40 Kl 7.53 ( 17) , 7.34 ( 2 5) , 7.23 (30), 172 
7.12 ( 35), 7.02 (40) 
K2 6.54 ( 17) • 6.42 ( 25) , 6 . 32 (30), 
6.23 ( 35) , 6.14 (40) 
pol 25 . 06 KH 2Po 4 62 13.74 173 
gl 20 . 01 62 13.90 168 
gl 25 .10 KN0 3 Kl 7. 93, K2 6.64 
171 
Mn 2+ gl 25-40 Kl 2.64 ( 2 5) , 2.60 ( 40); 172 
K2 1. 94 ( 2 5) , 1. 90 (40) 
gl 20 . 01 Kl 2.00 168 
gl 25 .10 KN0 3 Kl 2.55 
171 
Ni 2+ gl 17-40 Kl 4. 98 ( 17). 4.92 ( 25) , 4. 86 ( 30), 172 
4.83 ( 35) , 4. 77 (40) 
K2 4.32 ( 17) • 4.20 ( 2 5) , 4. 14 ( 30) , 
4. 10 ( 35), 4.04 (40) 
K3 3.21 ( 17). 3 .08 (25), 3.03 (30), 
2.93 ( 35), 2.85 (40) 
gl 20 . 01 62 9.2 168 
gl 25 .10 KN0 3 Kl 5. 18, K2 4.31 
171 
zn 2+ gl 17-40 Kl 4.20 ( 17). 4. 19 ( 2 5) , 4. 17 ( 30) , 172 
4.16 ( 3 5) , 4.14 (40) 
K2 3.99 ( 17) • 3.93 ( 2 5) , 3.89 ( 30) , 
3.84 ( 35) , 3.81 (40) 
gl 20 . 01 62 7.8 168 
gl 19 .005 ZnS0 4 62 8.0 
169 
gl 25 . 10 KN0 3 Kl 4. 11, K2 3.96 
171 
Table 2.06 
Stability cons tan ts of complexes of cysteine H2L 
Metal Method Temp.(°C) Medium Log of equilibrium constant Ref. 
H+ gl 20 . 0 1 Kl 10 . 28, Kl2 8.36, K13 1.96 168 
Kl 10. 28 197 
gl 25 .15 KN0 3 Kl 10. 55, Kl2 8.48 
178 
E 25 -.o Kl 10 . 51, Kl2 8 . 60 1 79 
E 12-37 '\, 1 KN0 3 Kl 10 . 51 
180 
K12 8 . 99 ( 12) , 8.60 ( 25), 8 . 25 (37) 
52 
N1 2+ gl 20 . 01 132 19. 3 16 8 
gl 25 .15 Kl 10.48, K2 g.31 148 
gl 25 .10 KN0 3 Kl 9.64, K2 9.40 181 
gl 20 .1 NaCl0 4 Kl 9.0 ±0.3 182 
132 20.16±0.01 
K(Ni 2+ + HL- ~ NiHL+) 15.43±0.05 
K(2N1 2+ + 2- 2-, 3L ;! N1 2L3 33.01 ±0.07 
K(3Ni 2+ + 4L 2- _... Ni L 2-) 
- 3 4 45 .72±0.09 
gl 20 .1 NaCl0 4 Kl 9.83, K2 10.38, K3 2.87 183 
Hg2+ Hg 12-25 1 KN0 3 62 45.40 ( 12 ) , 4 3 . 5 7 ( 2 5) 184 
gl 20 .0025 Hg(N0 3) 2 62 20.5 169 
gl 25 .10 KN0 3 Kl 14.21 181 
Pb 2+ gl 25 . 15 KN0 3 Kl 12.20 178 
pol 25 . 15 KN0 3 Kl 12.75 17 8 
gl 25 . 1 KN0 3 Kl 11. 39 181 
gl 20 . 1 NaCl0 4 Kl 12.74, K2 4.15, K3 2.59 183 
Table 2.07 
Stability constants of complexes of penicillamine H2L 
Metal Method Temp.(°C) Medium log of equilibrium constant Ref. 
H+ gl 25 . 15 KN0 3 Kl 10. 46, K2 7. 97, K3 2.44 185 
gl 25 . 10 KN0 3 Kl 10.43, K2 7.88 181 
gl 20 . 1 NaCl0 4 Kl 10.68±.01, K2 8 .03±. 01 182 
gl 22 . 1 KN0 3 Kl 10.55, K2 8.09, K3 <2.5 186 
ci• gl 25 . 15 KN0 3 Kl 11. 4, K2 7. 1 185 
gl 25 . 10 KN0 3 Kl 10.88 181 
pol 25 . 2 63 13. 08 187 
gl 22 . 1 KN0 3 Kl 10.92 186 
Hg2+ gl 25 . 15 KN0 3 Kl 17. 5, K2 6.0 185 
gl 25 . 10 KN0 3 Kl 16. 15 181 
gl 22 . 1 KN0 3 Kl 16.4 186 
Pb 2+ gl 25 . 15 KN0 3 Kl 13.0, K2 4.3 185 
gl 25 . 10 KN0 3 Kl 12.37 181 
gl 20 . 1 NaCl0 4 Kl 13.75, K2 4.3, K3 3.14 183 
gl 22 . 1 KN0 3 Kl 12.88 186 
53 
Table 2.08 
Stability constants of complexes of methionine HL 
Meta 1 Method Temp.( 0 c) Medium Log of equilibrium constant Ref. 
H+ gl 10-40 "' . 05 Kl 9.7 (10), 9.28 (20), 188 
9.15 (30), 8.92 (40) 
Kl2 2.13 (10), 2.125 ( 2 5) , 
2.125 (30), 2.12 (40) 
gl 20 1 NaCl0 4 Kl 9. 13, K12 2.26 160 
25 Kl 9.3 189 
gl 20 1 KCl Kl 9.13 161 
gl 25 .15 KN0 3 Kl 9.10 178 
gl 20 "' . 01 Kl 9.34, Kl2 2.20 190 
E 25 Kl 9. 21, Kl2 2.28 178, 191 
gl 18 'v0 Kl 9.31 169 
gl 20 .15 NaCl0 4 Kl 9. 20, K2 2.17 192 
gl 25 .10 KN0 3 Kl 9.04 181 
pol 25 .6 Kl 9.15±0.04 193 
gl 37 .15 KN0 3 Kl 8.91, K2 2.25 194 
Cd 2+ gl 25 . 15 KN0 3 Kl 3.88, K2 3.11 178 
p.e 20 . 1 KN0 3 Kl 5.4, K2 3.3, K3 2.1 140 
gl 25 .10 KN0 3 Kl 3. 6 7, K2 3. 36 181 
Hg2+ gl 25 .10 KN0 3 Kl 6.52, K2 4.93 181 
pol 25 .6 KN0 3 62 = 17.62±0.05 195 
Pb 2+ gl 25 . 15 KN0 3 Kl 4.40 178 
gl 25 .10 KN0 3 Kl 4.38, K2 4.24 181 
54 
Table 2.09 
Stability constants of complexes of glutathione H 3L 
Metal Method Temp. (°C) Medium Log of equilibrium constant Ref . 
H+ 22 K1 9.62, K12 8.66, 196 
K13 3.53, K14 2.12 
Kl 9.20, Kl2 8. 66, K13 3.53 19 7 
gl 25 . 15 KN0 3 Kl 9.65, Kl2 8. 75, K13 3.59 198 
gl 25 . 16 Kl 9 . 62, Kl2 8.74 199 
25 Kl 10 . 0, K12 8. 7, K13 3.5 200 
cl• gl 25 . 15 KN0 3 K1 10.50 178 
Hg2+ pol 12, 25 1 KN0 3 ~2 43.47 (12), 41.58 (25) 184 
Pb 2+ gl 25 .15 KN0 3 K1 10.60 178 
zn 2+ gl 25 .15 KN0 3 K1 8.30 198 
2.3 Problems arising from metal-ligand interactions. 
It is well know that when copper(!!) is mixed 
with a thiol, for example cysteine, copper(!) and 
t . f d 177 cys ine are orme; 
2RS + 2Cu 2+ 2Cu+ + RSSR 
2RS 2RSCu 
If the mole ratio of copper(!!) to cysteine was in 
excess of 0.5 to 1, Kolthoff and Stricks 177 
suggested that the copper(!) complex reacted with 
more copper(II) to form the dimer and copper(I); 
2RSCu + 2Cu 2+ RSSR + 4Cu+ 
229 Recent work in this laboratory has indicated that 
the latter suggestion is probably incorrect. A 
black-violet colour is produced when the mole ratios 
of copper(II) to cysteine are in excess of 0.5 to 1 
and this would not be expected of a mixture of 
copper(I) and cystine. A mixed-valence complex 
of copper(I)-copper(II) has been postulated, charge 
transfer causing the intense colouration. Intense 
colours have been reported when copper(II) was mixed 
with thiomalic acid, 230 and with penicillamine, 231 and 
mixed-valence complexes were suggested in both cases. 
55 
These reactions lead to considerable uncertainty 
in attempts to study the complex formation between 
copper(II) and thiols and doubt is cast on the claim 
by Kuchinskas and Rosen that they determined the 
stability constants for copper(II)-penicillamine 
185 
complexes. 
No attempt has, therefore, been made in the 
present work to study copper(Il) with thiols. Blood 
plasma is believed to contain low concentrations of 
copper(II) in the presence of cysteine (see Table 1.01). 
It is not at present known whether, in plasma, the 
presence of ligands which preferentially stabilise 
copper(Il) can lower the oxidation-reduction potential 
of copper(ll)/copper(I) sufficiently for reaction 
with cysteine to be incomplete or, possibly, prevented. 
Zinc(ll) and cystine form insoluble complexes 
and Dr. Hallman, working in this laboratory, found 
that it was not possible to obtain stability constant 
values. He was, however, able to study the mixed-ligand 
complexes formed in solutions containing zinc(Il), 
cystine, and histidine in molar ratios of 1:1:1 and 
1:1:2 (Zn(II) = 1.8 x l0- 4M). 
56 
2.4 Mixed-ligand complex formation. 
Mixed-ligand complexes, in which the metal ion is 
simulta~eously bonded to two or more different 
complex~ng species, are probably formed in most 
solutions which contain metal ions and more than one 
ligand. For related ligands the stability constant 
of a mixed complex, MAB, is usually comparable with, 
or slightly greater than, the mean of the constants 
for the species MA 2 and MB 2 . 
Spectrophotometry has been used to determine 
the stability constants of mixed-ligand complexes, 
232-4 including those of palladium with halide ions 
and copper(II) with the oxalate ion and 
ethylenediamine. 235 The latter system has also 
been studied by polarography. 236 Liquid-liquid 
extraction methods have been developed for the 
evaluation of equilibrium constants for the systems 
of coordination number four and this technique has 
been applied to the mercury(II) bromide-iodide system. 
Mixed-ligand complex formation has been studied 
extensively by potentiometric titrations. The systems 
studied include copper(Il)-1,2-diaminopropane-
5-sulphosalicylic acid, 238 the lanthanides with 
hydroxyethylethylenediaminetriacetate and imino-
diacetate,239 nickel(Il)-oxalate-ethylenediamine, 240 
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nickel(II) with each of the three possible pairs 
of the ligands ethylenediamine, histamine, and 
serine monoanion, 241 and copper(II) with each of the 
six possible pairs of the ligands ethylenediamine, 
h . . . . d l' 1 t d. . 242 istamine, serine monoanion, an sa icy a e ianion. 
Computers have been used in several cases to calculate 
the stability constants of the mixed-ligand 
238 241-2 
complexes. ' 
Mixed-ligand complex formation is important in 
various enzyme-catalysed reactions. Many enzymes 
contain coordinat~d metal ions and, during the 
enzymatic process, coordination of the substrate also 
takes place and a mixed-ligand complex is formed. 
Inhibitors are compounds which are preferentially 
coordinated to the metal ion in the enzyme and which 
therefore hinder the coordination of the substrate. 
The presence of protein-zinc-chelate mixed complexes 
243 has been demonstrated by Vallee, Coombs, and Williams 
in systems containing 1:10 phenanthroline (or 
8-hydroxyquinoline) and carboxypeptidase or yeast-, 
or liver-, alcohol dehydrogenase. 
2.5 Methods used for stability constant determination . 
The calculation of stability constants has been 
facilitated by high-speed digital computers. The 
potentiometric method yields data which is most suited 
58 
to computer analysis and, where possible, it is the 
method of choice. It has been used throughout the 
present study. There are other methods, including 
spectrophotometry and polarography, available for 
stability constant determination but these are less 
. precise. 
Equilibrium constants for the formation of 
complexes in solution at a given temperature can be 
reported as activity quotients (which should be 
independent of the ionic medium), as concentration 
quotients (involving the concentration of all species) , 
or as 'practical', or mixed, stability constants which 
contain the activity of the hydrogen ion and the 
concentration of all other species. If the 'practical' 
constants or the concentration quotients are determined 
in the presence of a large excess of background salt, 
it may be assumed that the activity coefficients are 
independent of the concentrations of the reacting 
species and depend only on the nature and concentration 
2 
of the bulk electrolyte. 
'Practical' constants were used in this study and it 
was assumed that the activity of the hydrogen ion 
(H+) -- 10-pH. Th H t d ' 1 t ' e p measuremen s were ma e in sou ions 
of a constant ionic strength of 0.15 M KN0 3 . The 
constants determined under these conditions are mutually 
5 9 
comparable and thus may be used with significance in 
COMICS. Potassium and nitrate ion were assumed not 
to form complexes with any other solute species. 
For the purpose of mass balance equations [H+] 
was estimated from the pH measurements by 130 
pH log F 2.01 
where 
log F log f - ~ Ej + ~ pH 2.02 
f is the activity coefficient of hydrogen ions,~ Ej 
is the residual liquid junction potential, and~ pH 
is the sum of any systematic errors in the pH 
measurements. The value of F was assumed to be 
constant for all of the measurements. Log f was 
expected to be the largest term on the right hand 
side of equation 2.02 and, for a first estimate, F 
was taken to be equal to f, where f = 0.75 as calculated 
244 from the Davies equation 
l !-::: -Az z µ 2 -1 2 - !-::: l+µ 2 0. 3µ l 2.03 
whereµ is ionic strength, z 1 z 2 are ionic charges and 
II A is a parameter from the Debye-Huckel theory whose 
value is temperature dependent. From previous work in 
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130 this group, the value of F was adjusted to 
0.77 ± 0.05 on the basis of a minimum in a residual 
least - squares parameter as F was varied. The value 
of pK was taken to be 13.62 at 37°c. 263 
-w 
264 Subsequent work and discussion resulted in 
the use of F = 0.80 for stability constant calculations 
in the present work. Some calculations were made to 
assess the effects on the results of the uncertainty 
in F, and are discussed in Chapter V. 
245 The computer programme SCOGS was used in this 
study to analyse the systems. This progranune employs 
a non-linear least-squares method and may be used 
to calculate equilibrium constants for hydrolysed 
metal ions, protonated ligands, and metal complexes 
which may be simple,protonated, hydrolysed, 
polynuclear, or mixed-ligand. 
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CHAPTER III 
EXPERIMENTAL. 
3.1 Apparatus. 
It was important that all the stability constants 
should be obtained with a high level of accuracy and 
the most suitable method is the potentiometric 
method. 
A special titration cell had been previously 
designed in this laboratory and had been found to 
give very accurate and reproducible results when 
the circulating water in the jacket was maintained 
246 
at 20 ± 0.02°C. The recorded pH values of, for 
example, phthalate buffer remained constant to 
within ± 0.002 pH units for one week . 
This titration cell, shown in Figure 3 . 01, 
was used in the present work in conjunction with a 
"Vibron" electrometer model 33B-2 (E.I.L . ) fitted 
with an internally shielded glass electrode and a 
saturated calomel electrode. A "Rectiriter" recording 
milliameter (Texas Instruments Inc.) was used to 
assess pH stability . The titration vessel consisted 
of two water-jacketed parts joined by a ground 
glass joint. The lower portion was the usual type 
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Figure 3.01 pH titration cell 
of water-jacketed beaker, while the upper portion, 
serving to enclose the upper ends of the electrodes, 
was sealed at the top with a rubber stopper hrough 
which passed the electrode leads, inert gas supply, 
thermometer, and reagent addition tube. At the 
bottom of this upper section, the electrodes etc. 
passed _ through a rubber stopper into the cell. The 
height of the gas supply tube could be adjusted to 
permit flushing of the solution, or the space 
above, with an inert gas. The titrant was added, 
via the reagent addition tube, from an "Agla" 
micrometer syringe which had been previously 
calibrated using distilled water. A polythene 
capillary tube was connected to this syringe and 
this tube was supported by a stainless steel tube 
which was inserted into the reagent addition tube. 
The solution was stirred magnetically. 
Several different glass electrodes were used in 
this study, namely the E.I.L. GHS 33, the Jena U 015, 
and the Titron (Titron Instruments, Victoria, 
Australia). A saturated calomel electrode was used 
for all systems and, for work with lead(II) and 
mercury(Il) solutions, this was fitted with a salt 
bridge. In this case, the calomel electrode was 
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sealed inside a tube which was plugged by s i ntered 
glass. Above the glass sinter was a 1 cm. plug 
of an agar solution [agar (6%), sodium nitra t e 
(0.20 M) and ammonium nitrate (1.40 M)] 246 - 7 and 
the rest of the tube was filled with a neutral 
solution of sodium nitrate (0.20 M) and ammonium 
nitrate (1.40 M). In previous studies at 20 °C, 
3% agar solution was used but in this study at 37 °C, 
a 6% agar solution was necessary. The bridge 
solution used gives equal transference of charge 
by positive and negative ions, and should minimise 
the junction potentials due to the bridge. The use 
of the salt bridge resulted in negligible flow of 
potassium chloride and thus eliminated any problems 
which might have occurred due to the formation of 
insoluble Pbcl2 or HgC1 2 • This bridge was stable 
for up to two weeks, after which it was necessary 
to replace the salt bridge assembly. When not in 
use, the electrode was stored either in distilled 
water or in potassium hydrogen phthalate . 
The electrometers and pH measuring unit were 
earthed for satisfactory electrostatic stabi lity. 
The pH instability due to electrothermal effects in 
the head of the glass electrode appeared to be 
adequately compensated for by the upper por t i on o f 
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the water jacket. The photosensitivity of the glass 
electrode was a problem but this was eliminated when 
the thermostat water was strongly coloured by a 
mixture of red and blue writing inks. As an 
additional precaution, the room was permanently 
illuminated. 
3.2 Titration procedure. 
At the start of the experiment, the pH meter 
was standardised with potassium hydrogen phthalate 
buffer (O.OSM, pH= 4.028 248 ). The standardisation 
of the pH meter was then checked in sodium 
tetraborate (O.OSM, pH - 9.082 248 ). If necessary, 
small adjustments were made to the instrument 
temperature compensation to ensure that the 
calibration matched the buffer standards exactly. 
The electrodes were then normally rechecked in 
potassium hydrogen phthalate. Once the Nernst 
slope was set in this way, it was not normally 
necessary to alter the temperature control until one 
of the electrodes needed to be replaced. 
The upper portion of the cell was removed, the 
electrodes washed with distilled water and the lower 
portion of the cell was rinsed first with distilled 
66 
water and then with acetone. The acetone was 
evaporated by compressed air. The solution to be 
titrated (normally 50 ml) was pipetted into the 
titration vessel. The electrodes were carefully 
dried by an absorbent tissue and the upper portion 
was replaced. The solution was left to reach 
37 ± 0.05 °C (usually about 20 minutes) and 
nitrogen was bubbled through the solution. 
The stock solution, 0.15M in KN0 3 , was prepared 
in a 200 ml . volumetric flask. The required volumes 
of stock ligand and stock metal solutions (and free 
nitric acid if required) were added and the volume 
was adjusted using boiled-out distilled water. 
For pK determinations, the metal solution was 
-a 
omitted from the titration solution. Grade 'A' 
volumetric glassware was used throughout. 
After equilibration, the solution in the 
titration cell was titrated by "carbonate-free" 
potassium hydroxide solution (generally ca. lM) 
from the "Agla" micrometer syringe. The tip of the 
polythene capillary tube was withdrawn from the 
solution after the addition of each aliquot. 
Magnetic stirring and nitrogen flow were maintained 
throughout the titration. It was found that the 
pH was affected by turning off the stirrer but the 
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nitrogen flow had no effect. Attainment of constant 
pH after the addition of KOH, as gauged by the 
trace on the Rectiriter, usually took 3-5 minutes. 
The titrati on was normally terminated on, or before, 
precipitation which was detected by a steady downward 
drift in pH. At the end of the titration, the 
electrodes and the l ower portion of the titration 
vessel were rinsed with distilled water and the 
electrodes were placed in potassium hydrogen 
phthalate buffer. The titration was discarded if 
agreement was not within ±0.005 pH units of the 
calibration. 
The actual concentrations of the metal and 
ligand depended upon the solubility of the complexes 
formed, more d ilute solutions being used in attempts 
to overcome the insolubility problem. A range of 
metal to ligand concentration rati os was used in 
each system . Professor R. Montgomery, in this 
laboratory, developed a doub l e titration technique 
for working at c onstant pH. A solution of known 
ligand concentration, 0.15 Min potassium nitrate, 
was pipetted into the titration vessel, allowed 
to equilibrate and an aliquot of metal ion solution, 
containing free nitric a cid, was added. Alkali was 
added t o the solu t i on t o bring the pH b ack to the 
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selected pH value. This technique gave a wide range 
of metal to ligand ratios and it was hoped that it 
would be useful in the determination of stability 
constants of relatively insoluble complexes. This 
technique was used in the present work for some 
mercury(II) and lead(II) systems. 
3.3 Reagents. 
a) Metal salts. 
In order to minimise complex formation of the 
metal ions with all components of the system, except 
the ligands under study, the only inorganic anion 
permitted was nitrate. 
Manganese(II) nitrate (Merck, A.R.), cobalt(II) 
nitrate (Hopkin and Williams, A.R.), nickel(II) 
nitrate (B.D.H., A.R.), zinc(II) nitrate (Baker 
Analysed Reagent), lead(II) nitrate (B.D.H., A.R.), 
and mercury(II) nitrate (Mallinckrodt, A.R.) were 
used without further purification. Cadmium(II) 
nitrate (B.D.H., L.R.) was recrystallised from 
distilled water. 
Approximately O.OSM metal nitrate solutions 
were prepared and free nitric acid was added to the 
manganese(II ) , lead(II), and mercury(II) nitrates to 
prevent hydrolysise The solutions were all 
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standardised against the d i sodium salt of 
ethylenediaminetetraacetic acid. Erichrome Black T 
indicator was used for zinc 249 , cadmium 249 , 
250 
and manganese. Murexide indicator was used 
for nickel 249 , Fast Sulphon Black F for copper 251 , 
252 Catechol Violet for cobalt , and Zylenol Orange 
for lead. 251 Mercury(II) nitrate was standardised 
using 1 : 10 phenanthroline solution and 
d . h 1 b 'd . d ' 253 1p eny car az1 e as in 1cator. 
Potassium nitrate (A.R.) was recrystallised 
from water, dried at 80 °C for 24 hours, powdered, 
and heated at 120 °C for 3 hours. 
b) Ligands. 
The sources of the ligands and the purifications 
were as follows; 
Glycine: B.D.H., A.R., recrystallised from distilled 
water and dried at 110°C for one hour. 
L-Leucine: Sigma Chemicals, recrystallised from 
aqueous ethanol and dried at 110°C for 2 hours. 
The following ligands were vacuum dried over phosphorus 
pentoxide before use: L-isoleucine, L-ornithine 
hydrochloride, L-arginine, and glutathione (Sigma 
Chemicals); L-methionine, and N-(2-mercaptopropionyl) 
glycine (Calbiochem., A grade); L-cystine, L-cysteine, 
and D-penicillamine (Fluka puriss). 
70 
With the exception of the thiols, stock solutions 
were prepared from boiled-out distilled water and 
kept in the refr'gerator for a miximum of three days . 
When required, fresh solut'ons of the thiols were 
prepared, under nitrogen, from boiled-out distilled 
water. 
The purity of all the ligands was determined by 
potentiometric titration. No analyses for the -SH 
group were attempted because the potentiometric 
standardisation was thought to be more reliable and 
has b 'd l d 178,181,198 een wi e y use . Iodometric methods 
can result in the production of non-stoichiometric 
amounts of iodine 254 and, although an iodometric 
method was found to be satisfactory for L-cysteine, 
f 1 f . · 11 . 255 none were success u or penici amine. 
S-methylglutathione. This was synthesised because 
the pK of the amino group was required in the 
-a 
calculation of the microconstants for the ionisation 
of glutathione. 
S-methylglutathione was synthesised by the 
method of Martin and Edsall 199 after an initial 
unsuccessful attempt to methylate glutathione by 
iodomethane in sodium hydroxide solution. This method 
failed because the S-methylglutathione is very soluble 
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in water and could not be separated from the sodium 
hydroxide. 
The method of Martin and Edsall 199 is based on 
the formation of the insoluble silver salt of 
glutathione which can then be methylated; 
-+ 
G-S-Ag + 
G-S-Ag + 
-+ G-S-CH 3 
~H 0 
2 2 
+ AgI 
where GSH represent glutathione. No satisfactory 
method of recrystallisation could be found and so 
the precipitation technique used in the paper 199 
was repeated twice. The final white product melted 
at 190°C with decomposition. Analysis: Found: 
C, 40 . 6; H, 6.1; N, 12.9; S, 10.0%. Calculated 
s, 10.0%. 
Nmr spectra confirmed the preparation of 
S-methylglutathione. 
c) Other Reagents. 
pH standards. Potassium hydrogen phthalate 
(B.D.H., A.R.) was used as primary pH standard in this 
work. The solid was dried at 110°C for 2 hours and 
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a O.OSM solution was prepared using glass distilled 
water. The pH of this solution was taken to be 
248 4.028 at 37°C. The secondary standard employed 
was sodium tetraborate (B.D.H., A.R.) and the pH 
of a O.OSM solution in glass distilled water was 
248 
assumed to be 9.082 at 37°C. The pH values 
of this salt vary negligibly for minor differences 
in concentration caused by slight loss of water from 
the decahydrate, 256 and apart from storing the solid 
in an airtight container, no precautions were taken 
to maintain this degree of hydration. 
Ethylenediaminetetraacetic acid, obtained as the disodium 
salt (B.D.H., A.R.), was dried at 80 °C for 6 hours 
to give the dihydrated salt. 0.01 and O.OSM 
standard solutions were prepared using glass 
distilled water and were stored in polythene containers 
in the refrigerator. 
"Carbonate - free" potassium hydroxide, approximately 
lM, was prepared by dilution, under nitrogen, of an 
ampoule of a B. D.H . Concentrated Volumetric Solution 
with boiled-out glass distilled water. The stock 
solution obtained was standardised against hydrochloric 
acid using Phenol Phthalein or Methyl Orange. 251 The 
dissolved carbonate corresponds to the difference in 
these results and it was always less than 0.25% of the 
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total alkali. The stock solution of the base was 
stored in polythene bottles over soda lime in a 
desiccator. 
Hydrochloric acid solutions, used as primary 
standards for acid-base titrations, were prepared 
using A.R. acid, and standardised in the usual way 
against anhydrous sodium carbonate which had been 
dried at 260°C for~ hour and allowed to cool in a 
desiccator. 
Nitric acid solutions, used in the potentiometric 
titrations, were prepared by dilution of an ampoule 
of a B.D.H. Concentrated Volumetric Solution with 
boiled-out glass distilled water. Anhydrous 
sodium carbonate was used for standardisation. 
Nitrogen was "oxygen-free" grade. For use in the 
potentiometric titrations, it was passed through a 
long tube of self-indicating "Carbasorb" (B.D.H., L.R.), 
then through a bottle containing SM potassium 
hydroxide, and finally through a bottle of boiled-out 
glass distilled water. In this manner, the carbon 
dioxide was removed and the nitrogen was saturated 
with water vapour. In the systems involving easily 
oxidisable compounds, the nitrogen was passed through 
a bottle containing Fieser's solution (alkaline sodium 
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dithionite solution with added sodium anthraquinone -
2-sulphonate) which removed traces of oxygen. 
Other reagents used in quantitative studies were 
of A.R. grade. 
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CHAPTER IV 
CALCULATION OF RESULTS 
The quantitative study of chemical equilibria 
had its origins in the latter half of the last 
century with the derivation of the Law of Mass 
Action which was based mainly on the work of 
van't Hoff 265 , and Guldberg and Waage. 266 The 
first calculations of equilibrium constants from 
267 
experimental data were due to Ostwald , but it 
was not until the early part of this century that 
various workers began to examine metal complex 
equilibria. Present day calculations concerning 
metal complex systems are based largely on the 
. 268 201 269 270 
methods of N. and J. BJerrum ' and others, ' 
the thesis of J. Bjerrum being a major landmark. 
4.1 Stability Constant Definitions. 
N. Bjerrum 268 considered the successive 
reaction of a metal M with a series of ligand 
molecules (or ions) to occur in a sequence of 
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* equilibria, 
M + L ML 
ML + L ~ ML 2 
• • • • • • • • • • • • • • • 
4.01 
For each of these reactions, it is possible to define 
an equilibrium constant. The stepwise formation 
constants apply to the process of association and 
are defined as 
* Footnote. 
Kl 
K2 
[ML] 
[M] [L] 
[ML] [L] 
In the interests of clarity, the charges of ionic 
species will be omitted here, and elsewhere in the 
thesis, where they are unimportant to the discussion. 
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[MLN] 4 . 02 
These constants may be combined to give the stability, 
or complexity, constant SN for the (N)th species 
which is the product of the individual stepwise 
formation constants, . i.e. for the equilibrium, 
M + N (L) ~ MLN 
SN is given by 
SN - [MLN] - Kl.K2. • • • • • 
[M] [L]N 
N. Bjerrum defined the quantity n as the average 
number of ligands bound to each metal atom, thus 
-
n 
n=N 
I: nS [L] n 
n 
n=l 
n=N 
~ 
1 + I: S [L] n 
n 
n=l 
-n has been termed the formation function, and the 
plot of n versus log[L] is the formation curve. 
Provided all the complexes formed are mononuclear, 
the quantity n is a function of [L] only. In this 
case the formation curve for any given ligand is 
independent of the total metal ion concentration. 
4.03 
4 . 04 
78 
Polynuclear complex formation is often important 
~ 
in inorganic soluti ons. Sillen developed his "core 
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and links" approach to deal with such systems, in 
which all members of a related series of complexes 
were assumed to be formed from a central unit (the "core") 
by the addition of one or more constant portions (or 
"links "). Any member of the "core plus links" series 
can thus be described by one general formula. This 
type of system is often found in metal ion hydrolysis, 
and gives rise to a series of formation curves for 
different values of total metal concentration [MT]. 
The curves all have similar shape, but are shifted 
parallel to the log [L] axis. The spacing is regular, 
6 log [~] / 6 log [L] being constant. From the 
magnitude of the spacing, it is possible to calculate 
the composition of the "core and linking" species, 
and by a variety of methods the relevant equilibrium 
t t b bt . d 271 cons ans may e o aine. 
This treatment often gives very satisfactory 
results with simple systems. In metal chelate systems, 
however, there may be no good reason to assume that a 
particular "core plus links" series should predominate, 
and it is often impossible to obtain accurate results 
over a very wide range of total metal concentrations. 
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This means that the "core plus links" hypothesis, 
if used, should be applied with caution because an 
apparent fit to the data by a given series over a 
restricted range of concentrations, may at times be 
purely fortuitouse 
As defined in equation 4.04, n relates only to 
mononuclear complexes. The expression can be 
generalised to include all types of complexes by 
writing it in the form, 
n 4.05 
where [LT] and [MT] are the total concentrations of 
the ligand and metal respectively, and [LU] is the 
concentration of the ligand not complexed with metal. 
This quantity includes the free ligand and any 
protonated species which are present. 
The stability constant of a metal complex can, 
in principle, be determined by any method which gives 
the concentrations in equation 4.03. Numerous methods 
are available. 2 The essence of all of these is the 
measurement of the requisite quantities without 
disturbing the equilibrium. Sometimes one component 
may be measured potentiometrically or polarographical l y . 
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If the spectra of the various species are known, 
and sufficiently different from one another, it may 
be convenient o measur e the concentrations 
spectrophotometrically. Solubility, ion-exchange, 
and a variety of other equilibrium processes have 
also been employed to give the necessary data. 
Accurate data can be obtained from potentiometry 
and, where suitable, it is generally the method of 
choice. Potentiometry using a glass electrode is a 
particular example of a class of methods in which 
a competition between the metal and another ion for 
the ligand is studied. 2 In this case the other ion 
is the proton, and since the equilibrium constant 
for the reaction between the ligand and the proton 
may be separately determined, measurement of the 
hydrogen ion concentration can, under suitable 
circumstances, provide all the data necessary to 
derive the stability constants. 
4.2 Evaluation of pK values of a ligand . 
--------..;_-.a 
Ligands are Lewis bases, and their complexing 
action depends on their ability to accept positively-
charged metal ions as well as protons. Thus, the 
monobasic ligand, L- , exists in aqueous solution 
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...... 
in equilibrium with its conjugate acid, HL, 
+ L HL 
The "practical" dissociation constant of HL is given by 
K 
-a 
4.06 
The convention that square brackets denote molar 
concentration and round brackets denote activities will 
be used throughout this thesis: 
The total ligand concentration [LT] is given by 
[L] 
[L] ( 
+ 
l + (H ) [HL] + l 4.07 
K 
-a 
and, from the principle of electroneutrality, 
[L ] + [OH ] + 
where [K+] = concentration of added inorganic base 
and [N0 3 ] = concentration of inorganic acid (if any). 
Thus, from equations 4.07 and 4.08, 
K - (H+) Q where Q - [LT] 
-a 
[LT] - Q l + (H+) 
K 
-a 
i.e: pK - pH + log 
[ [LT] Q - Q l -a 
4.08 
4.09 
C 
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This calculation is less simple if the two pK 
-a 
values of a dibasic ligand are less than 2.5 pH units 
272 
apart, but a method similar to that of Speakman 
may be employed . 
4.3 Calculation of stability constants. 
a) Simple treatment. 
When the pK values of the ligand have been 
-a 
obtained, the free ligand concentration and the 
formation function, n, may be calculated from a 
potentiometric titration in which both metal and 
ligand are present. For a ligand, L, with 
+ protonated forms HL and H2L, equation 4.05 becomes 
(H+) 
2 
n - [LT] [L] [ 1 + + (H+) I 
K2 Kl K2 
[MT] 
If the stepwise formation constants K1 , 
K2 ....... ~ decrease in value sufficiently 
4.10 
rapidly as the series is ascended, certain simplifying 
. b d 273 h ' f assumptions can e ma e. T us, i K1 >> K2 , so 
that the first complex is completely formed before 
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appreciable amounts of the second species are present, 
then 
Kl - n 4.11 
(1-n) [L] 
K2 - (n-1) 
(2-n) [L] 
and, in general, KN could be obtained from the formation 
curve as the value of 1/[L] at the point where 
These approximations have been widely used 
although it has not always been established that the 
necessary conditions have been met. The difference 
between constants is frequently not great enough for 
the method to yield accurate values. It is also 
known that, in some cases, successive formation 
constants increase. 
In a system of 1:1 and 1:2 complexes, the 
h . l th d f I . d t · 274 · grap ica me o o rving an Rosso ti is 
rigorous and is analogous to the calculation of 
overlapping pK values. The equation follows from 
-a 
equation 4.04, 
n 
(1-n) [L] 
(2-n) 
(1-n) 
4 .12 
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If K1 is small relative to s2 , the value o f K1 
obtained by this method may be inaccurate because the 
intercept is close to the axis. When other species 
are present, in particular when these are polynuclear, 
protonated, or hydrolysed complexes, it is necessary 
to use more advanced methods. 
b) Using a computer. 
The methods described in section (a) are useful 
in simple situations, and for obtaining approximate 
stability constant values. The development of 
programmable electronic digital computers, however, 
has overcome the limitations imposed by graphical 
methods and has provided a powerful and general tool 
for the treatment of experimental data. 
There are two main categories of computer 
programmes for the evaluation of stability constants, 
those depending on rr calculation and those employing 
curve fitting or "pit-mapping" techniques. The 
274 graphical technique of Irving and Rossotti can 
be replaced by a least-squares treatment for obtaining 
275 
stepwise formation constants of mononuclear complexes. 
276 -Datta and Grzybowski calculated n and free 
ligand concentrati ons and then applied weighting 
factors and variances in a computer programme, based 
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on a graphical method 277 , to obtain K1 and K2 • 
They computed the theoretical titration curve using 
these values to check the closeness of fit . The 
278 programme described by Unwin, Beimer, and Fernando 
applies only to simple systems in which the two 
mononuclear complexes, ML and ML 2 , are formed and 
requires the prior calculation of n and free ligand 
concentrations. 
Although n values may be calculated from the 
titration data of a system containing protonated, 
hydrolysed, or polynuclear species, they cannot be 
used for the evaluation of stability constants. More 
mathematically complex programmes must be used and 
there are two basic methods which have been discussed 
in the literature. The least-squares approach was 
279 
used in simple cases by several groups and was 
f . . t . 1 f b b · 2 80 irst wri ten in a genera orm y To ias. The 
mathematical approach has been discussed by Wentworth. 281 
~ 
The second method is due to Sillen and is employed in 
a series of programmes of the "LETAGROP" or "pit-
. 282-3 
mapping" type. In these programmes, the problem 
is still to find a set of constants which minimise an 
appropriate error-square sum, but rather than doing 
this by the conventional least-squares technique, the 
error-square sum function for the n parameters is 
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defined as a "paraboloid inn-dimensional space", 
the equation of this surface is calculated, and the 
minimum or "pit" is searched for. 
Both of these approaches can give satisfactory 
results if used properly. The "pit-mapping" method 
is more unwieldy to programme and, at least in its 
1 . . 1 1· bl 280 ear ier versions, was ess re ia e. Some of 
these problems, however, appear to have been overcome 
by employing more sophisticated mathematical 
t h . 283 ec niques. 
The Gaussian method can also fail if the matrix 
is ill-conditioned (the vectors of the A matrix may 
be nearly linearly dependent) and if the starting 
values are not close enough for a truncated Taylor 
series to be a useful approximation. The likelihood 
of failure can be decreased in various ways, one of 
the most effective being to approach the minimum by 
the iterative method of Davidon as improved by 
Fletcher and Poweli. 284 
A modified form of the GAUSS programme of Tobias 
and Yasuda 280 is intended for all kinds of equilibria 
285 in a one metal - one ligand system. It has a 
shorter running time and a more reliable convergence 
in cases where the initial estimates of the constants 
are poor. 
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4.4 Method used in this study. 
245 A more general prograrrune SCOGS was developed 
in this Department and it uses a conventional non-
linear least-squares approach. It is capable of 
calculating simultaneously, or individually, 
association constants for any of the species formed 
in systems containing up to two metals and two 
ligands, provided that the degree of complex 
formation is pH dependent. SCOGS may be used to 
analyse appropriate pH titration data to yield acid 
association constants (and hence pK s), metal-ion 
-a 
hydrolysis constants, stability constants of simple 
complexes (ML, ML 2 , etc.), and stability constants 
of polynuclear species (M2L3 , M3L4H, M2L2 (0H) 2 etc.). 
In addition, SCOGS may be used to calculate constants 
for "mixed" complexes containing two different metals 
or two different ligands. For a mixture of two 
metals, A and B, and two ligands, Sand T, 
association constants may, in principle, be 
calculated with the prograrrune for any species (j) 
which can be described by the general formula 
where Aj~ Bj ~ Sj~ Tj ~ are positive integers, or zero, 
and Wj is a positive integer (for a hydrolysed species), 
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zero, or a negative integer (for a protonated 
species). The constant calculated is the "practical" 
overall formation constant, Bj, given by the 
expression 
4.13 
The stability constants quoted here were 
calculated by this computer programme on an IBM 360/50 
computer and the programme will be described briefly 
for completeness. The programme is in three parts, 
the main programme, and two subroutines, one of 
which is a standard IBM matrix inversion routine. 
The main programme deals with the input of 
data, the setting up, and solution of the least-squares 
equations, and the output of results. SCOGS 
minimises the sum of the squares of the residuals 
in titre, L,R., where for the ith point, 
i i 
R. = (actual titre of base)-(titre calculated from 
i 
input data using current 
estimates of the constants, 
and the experimental value 
of pH). 
In this case, the variance of R. is not expected to 
i 
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change markedly during a series of experiments and 
constant weighting factors have been used. 
The subroutine COGSNR is used repeatedly o 
determine the concentrations of all species in 
solution. It employs a generalised form of the 
Newton-Raphson iteration which has been widely used 
in the solution of problems involving one, or two, 
1 . t ' 286 h h d h non- inear equa ions. Te met o may, owever, 
be applied to more complicated problems and in this 
programme, it is used to solve up to four simultaneous 
non-linear equations. The iterative procedure 
terminates when satisfactory convergence has been 
achieved and the concentration of each species is 
calculated, as is the analytical hydrogen ion 
concentration. 
The latter quantity (HO in the subroutine) 
calculated from an equation of the form 
HO (OH) 
n 
E WjCj 
j=l 
. is 
where f+ denotes the activity coefficient under the 
experimental conditions and Cj is the concentration 
of the j th species. HO, and the various species 
concentrations, are then returned to the main 
programme. 
4.14 
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4.5 Modifications to SCOGS. 
Two small modifications have been made to SCOGS 245 
since it was published. The micrometer syri nge i s 
now routinely calibrated and allowance has been made 
in the programme for the burette correction. The 
modification to the titration procedure developed 
by Professor Montgomery (discussed in Chapter III) 
has also been incorporated into a version of SCOGS. 
Recently, 287 it was found that there was an 
error in the derivation of the equation for the 
calculated titre in SCOGS. The changes in the equation 
cause no significant alteration to the values obtained 
from titrations in which the volume of titre is low, 
and therefore do not affect the constants obtained 
in this thesis. 
4.6 Criteria for the acceptance of species postulated 
in SCOGS. 
The errors incurred in the collection of titration 
data are systematic and, whereas well-designed graphica l 
288 
methods show systematic errors clearly, these can 
be obscured in the complex calculations of a computer 
programme. In the programme LETAGROP, 282 the 
assumption was made that the only errors i nvolved were 
91 
random and that there were no systematic errors. As 
there is no statistical method available to overcome 
282 this problem, Sillen and co-workers suggested 
that systematic errors should be routinely treated 
as unknown constants to be determined. If the 
systematic error was allowed to refine, a minor 
complex might be thrown out and the data would be 
explained as well, if not better, with the complex 
omitted and a systematic error assumed. Tests of 
data for systematic errors have been described in the 
l ' t t 289 i era ure. 
In an attempt to overcome these problems in this 
work, a large number of measurements is used for each 
system, and the inclusion of a species in the results 
is based on whether the fit to the data is improved, 
whether the species is chemically feasible, and 
whether the stability constant calculated is meaningful. 
The fit to the data is measured by the standard 
deviation in titre (SDT) but it is difficult to 
decide if the decrease in standard deviation in titre 
is significant or purely fortuitous, caused by an 
increase in the number of variables. If the SDT is 
improved by the inclusion of a complex, the chemical 
feasibility of that complex is considered and its 
stability constant is compared with constants from 
92 
similar systems. The calculated standard deviation 
in constant is another useful indication of the 
significance of the species because, although a small 
standard deviation is not proof of significance, it 
is unlikely that a significant complex will have a 
high estimated deviation in constant. 
The concentration of the species is also used as 
a criterion of significance. The definitions adopted 
are that a major species is one for which the computed 
concentrations are greater than 5% of the total 
metal-ion concentration for at least 5% of the data; 
that a minor species is one for which the computed 
concentrations are greater than 1% of the total 
metal-ion concentration for at least 5% of the data 
(but not a major species); that negligible species 
are those less important than minor species. 130 
4.7 The programme COMICS. 
This programme 3 calculates the equilibrium 
concentrations of all species in multi-metal - multi-
ligand mixtures from the pH of the solution, the total 
concentration of each metal, and each complexing agent, 
and the relevant equilibrium constants. 
1 
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4.8 Other programmes used. 
From titration data, the programme STOTD 2 
calculates both n and the functions of rr required for 
the Irving-Rossotti plot. 
The programme GENSPEC calculates, at a specified 
pH, the equilibrium concentrations of each constituent 
of a given system. A graph of percentage composition 
versus pH is also plotted. 
94 
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CHAPTER V 
RESULTS AND DISCUSSION 
Initial estimates of the stability constants 
required by SCOGS 245 before refinement could 
begin. These estimates were made from Irving-
Rossotti plots 2 , or from published data 22 for 
similar systems, either directly or by combining 
comparable stepwise constants. In practice it was 
convenient to refine values for K1 and s2 and then 
progressively add estimates for the species ML 3 , 
MOH , ML (OH) , ML (HL) , and where appropriate, 
m n m n 
ML , increasing in complexity until all of the 
n m 
major and mino r species had been ascertained and 
their stability constant values had been refined 
simultaneously. In the present work, data from all 
of the titrations for each system were treated at 
the same time. 
SCOGS calculates overall stability constants 
(as defined by equation 4.03) and, unless otherwise 
indicated, these are the constants quoted in this 
thesis. 
q 
95 
5.1 Ligands bonding through nitrogen and oxygen. 
Table A.01 (in the Appendix) summarises the 
titration data for the determination of the p!Sa_ 
values of L-leucine, L-isoleucine, L-ornithine 
hydrochloride, and L-arginine. Tables A.02-A.06 
summarise the titration data for the determination 
of the stability constants of the metal complexes 
of glycine, L-leucine, L-isoleucine, L-ornithine 
hydrochloride, and L-arginine. Table A.07 gives 
representative titrations for solutions containing 
metal ions and L-methionine. 
a) pK values of ligands. 
=--a 
The pKa values of glycine (pKal = 9.38, 
2.38) 130 and L-methionine (pK 1 8.91, -a 
2.25) 194 at 37°C and 0.15M (KN0 3 ) are known. 
There is no theoretical guide to the value to 
be assigned to F, the factor required to convert 
the pH to hydrogen ion concentration, defined by 
equation 2.02, but, as discussed elsewhere 130 , a 
value between about 0.70 and 0.85 would be expected. 
The effect of variation in Fon the pK values of 
-a 
L-leucine, L-isoleucine, L-ornithine hydrochloride, 
and L-arginine is summarised in Tables 5.01-5.04. 
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The estimated standard deviations in constant 
are those calculated in SCOGS and all titrations were 
carried out at 37 ° C and an ionic strength of 
TABLE 5. 01 
Effect of F on the pK values of L-leucine 
-a 
F SDT x 10-3 , ml. pKal P~2 
0.70 3.26 9.36 ± 0.01 2.24 + 0.01 
0.75 2.58 9.36 ± 0.01 2.31 ± 0.01 
0.80 2.10 9.36 + 0.01 2.36 + 0.01 
0.85 1.94 9.36 + 0.01 2.41 ± 0.01 
0.90 2.10 9.35 + 0.01 2.46 ± 0.01 
TABLE 5.02 
Effect of F on the pK values of L-isoleucine 
-a 
F SDT X 10-3 , ml. pKal pKa2 
0.70 2.95 9.37 + 0.01 2.22 + 0.01 
0.72 1.84 9.37 ± 0.01 2.26 + 0.01 
0 . 75 1.53 9.37 + 0.01 2.29 ± 0.01 
0 . 77 2.19 9.37 + 0.01 2.33 + 0.01 
0 . 80 3.19 9.36 + 0.01 2.36 + 0.01 
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TABLE 5 . 03 
Effect of F on the pK values of L-ornithine hydrochloride 
-a 
SDT -3 pKal pKa2 pKa3 F X 10 ,ml , 
0.70 1.79 10.28 + 0.01 8.54 + 0.01 1.66 + 0.01 
0.72 1.03 10.26 + 0.01 8.55 ± 0.01 1.75 + 0.01 
0.75 1.25 10.24 + 0.01 8.55 ± 0.01 1.83 + 0.01 
0.80 2.94 10.22 ± 0.01 8.55 + 0.01 1.92 + 0.01 
0.85 4.72 10.20 + 0.01 8.55 + 0.01 2.04 ± 0.02 
TABLE 5.04 
Effect of F on the pK values of L-arginine 
-a 
F SDT X 10- 3 , ml. p~l pKa2 
0.75 3.03 8.82 + 0.01 1.10 + 0.06 
0.77 2.89 8.82 ± 0.01 1.63 ± 0.03 
0.80 2.70 8 .82 ± 0.01 1.82 + 0.02 
0.85 2.31 8.81 + 0.01 2.09 + 0.01 
0.90 2.37 8.81 ± 0.01 2.27 ± 0.01 
The variation in F has little effect on the higher 
pK values but it has a large effect on the lower ones 
-a 
because the hydrogen ion concentration becomes a major 
term in the calculations, especially for pK values less 
-a 
than 2.0. Thus, pKa3 for ornithine and pKa2 for arginine 
are strongly dependent on the value assigned to F. 
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The standard deviation in titre (SDT), which is 
obtained when the complete titration curve is used to 
calculate the pK values of the ligand, is plotted 
-a 
against the value of Fused in the calculation. 
Figure 5.01 shows these curves. The minima range 
from F = 0.73 to F = 0.87 and this agrees with 
130 published work from this laboratory. In the 
absence of any other guide, a mean value of F = 0.80 
is used for all calculations. 
The pK 1 of L-ornithine hydrochloride is assigned -a 
168 to the terminal amino group, following Albert , 
Perkins 169 , Perrin 160 , and Batchelder and Schmidt. 170 
171 It was suggested that the first dissociation step 
involved both basic groups but, since the predicted 
pK values 
-a 
at 20 °c for ornithine are 10.6 for the 
terminal amino group and 9.1 for the amino acid 
nitrogen 257 this is probably incorrect. group I 
The guanidine group of arginine is assumed to be 
fully ionised in the pH range studied and no attempt 
was made to determine the pKa. A "practical" pKa 2 
value for arginine, equal to 2.17 at 37°C was calculated 
f th d . d t 2 5 8 h . t . 2 4 4 rom ermo ynamic a a using t e Davies equa ion 
and the relationship 
K = K 
-prac -ThD 
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Fig. 5.01. Variation of SDT with assumed 
value of F for pK titrations of 
-a 
(1) L-ornithine hydrochloride, (2) L-i soleucine, 
(3) L-leucine, and (4) L-arginine. 
Although probably fortuitous, this value nevertheless 
agrees with the pK 2 predicted at the minimum of -a 
the SDT versus F plot (2.18 at F = 0.87). 
b) Stability constants of metal complexes. 
Simple, protonated, and hydrolysed species are 
considered for each system and Tables 5.05-5.10 
summarise the results. For glycine, L-leucine, and 
L-isoleucine, the stability constants calculated 
for a "ML only" system are given for comparison 
n 
with the complete computer analysis of the data. 
Table 5.09 shows the effect of the variation in F 
on the stability constants of metal-arginine 
complexes. 
TABLE 5. 05 
Stability constants of glycine with M2+. 
(1) Cobalt (II) 
"ML only" approach 
n 
log Kl 4.58 + 0.03 4.62 + 0.01 
log S2 8.33 + 0.01 8.32 ± 0.01 
* * log S3 10.42 + 0.07 10.44 ± 0.07 
log SML(HL) 15.09 + 0.25 
SDT X 10- 3 , ml. 2.32 2.37 
101 
log Kl 
log S2 
log S3 
SDT x 10- 3 , 
log Kl 
log S2 
log S3 
log SMHL 
log SML OH 2 
SDT x 10-3 , 
( 2) Nickel (II) 
5.66 + 0.01 
10.28 + 0.01 
13.44 + 0.02 
' ml. 2 .19 · 
(3) Cadmium(II) 
4.17 + 0.03 
7.52 + 0.03 
10.60 ± 0.19 
* 
-2.76 ± 0.10 
ml. 1.81 
TABLE 5.06 
"ML only" approach 
n 
4.14 + 0.01 
7.51 + 0.01 
* 9.33 + 0.07 
1.99 
Stability constants of L-leucine with M2+ 
(1) Manganese(II) 
log Kl 2.33 + 0.07 2.41 ± 0.02 
log S2 4.66 + 0.05 
log SML(HL) 13.39 + 0.27 
log SMLOH -7.09 + 0.06 
SDT x 10- 3 , ml. 1.03 1.69 
102 
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(2) Cobalt(II) 
"ML only" approach n 
log Kl 4.22 ± 0 . 03 4. 2 6 + 0 . 01 
log (32 7 . 76 ± 0.02 7.72 + 0 . 02 
log S3 10.18 + 0.08 
log SML(HL) 14.91 + 0.26 
* log SML OH -2.02 ± 0.06 
SDT 
2_3 
ml. 1.54 1.97 X 10 , 
( 3) Nickel (II) 
log Kl 5.34 + 0.02 5.31 + 0.01 
log (3 2 9.70 + 0.02 9.68 + 0.01 
log SMHL 10.37 + 0.35 
SDT X 10- 3 , ml. 1.28 1.29 
(4) Copper (II) 
log Kl 8.04 + 0.04 7.99 + 0.01 
log (3 2 14.69 + 0 . 05 14.43 ± 0.02 
log SMHL 11.49 ± 0.13 
log SML(HL) 19.43 + 0.11 
SDT x 10- 3 
' 
ml. 1.57 2.58 
(5) Zinc(II) 
log Kl 4.51 + 0.02 4.55 + 0.01 
log (3 2 8.56 ± 0.01 8.57 + 0.01 
* log (3 3 11.24 + 0.18 
* log SML (HL) 15.17 + 0.16 
* log SMLOH -4.25 + 0.10 
SDT x 10-3 , ml. 0.80 0 . 91 
log Kl 
log S2 
log SMLOH 
SDT X 10- 3 , ml. 
(6) Cadmium(II) 
3.84 + 0.01 
7.00 + 0.02 
-5.39 + 0.04 
0.83 
TABLE 5.07 
11 ML only II approach 
n 
3.81 ± 0.01 
7.12 ± 0.01 
1.75 
Stability constants of L-isoleucine with M2+ 
(1) Manganese(II) 
log Kl 2.15 + 0.07 2.12 + 0.09 
log S2 4.54 ± 0.14 
* log SMLOH -7.31 + 0.13 
SDT X 10- 3 , ml. 2.92 2.95 
(2) Cobalt(II) 
log Kl 4.21 ± 0.07 4.15 + 0.02 
log s2 7.54 + 0.22 7.42 + 0.02 
* log S3 9.42 + 0.19 
log SMHL 11.23 ± 0.53 
log SML (HL) 15.45 + 0.57 
log SMLOH -5.21 + 0.12 
SDT x 10 - 3 , ml. 3.30 3.81 
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log Kl 
log S2 
log S3 
SDT x 10-3 I ml. 
log Kl 
log S2 
log SMLOH 
SDT X 10- 3 I ml. 
log Kl 
log S2 
log SMLOH 
log SML(HL) 
SDT x 10- 3 I ml. 
log Kl 
log S2 
log SMHL 
log SMLOH 
log SML OH 2 
SDT x 10- 3 , ml. 
(3) Nickel (II) 
5.19 + 0.01 
9.34 + 0.01 
12.01 + 0.04 
1.61 
( 4) Copper (II) 
7.95 + 0.01 
14.68 + 0.01 
0.31 + 0.05 
2.07 
(5) Zinc (II) 
4.40 + 0.04 
8.08 + 0.06 
-3.62 ± 0.05 
15.25 ± 0.34 
1.64 
(6) Cadmium(II) 
3.81 + 0.04 
6.71 + 0.08 
11.25 + 0.11 
-5.82 + 0.17 
* 
-3.09 ± 0.17 
0.85 
"ML only" approach 
n 
7.94 + 0.01 
14.66 ± 0.02 
4.30 
4.43 + 0.02 
8.47 + 0.02 
3.17 
3.58 + 0.01 
6.78 + 0.01 
1.83 
105 
TABLE 5.08 
S ability constants of L-ornithine 
hydrochloride with M2+ 
(1) Manganese(II) 
log Kl 2.67 ± 0.03 3.44 ± 0.16 
log SMHL 12.08 ± 0.02 13.20 ± 0.18 
log SMH L 21.56 + 0.20 
SDT 
2_3 
ml. 1.38 X 10 1 0 .. 97 
(2) Cobalt(II) (3) Nickel (II) 
log Kl 4.94 + 0 . 02 6.86 + 0 . 03 
* log S2 8.46 + 0.02 11.65 + 0.01 
log SMHL 13.81 + 0 . 01 14 . 84 + 0 .01 
log SML(HL) 18. 29 ± 0.01 20.92 + 0 . 01 
log SM(HL) 2 
27.07 + 0 . 01 29.02 + 0 . 01 
SDT x 10-3 ml. 0.72 1.73 I 
(4) Copper (II) (5) Zinc(II ) 
* log Kl 9.78 + 0.28 5.96 + 0.05 
log S2 14.77 + 0.06 
log SMHL 17.42 + 0.01 14 . 08 + 0.01 
log SML(HL) 24 .7 3 + 0.02 19.31 ± 0 .03 
log SM(HL) 2 
33.64 0.01 27 . 62 ± 0.03 
log SMLOH 0 . 89 0.16 -2 .5 9 ± 0.03 
SDT x 10-3 , ml. 2.88 1.95 
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(6) Cadmium(II ) 
log Kl 4.47 ± 0.03 
log SMHL 13.36 + 0.01 
log SML(HL) 17.01 + 0.05 
log SM(HL) 2 
26.21 + 0.01 
SDT x 10- 3 ml. 1.18 I 
TABLE 5.09 
Effect of Fon the stability constants of 
L . . . th 2+ -arginine wi M 
(1) Manganese(II) 
F=0.75 F=0.80 F=0. 85 
log Kl 1.97 ±0.11 1.97 ±0.07 1. 93±0.02 
* * * log SMLOH -7.97±0.79 -7.96 ±0.45 - 8.00 ±0.13 
SDT X 10-3 I ml. 5.93 3 . 47 0.92 
(2) Cobalt(II) 
log Kl 3.70 ±0.03 3.70 ±0.02 3.70 ±0.0 1 
log B2 6.90 ±0.03 6.90 ±0.02 6 . 88 ±0 . 01 
SDT X 10- 3 I ml. 6.76 4.45 1.7 8 
......... 
1 08 
(3) Nickel (II) 
F=O. 7 5 F=0.80 F=0.85 
log Kl 4.83 ± .01 4.79 ±. 02 4 . 83 ±. 01 4 ., 8 3± . 01 
log (32 8.88±.01 8.93±.02 8.88 ± .01 8 . 87 ±. 01 
log S3 11.78±.04 11.69 ± .04 11.78 ± .03 11.76 ± .03 
log SML(HL) 15.23 ± .17 
* log SML OH -1.56 ± .08 
SDT 
2_3 
ml. 2.13 1.49 1.81 1.52 X 10 , 
(4) Copper(II) 
log Kl 7.40±.02 7.38±.01 7.37±.02 7.39±.01 
log S2 13.68±.02 13.66±.01 13.64 ± .01 13.65 ± .01 
* log S3 15.84 ± .06 
* * log SMHL 10.08±.30 9.66±.44 
* log SML 2 (HL) 
24.06±.10 
* * * * log s 3.18±.06 3.17±.04 2.97±.04 3.18 ± .03 M2 (0H) 2L2 
SDT -3 1.22 1.14 0.82 1.02 X 10 , ml. 
( 5) Zinc (II) 
log Kl 4.03±.03 4.03 ± .02 4.03 ± .04 
log S2 7.56 ± .09 7.56±.06 7.54 ± .04 
log SMLOH -4.25±.16 -4.25 ± .11 -4.26 ±. 06 
SDT X 10-3 , ml. 5.73 3.68 2.24 
log Kl 
log s2 
-3 SDT x 10 , ml. 
(6) Cadmium(II) 
F=0.75 F=0.80 
3.25±0.04 3.25±0.03 
6.27±0.03 6 . 27 ±0. 02 
5.57 3.74 
TABLE 5.10 
F=0.85 
3.24±0.0 
6.26±0.01 
1.67 
Stability constants of L-methionine with M2+ 
( 1) Cadmium (II) ( 2) Lead (II) 
log Kl 3.58 ± 0.02 4.43 + 0.04 
log S2 6 .7 2 + 0 . 01 
* log SML(HL) 13.81 + 0.20 
log S.MLOH -3.60 + 0.03 
* log SML 20H 
-3.45 + 0.04 
SDT -3 ml. 0.98 3.10 X 10 , 
* Denotes minor species, major species unmarked. 
c) Discussion. 
The most important complexes of L-ornithine are 
those in which the terminal amino group is protonated 
and these are denoted by MHL and M(HL) 2 . The 
ornithine anion, L, forms complexes ML and ML 2 , and 
1 09 
the monoprotonated 1:2 complex ML(HL) is also formed. 
In the copper(II)-L-ornithine system, ML is a minor 
species and in the cobalt(II) system, ML 2 is a minor 
species. For all the other amino acids studied, ML 
and ML 2 are major species. The amino group of these 
amino acids is assumed to be protonated in the 
complexes MHL and ML(HL). 
The significance of a complex which refines in 
the SCOGS analysis is judged by whether it improves 
the fit to the titration data (as measured by the 
SDT), and whether it is chemically feasible (see 
section 4.6 for details). Protonated and hydrolysed 
complexes are present in most of the systems studied 
and in some cases are major species. For example, 
the SDT is considerably reduced by the inclusion of 
MHL and ML(HL) in the analysis of the copper(II)-
L-leucine system and both are major species. 
Nickel(II) with the amino acids glycine, L-isoleucine, 
and L-leucine, cobalt(II) with glycine, L-isoleucine, 
and L-arginine, manganese(II) with L-isoleucine, and 
cadmium(II) with L-arginine are, however, adequately 
described by the simple complexes, ML, ML 2 , and in 
some cases, ML 3 . This does not necessarily mean 
that stability constants could not be obtained for 
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protonated and hydrolysed species but rather that 
their inclusion did not significantly improve the 
fit to the data. Thus, a stabili ty constant i s 
refined for MHL in the nickel(II)-L-isoleucine 
system, and for ML(HL) in the cobalt(II)-glycine 
system, but the SDT does not change and both 
constants have a high estimated standard deviation 
in constant (ESDC). Although a low ESDC is not 
proof of the significance of the complex, it is 
generally true that a major species has a low ESDC 
whereas that of a minor, or a negligible, species is 
higher. In most cases, the log K1 and log s2 values 
are unaffected by the inclusion of protonated or 
hydrolysed complexes. There are exceptions, for 
example, log K1 for cadmium(II)-L-isoleucine, 
log s2 for cadmium(II)-L-leucine, c opper(II)-
L-leucine, and zinc(II)-L-leucine, where the difference 
between the calculated stability constant values is 
significant (outside the limit of 3 x ESDC). This 
means that it is important that all possible species 
should be considered in the computer analysis of 
metal-amino acid titration data. 
Table 5.09 shows the effect of the variation of 
F from 0.75 to 0.85 on the stability constants of the 
metal-arginine systems. Over this range, the stability 
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constants of the metal-arginine complexes are 
unaffected. The standard deviation in titre, 
however, decreases with increase in F and 
calculation of the stability constants at F = 0.90 
(not shown in Table 5.09) shows that the optimum 
fit to the data is obtained around F = 0.85. This 
corresponds to the minimum for L-arginine in 
Figure 5.01. 
The copper(II)-L-arginine system, in which 
log S values are refined for ML 3 and ML 2 (HL) at 
F = 0.80, illustrates the problems associated with 
the computer analysis of data. The stability constants 
for these species have reasonable estimated standard 
deviations, the fit to the titration data is improved 
by their inclusion, and they are present in 
concentrations indicating that they are minor species. 
Copper(II), however, is known to favour four 
coordination and, because of the Jahn-Teller effect, 
only increases its coordination number to six by 
very weak interactions in a distorted octahedral 
configuration. Ethylenediamine and ammonia are known 
to form six coordinate copper(II) complexes but the 
1:3 complex of the former only forms at extremely 
high concentrations of ethylenediamine. The addition 
of the fifth and sixth ammonia molecules is difficult 
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and [Cu(NH 3 ) 6 ]
2
+ is only formed in liquid ammonia. 
It is therefore unlikely, but not impossible, that 
the complexes ML 3 and ML 2 (HL) could be present in 
the solution. They are, however, not important 
species and the copper(II) system may be adequately 
described by ML, ML 2 , and M2L2 (0H) 2 . The latter 
complex has been previously reported and it 
contains bridged hydroxyl groups. 259 
+ The glycine zwitterion, HL - , would be expected 
to function as a monodentate complexing agent 
because, like the acetate ion, it possesses a 
carboxylate group. Such complexes would be much 
weaker than the bidentate chelates formed by the 
glycine anion but, in acid solutions, they could be 
present in significant concentrations. The stability 
constants of the acetate anion with some divalent 
metal ions are as follows: Cadmium(II), 1.5 
(25°C, I=O.lM); cobalt(II), 1.5 (3 0 °C , I-+O); 
nickel(II), 1.0 (25°C, I=O.lM); copper(II), 1.84 
(35 °C, I=O. 2M) ; zinc (II) , 1. 0 (25 ° C, I=O. lM) ; 
manganese(II), 0.84 (25 °C , I=O) . 22 
From the SCOGS analysis , the protonated species 
MHL and ML(HL) are consistent with the titration data. 
The stability constant for the formation of the 
monoprotonated complex, log Ki, is defined by the 
113 
equilibrium 
M + HL ~ MHL 
I 
log Kl [MHL] 
[M] [HL] 
and this may be compared with the log K1 for the 
acetate ion. Log Ki values for cadmium-glycine 
(=1.22) and for copper-L-arginine (=1.26) are 
lower than log K1 for the corresponding acetate 
complex and this is consistent with the electron 
+ 
withdrawing effect of the -NH 3 group which tends 
to decrease the metal binding ability of the 
carboxyl group. For cadmium-glycine and copper-
L-leucine, the log K1 values are 1.89 and 2.13, 
that is, greater than log K1 for the acetate 
complex. The experimental uncertainty in log SMHL 
for these complexes is high and, because the 
log Ki values are calculated from these constants, 
they will also have high estimated standard 
deviations. I The difference between log K1 and the 
log K1 of the corresponding acetate is not therefore 
significant. 
There is evidence in the literature for complex 
formation by the zwitterions of amino acids and the 
present results are in accord with this. Solubility 
measurements 260 have shown that the zwitterions of 
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glycine and DL-alanine form complexes with copper(II) 
. h · 1 1 . . t · 2 61 1 ions w i ea Raman spectra investiga ion a so 
suggests that, at low pH in solutions containing 
zinc(II) ions and glycine, monodentate complexes 
are formed with the metal ions bound through the 
carboxylate group. This concept is reinforced 
b . d 1H d . 2 6 2 f 1 . . th y ir an nmr stu ies o DL-a anine wi 
several divalent metal ions in deuterium oxide 
solutions. 130 Previous work in this Department 
has also indicated the presence of protonated species 
in solutions containing copper(II), zinc(II),and 
manganese(II) and amino acids. 
The formation of a hydrolysed species may be 
envisaged either as the loss of a proton from an 
aquated complex or as the attachment of a ligand 
to a hydrolysed metal ion. Hydrolysed species are 
postulated in the computer analysis of the titration 
data of all systems except manganese(II ), cobalt(II), 
nickel(II), and cadmium(II) wi th L-ornithine. Each 
metal ion forms hydrolysed species with at least 
one of the amino acids studied and some o f these 
hydrolysed complexes are present as major species. 
For example, the lead-L-methionine complex MLOH is 
very important at high pH . Using the stability constants 
calculated for the lead-L-methionine complexes, the 
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Fig. 5.02. Variation with pH of composition of solutions of 
(A) 0.0050M L-arginine and 0.0025M nickel(II) ions, 
(B) 0.0027M L-methionine and 0.0012M lead(II) ions. 
concentrations of all species are calculated from 
pH 6.4 to 8.8 for a solution of L-methionine 
(0.0027M) and lead(II) ions (0.0012M). The 
values are plotted in Figure 5.02. The hydrolysis 
+ 
constant for PbOH is fixed during the SCOGS analysis 
+ of the data and PbOH is a significant species. 
With the increase in pH, however, the concentration 
of the hydrolysed complex, PbLOH, rises and it 
becomes the most important species. The presence 
of hydrolysed species in this system and in the 
cadmium-L-methionine system, could account for the 
anomalous n values calculated at high pH (see 
Table A.07). 
The present results lie within the range of 
the reported stability constants (see Tables 2.01-
2.05 and Table 2.08). The importance of protonated 
and hydrolysed species in metal-amino acid systems 
is clearly demonstrated, however, and it is suggested 
that future analyses of similar systems should take 
account of these complexes especially as the log K1 
and log s2 values may be affected by their inclusion. 
For L-ornithine, the complexes MH 2L (in which 
both amino groups are protonated and the metal is 
bound through the carboxylate group), and M2L (in 
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which one metal ion is bound through the carboxylate 
group and the other chelated by both the nitrogen 
atoms) may be envisaged. With the exception of the 
complex MH 2L for manganese, these species are not 
consistent with the computer analysis of the titration 
data. A stability constant is obtained for MnH 2L 
but, although the SDT is reduced, the estimated 
standard deviations in constant for all the species 
are high. The calculated stability constants of 
MnL and MnHL are significantly altered when MnH 2L 
is included in the computer analysis (see Table 5.08). 
It is difficult to know whether the inclusion of 
MnH 2L is justified and this problem is encountered 
with other manganese systems, for example, 
manganese-L-isoleucine. The weak complexes formed 
by manganese(II) could account for this. 
Zinc(II) complex formation generally occurs 
at a higher pH than that of copper(II) and this may 
be illustrated by the consideration of the 
L-ornithine complexes. Using the computed stability 
constants, the concentrations of all species are 
calculated from pH 3.2 to 9.6 for a solution 
containing L-ornithine hydrochloride (0.0055M) and 
copper(II) ions (0.0026M). Similarly, the variation 
with pH in the composition of a solution containing 
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Fig. 5.03. Variation with pH of composition of solutions of 
(A) 0.0056M L-ornithine hydrochloride and 0.0025M zinc(II) 
1.ons, 
(B) 0.0055M L-ornithine hydrochloride and 0.0026M copper(II) 
1.ons. 
L-ornithine hydrochloride (0.0056M) and zinc(II) 
ions (0.0025M) is calculated and the results are 
plotted in Figure 5.03. Significant zinc(II) complex 
formation takes place above pH 5.4 whereas copper(II) 
complexes are significant at the start of the 
titration. A greater percentage of free zinc(II) 
than free copper(II) is present at the end of the 
titration. The very low concentrations of CuL explain 
why a high standard deviation in the stability constant 
is obtained from the SCOGS analysis. Precipitation 
occurs in the zinc(II) titrations before the species 
ZnL 2 is present in sufficiently large concentrations 
to allow the stability constant to be estimated. It 
is not possible to say which of the three complexes 
ZnL, ZnL(HL), or ZnLOH precipitates and the 
precipitate may be a mixture of all three. 
The stability constants of the nickel(II)-
L-ornithine complexes are used to calculate the pH 
dependence of the composition of a solution containing 
L-ornithine hydrochloride (O.OOSOM) and nickel(II) 
ions (0.0025M). This plot is shown in Figure 5.02. 
Significant nickel(II) complex formation takes place 
at a pH below that for significant zinc(II) complex 
formation but above that for significant copper(II) 
complex formation. Under these conditions, the 
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species NiL 20H is present in low concentrations. 
Table 5.11 summarises the effect of metal ions 
on the pK of the terminal amino group of L-ornithine 
-a 
hydrochloride and the modified nK' is described by i,--a 
the equilibrium 
Cu 
Ni 
Zn 
Co 
MHL F ML + and 
TABLE 5.11 
2+ Effect of M on the pK of 
-a 
L-ornithine hydrochloride 
pK' 
-a 
7.64 
7.98 
8.12 
8.87 
Cd 
[MHL] 
pK' 
-a 
8.89 
9.41 
10.22) 
From Table 5.11, the interaction of the metal ions 
with the ligand is seen the lower the pK of the 
-a 
terminal amino group so that the protonated metal 
chelate dissociates at a lower pH than the free 
ligand. A similar effect was noticed by McBryde in 
work on the metal complexes of tyrosine. 290 The 
magnitude of the effect on the pK depends upon the 
-a 
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position of the metal in the Irving-Williams 
series. 415 The stability constant for the complex 
CuL has a high estimated standard deviation and, 
because the calculation of pK' involves this 
-a 
constant, pK' will also have a high standard 
-a 
deviation. Copper(II) would still, however, exert 
the greatest effect on pK. Lenz and Martell 171 
-a 
observed that the lowering of the pK of the 
-a 
terminal amino group of ornithine by metal ions 
was in the sequence copper(II) > nickel(II) > 
cobalt(II). Although their stability constants 
for MHL agree with those reported in Table 5.11, 
their constants for ML are considerably highe.r 
(and are, in fact, not internally consistent), so 
that their calculated pK' values do not agree with 
-a 
the present results. 
Ornithine has three possible chelation sites, 
the terminal amino, the a-amino, and the carboxyl 
group. In the protonated complexes (the most 
important species), the terminal amino group is 
assumed to be the site of protonation, and the 
complexes will be bidentate as with the simple 
amino acids. The ornithine anion may chelate in 
the same way as the neutral molecule or via the 
two nitrogen atoms to form a seven-membered chelate 
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ring. Alternatively, chelation could occur through 
all three possible sites at the same time. Whereas 
octahedral or tetrahedral structures can be envisaged 
for both bi- and tri- dentate chelation $quare 
planar complexes can only be formed if the 
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ornithine is bidentate. Recently , circular 
dichroism studies indicated that the cqpper(II) 
complexes of the ornithine anion have bonding 
similar to that in the simple amino acids. This 
confirmed early work by Brubaker and Busch who 
also suggested that the corresponding nickel(II) 
complexes were chelated by the two nitrogen atoms 
f th 'th' . 207 o e orni ine anion. 
The guanidine group of arginine is assumed to 
be fully ionised and the complexes will be bidentate 
as in the simple amino acids. The log K1 values 
for lead(II) and cadmium(II) with L-methionine are 
consistent with the log K1 versus pKal plots for 
the appropriate metal ion with the simple amino acids. 
Thus, the sulphur atom of L-methionine may be assumed 
to take no part in the bonding. 
The lower stability of the L-ornithine complexes, 
compared with those of L-arginine, correlates with 
the lower basicity of the a-amino group of ornithine . 
This confirms the observations of Lenz and Martell 17 1 
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who suggested that the difference in basicity towards 
both metal ions and hydrogen ions was due to the 
difference in the inductive effects on the a-amino 
group by the terminal functional group. The greater 
effect of the terminal amino group was thought to be 
caused by the concentration of the po~itive charge 
on the nitrogen atom of the terminal amino group of 
ornithine, whereas, in arginine, it was dispersed 
over the nitrogen atoms of the guanidine gr9up. 
h . . 11 · 4 ' 5 d . b d . Te Irving-Wi iams or er is o serve in 
the stability constants summarised in Table 5.05-
5.10. 
5.2 Ligands bonding through sulphur. 
A biologically important property of naturally 
occuring thiols is their ability to form stable 
metal complexes, especially with zinc and the heavy 
metal ions. It is therefore desirable to know the 
nature and stability of these chelates. Previous 
studies of ligands bonding through sulphur have, in 
general, been based on the assumption that only 
stepwise complexes, ML , ML 2 , ML 3 , were formed, 
although it is known that polynuclear complexes 
b t . . 210-214 . . f may e presen as maJor species , arising rom 
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the bridging ability of sulphur atoms. This ability 
may be related to the fact that sulphur can accept 
f h 1 . b b d. 293 electrons rom t e meta ion y n- on ing. 
Increased electron density on the bound sulphur 
results and this facilitates bridge formation. 
Polynuclear, as well as protonated and hydrolysed, 
species are postulated for thiols. 
Information on the hydrolysis of lead was required 
as a preliminary to the analysis of the lead-thiol 
titration data. From a series of titrations 
(summarised in Table A.08) covering the metal ion 
concentration range of 0.001 to 0.005M with pH values 
from 3.0 to 7.0, hydrolysis constants for the aqua 
lead(II) ion in 0.15M KN0 3 solution at 37°C were 
computed to be:-
log S11 - -7.71±0.28 for Pb
2+ + H O ~ PbOH+ + H+ 2 ~ 
log S44 - -20.18±0.23 for 4Pb
2+ + 4+ 4H 2o ~ Pb 4 (OH) 4 + 
log S43 -23.05±0.32 for 3Pb
2+ + 2+ 
- 4H 2o ~ Pb 3 (OH) 4 + 
SDT x 10- 3 , ml. 2.70 
These hydrolysis constants are within the range of 
values reported in the literature. 22 The complex 
PbOH+ is the major species in the titration and the 
complexes Pb (OH) 4+ and Pb (OH) 2+ are present in 4 4 3 4 
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4H+ 
4H+ 
low concentrations. Thus, only the constant log s11 
was used in the SCOGS analysis of the lead(II) 
titrations with thiols. 
a) L-cysteine and D-pe~icillamine. 
The two highest pK values for L-cysteine and 
-a 
D-penicillamine at 37°C and I= 0.15M (KN0 3 ) are 
known (10.23, 8.07 for L-cysteine, and 10.49, 7.81 
for D-penicillamine 229 ) but, because the titrations 
of lead(II) with these ligands commence at low pH 
values, estimates are also needed of the pK values 
-a 
of the carboxyl groups. Direct titration of solutions 
of D-penicillamine (0.004M and O.OOSM, respectively) 
affords a pK value of 1.82 ± 0.01, taking F = 0.80. 
-a 
For reasons discussed in section 5.la, this pK is 
-a 
expected to be sensitive to variation in F. The 
estimate of the pK of L-cysteine (2.1 at 37°C) is 
-a 
obtained from the pK of L-alanine (2.377 at 37°C 130 ) 
-a 
by using the Taft equation to allow for the substituent 
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effect of the -SH group. 
182 The study by Perrin and Sayce , at 20°C and 
I= O.lM (NaCl0 4), on the nickel(II)-L-cysteine system 
was repeated at 37°C and I= 0.15M (KN0 3 ). Table A.08 
contains a summary of the titrations and the resul t s 
are shown in Table 5.12. 
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TABLE 5 .12 
Stability constants of L-cysteine with M2+ 
(1) Nickel (II) (2) Lead(II) 
log Kl 9.37 + 0.05 11.69 + 0.01 
log f3 2 19.65 + 0.01 
log SMHL 14.74 + 0.09 15.96 ± 0.03 
log f3 32.28 + 0.06 
M2L3 
SDT x 10-3 , ml. 0.86 1.39 
TABLE 5 .13 
Stability constants of D-penicillamine with M2+ 
log 
log 
log 
log 
SDT 
All 
(1) Cadmium(II) ( 2 ) Le ad (II) 
Kl 
f3 2 
SML (HL) 
f3M(HL) 2 
-3 
ml. X 10 , 
. 
maJor species. 
"ML only" approach 
n 
11.10±0.02 11.28±0.03 
18.75±0.04 
12.93±0.01 
18.81±0.01 
25.86±0.02 
31.79±0.06 
1.86 7.68 2.00 
In the nickel(II)-L-cysteine system, it is also 
possible to refine stability constants for the 
complexes ML 2 , MHL, M2L3 , and M3L4 but, in this case, 
no constant can be obtained for ML. Programmes, like 
SCOGS, rely on curve fitting techniques and it is 
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difficult to distinguish between different polynuclear 
species. Thus, the postulation of M3L4 in the 
programme is almost equivalent to the postulation 
of ML and M2L3 . 
Table A.08 summarises the titration data for 
lead(II)-L-cysteine and Table A.09 shows a 
representative titration, with calculated n values, 
for lead(II)-D-penicillamine. The stability constants 
obtained from the computer analysis of these systems 
are summarised in Tables 5.12 and 5.13. 
At the beginning of the titrations, the 
protonated lead(II)-cysteine and the 1:1 lead(II)-
penicillamine complexes are present in significant 
concentrations. The hydrolysed metal ion is present 
in low concentrations which is in contrast to its 
relative importance in the lead(II)-methionine 
system (see Figure 5.02). This can be accounted for 
by the greater affinity of lead for thiols than for 
nitrogen-oxygen binding ligands. 
The stability constants for the lead complexes 
correlate with the literature values in Tables 2.06 
and 2.07. 
Reported pH titrations up to pH 12 for lead(II)-
t . 178 d cys eine an 
181, 185-6 ld cou 
up to pH 10 for lead(II)-penicillamine 
not be confirmed. Precipitation 
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occurred above pH 5.5 with L-cysteine and above 
pH 8.5 with D-penicillamine. Similarly, published 
stability constant values for the 1:2 and 1:3 
complexes of lead(II)-penicillamine 183 are 
doubtful because the present results show that 
only the 1:1 complex was formed in appreciable 
concentrations before precipitation. This 
discrepancy probably arises from the use, by previous 
workers,of shorter titration times and less sensitive 
pH meters, so that the characteristic pH drift 
accompanying precipitation would be less likely to 
be detected . 
Table A.10 summarises the titration data for 
cadmium(II)-D-penicillamine and the stability 
constants calculated are shown in Table 5.13 The 
hydrolysis constant for the cadmium(II) ion was 
included in the analysis but the hydrolysed cadmium(II) 
ion was present in negligible concentrations. Table 5.13 
also shows the stability constants obtained by 
postulating ML and ML 2 only. The standard deviation in 
titre is considerably reduced by the inclusion of the 
complexes ML(HL) and M(HL) 2 which are important species. 
The improvement of the fit of the computer analysis to 
the titration date by the inclusion of a species (which 
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is chemically feasible) is the major criterion for the 
acceptance of that species. The log K1 of cadmium(II)-
D-penicillamine is reduced slightly by the inclusion 
of the protonated species in the analysis of the data. 
In penicillamine-metal complexes, it is believed 
that the ligand coordinates through the nitrogen and 
the sulphur atoms with cobalt(II), zinc(II), and 
nickel(II) whereas it is tridentate with mercury(II), 
cadmium(II), and lead(II) . 1811185- 6 Tridentate 
chelation has also been postulated in the 1:1 complex 
. 178 181 
of lead(II)-L-cysteine. ' Although cadmium 
can form six-coordinate complexes, four coordination 
. f d 29 is avoure. This may explain why log K2 for 
cadmium(II)-penicillamine is must less than log K1 , 
namely that in the 1:1 complex, penicillamine is 
tridentate whereas in the 1:2 complex, it is bidentate. 
The two higher pK values for L-cysteine and 
-a 
D-penicillamine cannot be unequivocally assigned to 
either the amino or the thiol group. Thus, in the 
protonated complexes, the proton may be either on 
the nitrogen or on the sulphur atom and no definitive 
statement can be made on the chelation of the ligand 
in these complexes. 
130 
b) N-(2-mercaptopropionyl)glycine. 
SH 
I 
CH 3 .CH.CO.NH.CH2 .co 2H 
The study of the complex formation of metal ions 
with peptides is a necessary extensicn to the COMICS 
approach and it may be regarded as a preliminary 
to considering metal-protein interactions in blood 
plasma. N-(2-mercaptopropionyl)glycine is selected 
as a model for a dipeptide because it contains an amide 
linkage, a carboxyl group, and a thiol group. There 
are several possible binding sites namely, the th i o l 
group, the amide oxygen or nitrogen, and the oxygen 
atom of the glycyl carboxyl group. Its complex 
formation with divalent metal ions has not previous ly 
been examined although it was used in a study of 
. d 1 · d 1 f t' 209 mixe - igan comp e x orma ion. 
1 31 
Table A.11 summarises the titration data f o r the 
determination of the pK values of N-(2-rnercaptopropionyl) 
-a 
glycine and these were computed to be:-
pKal - 8.27 + 0.003 SDT,ml. - 1.25 X 10-
3 
pKa2 - 3.48 + 0.004 SDT,ml. - 1.87 X 10-
3 
The only previously r eported values were p~1 - 8.74 and 
pKa2 = 3.60, at 22 ° C and O.lM (KNo 3 ) .
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-Representative titration data, and n values, for 
zinc(II), cadmium(II), and lead(II) with 
N-(2-mercaptopropionyl)glycine are given in Table A.12. 
The rr values are greater than 2 at high pH and the 
presence of species other than the 1:1, 1:2, and 1:3 
complexes is indicated. The results of the computer 
analysis of the data are shown in Table 5.14. 
TABLE 5.14 
Stability constants of N-(2-mercaptopropionyl)glycine 
with M2+ 
(1) Cadmium (II) ( 2 ) Zinc(II) (3) Lead(II) 
log Kl 6.28±0.02 5.32±0.01 6.44±0.02 
log S2 11.83±0.01 10.13±0.01 
log S3 15.33±0.02 13.47±0.03 
log s 21.13 ±0.17 
M2L3 
log s 31.43±0.06 
M3L4 
log SMLOH 0.77±0.04 
log SML OH 0.66±0.02 
SDT 
2_3 
ml. 1.41 2.10 3.86 X 10 1 
All major species. 
In addition to the simple species ML , polynuclear, 
n 
protonated, and hydrolysed species were postulated for 
cadmium(II), zinc(II), and lead(II). However, only the 
complexes shown in Table 5.14 refined. The inclusion 
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of the polynuclear ?pecies Cd 2L3 and Cd 3L4 considerably 
reduced the SDT obtained in the computer analysis of 
the data. The formation of polynuclear complexes 
with cadmium(II) and thiol-containing ligands has 
been t d . the 1·t t 215,255 repor e in i era ure. 
Precipitation occurs about pH 10.0 in the 
zinc(II) titration whereas the cadmium(II) complexes 
are less soluble, precipitating at about pH 8.8. 
The stability constants of the lead(II) complexes 
are used to compute the equilibrium concentrations of 
species present in a solution containing 
N-(2-mercaptopropionyl)glycine (0.0066M) and lead(II) 
ions (0.0012M). This is illustrated in Figure 5.04. 
The hydrolysed metal ion is not important under these 
conditions although the hydrolysed complex PbLOH 
accounts for a large proportion of the metal ion 
above pH 7.5. 
Similar computations for zinc and cadmium solutions 
containing N-(2-mercaptopropionyl)glycine are shown 
in Figures 5.04 and 5.05. From Fig~re 5.04, the 
precipitate which forms in the zinc(II) titration is 
probably ZnL 20H and, from Figure 5.0~, the precipitate 
is presumably CdL 3 . The polynuclear species Cd 2L3 
and Cd 3L4 are present in significant concentrations 
about pH 5.4. 
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Whereas in simple metal-amino acid complexes, 
hydrolysed species arise by the loss of a proton from 
an aquated metal complex , or by the attachment of a 
ligand to a hydrolysed metal ion, another possibility 
exists when the ligand contains an amide or a 
peptide linkage. This is the ionisation of the 
proton attached to this nitrogen atom. The formation 
of the N-(2-mercaptopropionyl )glycine complex, 
ZnL 20H, may be attributed to the loss of a proton 
from a coordinated amide group in the complex ZnL 2 , 
according to the equilibrium. 
The pK for this reaction is 9.47. A similar, but 
-a 
h t . . t. ( pK -- 5 . 3 5 at 3 0 ° C 2 9 4 ) , muc s ronger ionisa ion 
-a 
has been observed in the 1:1 copper-glycylglycine 
complex. The lead complex PbLOH of N-(2-mercapto-
propionyl)glycine could be formed by the loss of a 
proton from the complex PbL. Lead(II) hydrolyses 
easily, however, and PbLOH is more likely to form 
in the same way as the hydrolysed metal complexes of 
simple amino acids. 
In the complexes of N-(2-mercaptopropionyl)glycine, 
simultaneous chelation via the sulphur atom and the 
carboxyl oxygen is unlikely because an eight-membered 
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Fig. 5.04. Variation with pH of composition of solutions of 
(A) 0.0066M N-( 2-rnercaptopropionyl)glycine and 0.0012M 
lead(II) ions, 
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Fig. 5.05. Variation with pH of composition of a 
solution of 0.0047M N-(2-mercaptopropionyl)glycine 
and 0.0012M cadmium(II) ions. 
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chelate ring would be formed. It is difficult to 
predict the chelation in these complexes because 
of the lack of stability const~pt data on suitable 
model compounds (for example, 2-meroaptopropionic 
acid). Since the corresponding glycine complexes 
are less stable (for cadmium(II), log K1 = 4.17
22 ; 
130 . for zinc(II), log K1 - 4.89 ; for lead(II), 
1 5 4 7 2 2 ) , the t · · t · f th 1 h og K1 = . par icipa ion o e sup ur 
atom of N-(2-mercaptopropionyl)glycine in chelation 
is indicated. In the 1:1 complex, it is postulated 
that bonding occurs through the sulphur atom, the 
amide nitrogen, and perhaps also through the oxygen 
of the carboxyl group. Atomic models (Courtaulds) 
suggest that this chelation is possible. Although 
cadmium(II) and zinc(II) favour four coordination, 
it is possible that the coordination number is 
increased to six in the 1:2 N-(2-mercaptopropionyl) 
glycine complexes because the log ~ 2 values (for 
cadmium, 5.55; for zinc, 4.81) are only 0.7 and 0.5 
log units lower than the corresponding values for 
log K1 . This is in contrast to the large difference 
between log K1 and log K2 for cadmium-D-penicillamine 
where bidentate chelation was assumed in the 1:2 
complex. The coordination number of cadmium(II) and 
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--
zinc(II) must be increased to six in the 1:3 complexes 
of N-(2-mercaptopropionyl)glycipe. 
c) Glutathione. 
E 
CH 2SH 
A C I G H 
OOCCHCH 2cH 2CONHCHCONHCH 2COOH I D F 
+NH 
3 
B 
The naturally occuring tripeptide has interesting 
chelating properties and these were examined for the 
systems, zinc(II)- and cadmium(II)- glutathione. The 
four pK values of glutathione, determined by pH 
-a 
titration (see Table A.13) are:-
pKal - 9.42 + 0.01 pK - 3.54 + 0.01 
· -a3 
pKa2 - 8.54 + 0.01 P~4 - 2.04 + 0.01 
SDT X 10-3 
' 
ml. 0.84 SDT X 10- 3 
' 
ml. 2.14 
Zinc(II) and cadmium(II) complexes. 
Table A.14 contains the titration data (and 
calculated n values) for solutions containing 
glutathione and zinc(II), or cadmium(II), ions. When 
n values were plotted against pL, the points did not 
lie on a single curve, especially at low pH values. 
With increasing ratios of [LT]/[MT] the curves were 
displaced to greater values of pL, suggesting tnat 
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protonated complex species were also present. This 
was confirmed by computer analysis of the titration 
data and the results are given in Table 5.15. The 
pK values quoted are those for equilibria 
-a 
ML 
ML 4- _J 2 .-
TABLE 5.15 
Stability constants of glutathione with M2+ 
(1) Zinc (II) (2) Cadmium(II) 
log Kl 7.94 + 0.02 8.59 + 0.24 
log S2 12.41 + 0.01 13.39 + 0.05 
log SMHL 14.16 + 0.04 15.19 + 0.14 
log SML(HL) 21.56 + 0.01 22.81 + 0.04 
log SM(HL) 2 
28.60 + 0.02 30.45 + 0.04 
pK 8.82 + 0.06 9.12 + 0.10 
-a ML 
pK 9.86 + 0.02 
-a 
ML2 
* log 10.62 + 0.20 13.29 + 0.16 M2L 
SDT X 10-3 , ml. 1.44 4.01 
* Denotes minor species. 
The large uncertainty in the constant for zn2L 
and for several of the cadmium species (CdL, CdHL, 
and Cd2L) arises because, und~r the experimental 
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conditions, they are present in rather low concentrations. 
In Figures 5.06 and 5.07, the computer compositions 
of glutathione solutions containing zinc(II) and 
cadmium(II) ions are plotted against pH. The existence 
of a pH range (6.1 - 7.7) in Figure 5.06 where the 
predominant zinc complex is ZnL explains why an earlier 
estimate of log K1 , obtained by neglecting other 
complexes 198 , accords with the p;esent value. 
Conversely, Qecause there is no region in Figure 5.06 
where ZnL 2 is the only major species, analysis of the 
titration data only in terms of ZnL ano ZnL 2 would 
fail to yield a constant for log s2 . 
Several possible structures can be written for 
the complexes ML 4-and ML 2 , involving coordination 
to one or more of the following sites in the 
glutathione anion - an oxygen atom of the glutamyl 
residue (A), the amino nitrogen (B), the peptide 
oxygen (C) or nitrogen (D), the sulphur atom (E), the 
second peptide oxygen (F) or nitrogen (G), and an 
oxygen atom of the glycyl carboxyl group (H) (see 
page 138). From a consideration of stability constants 
of model zinc compounds, complexes in which the metal 
is bonded through the sites A,B,D, and E are suggested 
to be the most likely. Bonding by a-aminobutyric acid 
141. 
100 
80 
60 
ML(HL) 
40 
MLOH 
20 
5.0 6.0 7.0 8.0 9.0 
pH 
Fig . 5.06 . Variation with pH of composition of a solution 
of 0.0025M glutathione and 0.0012M zinc(II) ions. 
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Fig. 5.07. Variation with pH of composition of a solution 
of 0.0025M glutathione and 0.0012M cadmium(II) ions. 
and by glutathione through positions A and B may 
be compared, and, likewise, bonding by glutamine 
may be taken to be similar to bonding through A, 
B, and C, or A,B, and D, in glutathione. On the 
other hand, the sites F and H, or G and H, should 
bond less strongly than glycylglycine because they 
lack the terminal amino group of the latter. At 
15°C and with 0.005 M zinc sulphate solutions, 
169 log s2 for zinc-a-aminobutyric acid is 7.2 , 
compared to 8.4 169 for zinc~glutamine and 6.6 142 
(at 25°C and I~ 0) for zinc-glycylglycine. 
Similarly, for the 1:1 complex of zinc and 
a -aminobutyric acid, log K1 = 4.78 at 25°C and 
147 I= 0.2 , as against 3.80 for zinc-glycylglycine 
at 25°C and I~ 0. 142 
Atomic models (Courtaulds) indicateo that if a 
metal ion is bonded to sites A,B, and Din glutathione, 
it should be easy to form a further (5-membered) 
chelate ring by coordination involving the sulphur 
atom. (The alternative, of bonding through A,B, and 
C, and then E, is less likely because the new ring 
would be 7-membered and this would make only a small 
contribution to any additional stability.) The high 
value of log K1 found for the zinc-glutathione complex 
is also consistent with this additional chelation. 
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For these reasons ZnL is postulated to have the 
structure (I). Bonding of the zinc to the glutamyl 
0 0 
II 11 
o------c o-----c 
CH-S Zn NH 2 CH Zn ( NH 2-CH 2 I I CH 2 I 
CH NH--C CH 2 s C II I 
0 CH 3 CONHCH2COO 
(I) (II) 
portion in (I) should be similar to that due to the 
amino and carboxyl groups in the 1:1 zinc-
penicillamine complex (II), but the sulphur-
nitrogen chelate ring in (I) should be less stable 
than its counterpart in (II), linkage through a 
peptide nitrogen being weaker than through a 
primary amino group. This difference is reflected 
in the stability constants which, at 37°C and 
I= 0.15, are 7.94 and 9.52 229 , respectively. 
However, the possibility cannot be excluded that in 
CH 3 
(I) the glycyl peptide nitrogen atom is also attached 
to the zinc ion to form a further five-membered chelate 
ring. 
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Bonding in the bis complex must be different, 
because zinc has a maximum coordination number of 
six, but the sulphur atom would still appear to be 
4-implicated on the . grounds that log s2 for ZnL 2 is 
about four logarithm units . greater than for the bis 
complex of glutamine. On the other hand, log K2 
(4.47) is very much smaller than log K1 (7.94). 
These results can be explained on the basis that 
the second glutathione molecule is bonded to tpe 
zinc only through the glutamyl carboxyl and amino 
groups, the observed value of log K2 being similar 
to that reported for a-aminobutyric acid (3.76 at 
40°C and I= 0.2 147 ). 
Similarly, in the complex zn2L the constant 
for the addition of the second zinc ion to ZnL is 
only 2.68, a value which appears to be consistent 
with bonding through the remaining sites on 
glutathione, namely the glycyl carboxyl residue 
and the peptide nitrogen, with perhaps some 
contribution from a sharing of the sulphur atom with 
th th . . 182 e o er zinc ion. 
The observed pK values of 8.82 and 9.86 for 
-a 
- 4-the zinc-glutathione complexes ZnL and ZnL 2 are 
attributed to the ionisation of a proton from the 
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coordinated peptide . group. These can be compared 
to the stronger ionisation (pK = 5.35 at 30°C 294 ) 
-a 
observed in the 1:1 copper-glycylglycine complex and 
to that observed for the N-(2-mercaptopropionyl)glycine 
complex ZnL 2 (9.47). Analysis of the pH-titration 
data gave no evidence for the loss of a s~cond 
proton to form ZnL 2 (0H) 2 , nor, on the basis of the 
present interpretation, would such a species be 
expected because only one peptide linkage is believed 
to be involved in coordination to the metal. 
A complication in discussion of the protonated 
species MHL, ML(HL) and M(HL) 2 is the uncertainty 
as to the assignment of the two pK values which 
-a 
relate to the amino and the thiol groups. This is 
1 bl f . th . 1 219 a genera pro em or amino io s . The 
. . 
microconstants of glutathione (which were discussed 
in Chapter II) were calculated from the present 
results at 37°C and I= 0.15M (pK 1 = 9.42, -a 
pK 2 = 8.54 for glutathione, pK = 9.00 ± 0.01 for 
-a -a 
S-methylglutathione). The values obtained under these 
conditions are pk = 8.72, pk = 8.96, pk = 9.00, 
-v -x -y 
and pk = 9.24. On the assumption that it is the 
-z 
sulphur atom that is protonated in zinc-glutathione 
complexes, pkx was subtracted from log 6 'MHL and 
1 4 6 
---
log S 'ML(HL), and twice pkx from log S'M(HL) 
2 
to 
give 5.20, 12.60,and 10.68 as the constants for 
the formation of MHL, ML(HL), and M(HL) 2 from M + HL, 
M + L + HL, and M + 2 HL, respectively. Expressed 
in this way, the constant tor MHL is comparaple with 
that for the 1:1 complex of zinc and a-aminobutyric 
acid (4.78). Within experimental uncertainty, the 
stability constant for the formation ot ML(HL) from 
M, L, and HL is the same as for the formation of 
ML 2 from Mand 2 L. This suggests that the metal 
is similarly bound in the two complexes. 
Results for cadmium parallel those for zinc, 
except that the cadmium complex~s are somewhat more 
stable. The increased stability of the complex 
Cd2L relative to zn2L can be attributed to the 
greater polarisability of the cadmium ion which 
facilitates the interaction with the sulphur atom. 
Because of the greater size, it would also be 
expected that cadmium would bind more strongly than 
zinc to a seven-membered chelate ring. Size and 
polarisability, however, are probably not the only 
factors involved. The metal-peptide bond interact ion 
is slightly less than that of zinc, as shown by a 
higher pK for MLOH and by the failure to refine a 
-a 
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constant for the species ML 20H which, by analogy 
with zinc, would be expected to be present. 
Since there are no ligand field stabtlisation 
effects in zinc(II) or cadmium(II), their 
stereochemistry is determined solely by consideration 
of size, electrostatic forces, and covalent bonding 
forces. Four coordinate zinc and cadmium complexes 
tend to be tetrahedral although square planar zinc 
is known, for example, in the complex Zn(glycine) 2
203
. 
Cadmium increases its coordination number to six more 
easily than zinc, forming octahedral complexes. If 
the zinc, or cadmium, ion is four coordinate and the 
glutathione bonds through oxygen(A), amino nitrogen(B), 
and the sulphur atom(E) (see page 138), it appears 
from atomic models that a square planar, rather than 
a tetrahedral , configuration is more likely. For 
six coordinate zinc or cadmium an octahedral structure 
with the additional interaction with the peptide 
nitrogen(D) is possible. No definite conclusion may 
be reached, however, on the stereochemistry of the 
complexes. 
Lead(II) complexes. 
The lead-glutathione complexes are extremely 
insoluble and for total metal concentrations of 
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1 x l0- 3M, and metal-to-ligand ratios exceeding 1:6, 
precipitation occured above pH 4.8. The maximum 
value of n that could be obtained experimentally was 
0.25. From a SCOGS analysis of the data, 
log Kl 9.71 + 0.24 
log SM L 13.38 + 0.08 2 
10- 3 SDT, ml. - 1.41 X 
where M2L is the more important qpecies. These 
stability constants are only approximate as few 
points were obtained in each titration and the 
range of n values is small. 
To try to overcome the insolubility problem, 
the method developed by Montgomery (see section 3.2) 
was applied to the lead(II)-glutathione system. 
Because precipitation is minimal at low pH, the 
titrations were carried out at constant pH values 
of 4.0 and 4.2. However, the maximum n value 
calculated at pH 4.2 is 0.08. Both carboxyl groups 
of glutathione are ionised at pH 6.5 and it is possible 
that these charged groups increase the solubilities 
of the lead complexes. Then values calculated from 
a titration at a constant pH of 6.5 vary between 0.89 
and 1.02. (These relatively large n values are a 
reflection of the very high ligand-to-metal ratios 
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which exist initially in this titration method). From 
this titration, the stability constants were computed 
to be, 
log Kl ~ 7.77 + 0.09 
log 62 ~ 13.64 + 0.07 
SDT X 10- 3 , ml. ~ 2.29 
These constants have b~en obtained over only a 
narrow range of n, and they are not consistent with 
the results from more acid solutions. Both sets 
must be considered doubtful. A similar comment 
1 . t h lt f . d · 178 h app ies o t e resu so Li an Manning w o 
reported a value of log K1 for lead-glutathione, 
using n values up to unity. 
d) Mixed-ligand complex formation. 
Mixed-ligand complexes are likely to be important 
as models for metalloenzyme-substrate complexes, and 
also as components of multi-metal - multi-ligand 
systems in biological fluids. Because of their 
possible relevance in multi-metal - multi-ligand 
equilibria, stability constants were sought for 
mixed-ligand complexes in the following systems: 
nickel-cysteine-glycine, nickel-cysteine-leucine, 
nickel-cystine-glycine, and nickel-cystine-leucine. 
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Table A.15 summarises the titration data. 
For the calculation of the stability constants 
of mixed-ligand complexes, the stability constants 
of the metal ion with each individual amino acid 
were required. The constants for nickel(II)-
229 L-cystine at 37°C and I= 0.15M were known , and 
those for nickel(II) with glycine, L-leucine, and 
L-cysteine were determined in the present work. In 
analysing the titration data for metal, mixed-ligand 
mixtures, the constants for the metal ion with each 
ligand were given their known values while the computer 
programme sought to refine the estimates for the 
mixed-ligand complexes. The results are given in 
Table 5.16. 
TABLE 5.16 
Stability constants of some mixed-ligand complexes 
of nickel(II) with amino acids. 
Complex species log s 
[Ni (cystine) (glycine)] 11.30 + 0.0 4 
[Ni.H 2 (cystine) (glycine)]+ 27.09 ± 0.06 
[Ni (cystine) (leucine)] 11.31 ± 0.0 5 
[Ni.H 2 (cystine) (leucine)]+ 26.73 ± 0.16 
[Ni (cysteine) (glycine)] 14.29 + 0.0 5 
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Although species NiA2B and NiAB 2 ~ave been 
reported 241 for nickel(II) with each of the three 
possible pairs of ligands ethylenediamine, histamine, 
and serine monoanion, no such species were found 
in the systems listed above. A measure of the 
stability of a complex NiAB relative to the complexes 
NiA2 and NiB 2 is provided by the log K value for the 
disproportionation equilibrium 
NiA2 + NiB 2 r=== 2NiAB 
On statistical grounds, a value of log K = 0.6 would 
be predicted. 296 For [Ni(cystine) (glycine)] and 
[Ni(cystine) (leucine)] the constants are 1.05 and 
1.69, and are consistent with the general 
observation that mixed-ligand complexes are somewhat 
more stable than would be expected on statistical 
grounds. However, the constant for [Ni(cysteine) 
(glycine)] is -0.65 and, in the nickel-cysteine-
leucine system, no evidence for mixed-complex formation 
was found from titrations in which the molar ratios 
of nickel:L-cysteine:L-leucine were 1:1:1, 2:1:4, 
and 4:1:4. This apparent anomaly is likely to be 
conunon in nickel and zinc complexes of thiols because 
it is known that in such complexes, the second 
stepwise formation constant, log K2 , is appreciab ly 
152 
182 greater than the first, log K1 . Thus, a 1:1 
complex such as [Ni.cysteine] adds another cysteine 
anion more readily than nickel itself. When it is 
further considered that L-leucine forms less stable 
complexes than glycine with nickel(II), the lack of 
evidence for mixed-ligand complex formation in the 
nickel-cysteine-leucine system is not surprising. 
5.3 Mercury(II) complexes. 
Although mercury is extremely toxic, affecting the 
central nervous system ~nd forming stable complexes 
with the thiol groups occuring in cysteine, 
glutathione, and many sulphur-containing enzymes, 
there is a dearth Qf quantitative informqtion about 
such equilibria. This information is needed in any 
attempts to understand the effect of mercury on the 
distribution of metal ions a~ong amino acids in blood 
plasma. 
An estimate of the hydrolysis constants of 
mercury(II) was required as a preliminary to the 
stuQy of mercury-amino acid complexes. From a series 
of titrations covering the metal ion concentration 
range 0.001 - 0.005 M with pH values from 2.7 - 3.8, 
hydrolysis constants for the aquo mercury(II) ion 
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in 0.15M KN0 3 were computed to be 
log S21 - -7.03±0.04 for Hg2+ + 2B 20 ~ Hg (OH) 2 + 2H+ 
log S22 - -4.07 ±0.13 for 2Hg
2+ + 2H20 ~ Eg 2 (OH)~+ + 
SDT -3 X 10 1 ml. 8.49 
Of these, the species Hg(OH) 2 was the more important. 
The possible formation of other complexes 
( Hg(OH)+, Eg 2 (0H)
3+, and H9 4 (0H)~+) was considered 
2H+ 
but in each case no stability constant could be refined. 
The high standard deviation in titre suggests that 
these hydrolysis constants are unreliable. They also 
22 disagree with published values (which are, 
themselves, not consistent). For example, the results 
297 
of Anderegg, Schwarzenbach, Padmoyo, and Borg I 
extrapolated to 37°C, give log s21 = -6.08. 
Titration data were obtained in the pH range 
3-8 for solutions containing merQury(II) ions and 
L-methionine, D-penicillamine, N-(2-mercaptopropionyl) 
glycine, and glutathione. The mercury(II) concentration 
was 1 x l0- 3M and the metal-to-ligand ratios varied 
between 1:2 and 1:9. No satisfactory stability constants 
were obtained from computer analysis of these results, 
using either log s21 = -7.0~ (present results) or -6.08 
297 (extrapolated value ) , to allow for the hydrolysis 
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of mercury to Hg(OH) 2 . For example, using the former 
value, only the complex HgL (with log K1 = 10.78 ±0.12) 
was consistent with the data for the N-(2-mercapto-
propionyl)glycine system but the standard deviation 
in titre obtained from the calculation was 1.5 x 10-2 
(which is extremely large). In the D-penicillamine-
mercury system, stability constants were refined for 
HgL (log Kl= 14.39±0.07) and Hg2L3 (log S = 35.41±0.28) 
but the standard deviation in titre was again high 
(9.81 x 10-3 ). · No stability constants could be 
refined from titrations containing mercury and 
L-methionine or mercury and glutathione. 
However, if the hydroly$iS of the mercury(II) 
ion was ignored, stability constants could be obtained 
but these are not meaningful. When the ligand was 
methionine, a SDT of 5.4 x 10- 3 was obtained for 
HgL (log Kl - 7.83 ±0.04), HgL 2 (log S2 = 11.84 ±0.27), 
and Hg 2L3 (log SM L = 24.24±0.20). For glutathione, 2 3 
HgL (log Kl= 9.56±0.10) and Hg2L (log SM L = 13.31±0 . 05) 2 
refined, giving a standard deviation in titre of 
-3 2.0 x 10 . In the N-(2-mercaptopropionyl)glycine 
system, the species HgL (log K1 = 8.37±0.06) and 
Hg 2L3 (log SM L = 25.48±0.12) were consistent with 2 3 
the data and the standard deviation in titre was 
reduced to 7.1 x 10- 3 . In previous determinations 
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of the stability constants of mercury(II) complexes 
with these ligands (see Tables 2.06 - 2.09), the 
hydrolysis of mercury has been ignored. This 
simplification appears to be quite unjustified and 
casts serious doubt on the significance of the 
constants reported. 
Several factors may contribute to the failure 
to obtain meaningful stability constants. Thiols 
form very stable complexes with mercury so that 
even at a pH value of 3,n values of 0.6 and 0.8 
were calculated for D-penicillamine and 
N-(2-mercaptopropionyl)glycine with mercury. It 
298 has been suggested that the pH method is 
inappropriate in such cases because it cannot 
precisely define pL above a certain value, namely 
(pK + 2). Mercury readily hydrolyses, and it 
-a 
seems likely that mixed hydroxyl-mercury-ligand 
species, possibly of great complexity, are formed 
during titration with alkali. Such species have 
not hitherto been considered in attempts to refine 
stability constants for mercury complexes. They 
are not allowed for in the present analysis, largely 
because of the lack of any evidence as to their 
composition. 
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In the mercury(II)-glutathione system, the 
maximum n value obtained was 0.40 and, to try to 
overcome this insolubility problem, the method 
developed by Montgomery (see section 3.2) was 
applied at a constant pH of 6.8. The range of n 
value s calculated (between 0.97 and 1.00) was too 
restricted for an estimate of the stability 
constants to be made. 
The potentiometri c method appears to be 
unsuitable for the determination of the stabi lity 
constants of me rcury(II) complexes with thiols . 
Two alternative methods that may be suitable are 
calorimetric titration, which was recently used 
for the determination of the stability constants of 
mercury(II)-2-aminoethanol complexes 299 , and 
competitive complex formation. The latter technique 
has already been used by Kapoor, Doughty, and 
Gorin 217 to study the competitive complex formation 
between glutathione and chloride ions for mercury(II), 
but it suffers from the disadvantage that the 
resulting stability constants are relative to those 
of mercury(II) with the chloride ion. 
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5.4 Conclusion. 
With the aid of electronic computers and complex 
mathematical progr ammes, the stability constants of 
simple, protonated, hydrolysed, and polyn~clear 
species can be calculated from the pH titration data. 
The present results indicate the necessity to 
consider these species in the analysis of the metal 
complex formation of amino acids and peptides. 
Some of the limitations of the potentiometric 
method are apparent, especially from the studies 
on systems containing mercury. The involvement 
of the peptide, or amide group, in chelation is 
postulated for both glutathione and N-(2-mercapto-
propionyl)glycine and the study provides a useful 
basis for future work on the metal complex format ion 
of peptides as a model for proteins. 
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CHAPTER VI 
APPLICATION OF RESULTS: A MODEL 
FOR BIOLOGICAL SYSTEMS 
The first quantitative study of metal-binding 
in a multi-ligand system under physiological 
conditions appears to have been that o{ Neumann and 
8 Sass-Kortsak who, by ultracentrifugation and the 
64 
use of Cu, showed that in the competition between 
albumin and amino acids for copper(II) in blood 
serum, copper(II) is coordinated preferentially to 
histidine in both simple and mixed complexes. 
An alternative approach is possible using computer 
programmes designed to solve multiple simultaneous 
equations and this was discussed in section 1.1. 
6.1 The distribution of copper(II), zinc(II), and 
I 
manganese(II) among seventeen amino acids. 
I 
. 3 The computer programme COMICS was used to 
calculate the distribution of copper(II), zinc(II), 
and manganese(II) ions among seventeen amino acid s 
present in human plasma. 
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The present results were used in the COMICS 
calculations as well as pK and stability constant 
-a 
values which had been previously determined at 37°C 
and 0.15M (KN0 3 ). The sources of the published 
constants are summarised in Table 6.01 whilst 
Tables 6.02 and 6.03 contain hitherto unpublished 
results (obtained by various workers in this 
Department) . 
TABLE 6. 01 
Source of systems studied at 37°c, I 0.15M (KN0 3 ) 
Amino acid Metal . ion 
glycine H+ Mn2+ Cu 2+ Zn 2+ I I I 
L-alanine H+ I Mn2+, Cu 2+ Zn 2+ I 
L-proline H+ Mn2+, Cu 2+ Zn 2+ I I 
L-valine H+ I Mn2+, Cu 2+ Zn 2+ I 
L-histidine H+ Mn2+, Co 2+ N' 2+ Cu 2+ Zn 2+ Pb 2+ I I i ' I I 
L-serine H+ Mn2+, Co 2+ N' 2+ Cu 2+ Zn 2+ Pb2+ I I i ' I I 
L-threonine H+ Mn2+ Co 2+ N' 2+ Cu 2+ Zn 2+ Pb 2+ I I I i ' I I 
* Recalculated at F = 0.80 
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Ref. 
130 
130 
130 
130 
299* 
300 
300 
TABLE 6.02 
"Practical" pK values (previously unpublished) 
-a 
of L-amino acids at 37°C, I - 0.15M (~No 3). 
Amino acid pK values 
-a 
Cystine 8.69, 7.95, ( 1. 7) 
Glutamic acid 9 • 3 9 I 4.15, (2.13) 
Glutamine 8. 8 3, 2.15 
Tryptophan 9.09, 2.46 
Values in parentheses are estimates. 
TABLE 6.03 
Stability constants (previously unpublished) 
of copper and zinc complexes with L-amino acids 
at 37°C, I= 0.15M (KN03). 
Amino acid Metal 
Cysteine Zn 
Cystine Cu 
log 
Kl 
Constants 
log 
/32 
17.98 
Glutamic acid Cu 8.74 14.91 
Zn 4.76 8.54 
Others 
logSML(HL) - 24.33 
logSM(HL) - 29.86 
2 
log/3M L (HL) = 38.40 
3 3 
logSMHL = 16.20 
log/3M L = 28.07 
2 2 
log SMHL = 12.79 
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Table 6.03 continued. 
Glutamine Cu 7.24 13.40 
Zn 4.27 7.94 
Methionine Cu 7.67 14.08 
Zn 4.22 6.93 
Tryptophan Cu 8.05 15.32 
Zn 4.50 8.76 11.61 
From preliminary calculations, using constants 
obtained in single metal, single ligand systems, 
together with data on plasma composition, mixed 
complex formation appeared likely to be important 
for copper- cystine- histidine, zinc- cysteine-
histidine, zinc-cystine-histidine, zinc-
glutamic acid-histidine, and zinc-glycine-
histidine. The relevant constants, obtained by 
Dr Hallman from pH titration data on appropriate 
solutions are summarised in Table 6.04. 
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TABLE 6. 04 
229 Overall stability constant values of mixed-
ligand complexes at 37°C and I= 0.15M (KN0 3). 
Amino acid abbreviations refer to the anionic 
form, e.g. gly = NH 2cH2coo. Cystine is not 
abbreviated and, in the formulae below,denotes 
Complex log s Complex 
[Cu.Cystine.His] 18.51 [Zn.Cys.His] 
[Cu.H.Cystine.His] 25.80 [Zn.H.Cys.His] 
[ . . ] + Cu.H2 .cyst1ne.H1s 30.69 [Zn.H.Cys. (His) 2 ] 
[Cu2 .H.Cystine. (His) 2 ]+ 39.15 [Zn.Glu.His] 
[Zn. Cystine. His] 11.62 [Zn.H.Gly.His]+ 
[Zn.H.Cystine.His] 19.55 [Zn.H. (Gly) 2 .His] 
[ . . ] + Zn.H2 .cyst1ne.H1s 26.35 [Zn.H.Gly. (His) 2 ] 
The failure to obtain constants for zinc(II) -
cystine and for copper(II)-cysteine was discussed 
in section 2.3. Table 1.01 contains average values 
for "direct-reacting''copper(II), zinc(II), and 
manganese(II) and amino acid concentrations in human 
blood plasma. These concentrations were used in the 
COMICS calculation. Most methods of amino aciq 
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log s 
15.23 
21.60 
26.50 
10.75 
17.72 
23.10 
22.79 
analysis report only the total cystine plus cysteine . 
. h s . d 12s d . However, Brig am, tein, an . Moore use prior 
reaction with iodoacetic acid to prevent the 
conversion of cysteine to cystine, and their values 
have been taken. For the purposes of calculation, 
the copper bound in caeruloplasmin is assumed to be 
non-exchangeable. 128 The pH of the solution was 
taken as 7.4. Possible hydrolysis of copper(II), 
zinc(II), and manganese(II) ions was allowed for by 
including values of the appropriate constants 
obtained, for copper and zinc, by interpolation 
. 295 302 from the literature ' and for manganese, 
directly from the literature. 130 
Equilibrium concentrations of the metal 
complexes, the free metal ions, and the free amino 
acid anions were computed for a pH 7.4 solution 
using all the available stability constant values 
(determined at 37°C, 0.15M (KN0 3 )) for copper( I I) - , 
zinc(II)-, and manganese(II)Tamino acid complexes. 
A total of 190 species were considered. The r esults 
are listed in Tables 6.05 and 6.06. Complexes have 
been omitted from Table 6.05 i f they contain less 
than 0.2 % of the relevant metal ion. 
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TABLE 6.05 
Computed distribution of Cu(II) and Zn(I I) 
ions among seventeen amino acids. 
Column (a) shows the standard distribution. 
The other distributions were obtained when one of 
the concentrations was increased by its (published) 
-2 
standard deviation. For (b), His= 9.4 x 10 mM; 
for (c) Zn(II) = 7.0 x l0- 2mM; and for (d) 
Cu(II) = 2.2 x l0- 3mM. The concentration of each 
complex is expressed as a percentage of the total 
copper(II) or zinc(II) present. 
Distribution 
Complex (a) (b) (c) (d) 
% % % % 
[Cu.Cystine.His] 48 46 49 48 
[Cu.H.Cystine.His] 37 35 38 37 
[Cu(His) 2 ] 13 18 11 13 
[Cu(Gln) 2 ] 0.3 0.2 0.5 0.3 
[Cu.OH.His] 0.3 0.3 0. 3 0.3 
[Cu.H. (His) 2 ]+ 0.2 0.3 0.2 0.2 
[Cu.His]+ 0.2 0.2 0.3 0 . 2 
1 65 
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Table 6.05 continued. 
[Zn.His.Cys] 24 27 17 24 
[Zn.His]+ 21 22 23 21 
[Zn (Cys) 2 ] 
2- 16 14 11 16 
Zn 2+ 8.6 6.5 13.2 8.7 
[Zn.H.His.Cystine] 5.8 6.1 6.1 5.7 
[Zn(His) 2 ] 5.7 8.1 4.5 5.5 
[Zn. Gln] + 3.2 2.5 5.0 3.3 
[Zn.H.Cys.His] 2.2 2.5 1.6 2.2 
[Zn.His.Cystine] 1.7 1.8 1.8 1.7 
[Zn.H2 .His.Cystine] 1.5 1.5 1.5 1.4 
[Zn.Gly] + 1.4 1.1 2.2 1.5 
[Zn. H. ( Cys) 2 ] 
+ 1.3 1.1 0.9 1.3 
[Zn. Thr] + 1.3 1.0 1.9 1.3 
[Zn.Ser] + 0.9 0.7 1.5 1.0 
[Zn .Ala] + 0.9 0.7 1.5 1.0 
[Zn. Val] + 0.7 0.5 1.1 0.7 
[Zn.H.Gly.His]+ 0.4 0.5 0.5 0.4 
[Zn.Leu] + 0.4 0.3 0.6 0.4 
[Zn(Gln) 2 ] 0.3 0.2 0.5 0.3 
[Zn. Trp] + 0.3 0.2 0.5 0.3 
[Zn.Pro] + 0.3 0.2 0.4 0.3 
[Zn .Arg] + 0.3 0.2 0.5 0.3 
[Zn.Glu.His] 0.3 0.3 0.3 0.3 
Table 6.05 continued 
[ZnOH]+ 0.3 0.2 0.4 0 . 3 
[Zn.Glu] 0.2 0.2 0.4 0 . 2 
[Zn. H. Orn] 0.2 0.2 0.4 0.2 
[Zn.H.His. (Gly) 2 ] 0.2 0.2 0.3 0.2 
[Zn.H. (His) 2 .Cys] 0.2 0.3 0.1 0.2 
Mn2+ 98 98 98 98 
[Mn. H. Pro] 2+ 0.7 0.7 0.7 0.7 
[Mn. H. Val] 2+ 0.4 0.4 0.4 0.4 
[MnOH] + 0.2 0.2 0.2 0.2 
[Mn .His]+ 0.2 0.3 0.1 0.2 
TABLE 6.06 
Equilibrium concentrations of free amino acids 
and free metal ions. 
Values are the computed equilibrium concentrations 
of free amino acid anions and free metal ions present 
at pH 7.4 in a solution containing Cu(II), Zn(II), 
and Mn(II) ions and seventeen amino acids in the 
concentrations shown in Table 1.01. 
1 6 7 
Anion 
Ala 
Cys 
Glu 
Gly 
Ile 
Met 
Pro 
Thr 
Val 
cu2+ 
Mn2+ 
Concn. (mM) 
3.0 X 10-3 
1.4 X 10- 6 
4.8 X 10-4 
2.1 X 10- 3 
7.4 X 10- 4 
7.8 X 10- 4 
2.4 X 10- 4 
5.4 X 10- 3 
2.9 X 10-3 
3.4 X 10-lO 
6.9 X 10- 4 
Anion 
Arg 
Cystine 
Gln 
His 
Leu 
Orn 
Ser 
Trp 
zn 2+ 
Concn. (mM) 
3.4 X 10-3 
4.1 X 10-4 
2.0 X 10-2 
1.2 X 10-3 
1.4 X 10- 3 
5.5 X 10- 6 
3.7 X 10- 3 
1.1 X 10- 3 
-3 3.9 X 10 
To assess the effects of variation in composition , 
similar calculations were carried out after changing 
the concentrations of histidine (to 0.9 x 10-4 M), 
copper (to 0.22 x 10- 5 M), or zinc (to 0.7 x 10-4 M) 
by amounts equal to their reported standard deviations, 
and these results are also given in Table 6.0 5. The 
above alterations did not significantly change the 
metal ion distribution patterns, but with the 
increased zinc concentration there were decreases in 
2-the percentage o f zinc present as Zn(Cys) 2 and 
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Zn.His.Cys , as well as in Cu(His) 2 , reflecting 
the relatively low total histidine and cysteine 
concentrations. Similar calculations showed that, at 
the normal zinc and copper levels, small variat i ons 
in cysteine or cystine concentrations had only 
marginal effects. 
Although the present study considers the 
formation of 52 different copper complexes with the 
seventeen amino acids listed, three complexes 
account for more than 98% of the bound copper(II), 
with histidine and cystine being the most successful 
of the competing ligands. The mixed-ligand complex 
Cu.His.Cystine and its monoprotonated derivative 
are the major copper species present. Because so 
few species are present in appreciable amounts, 
varying the values of the stability constants by up 
to several times their estimated standard deviation s 
had a negligible effect on the metal ion 
distribution. Zinc(II) is distributed more even l y 
among the amino acids, so that 27 of the 68 poss i ble 
complexes contain at least 0.2% of the total zinc 
present. Histidine and cysteine are the pref e rre d 
amino acids, but the possibility must not be 
overlooked that zinc-cystine complex formation may 
1 69 
also be important. 98% of the total manganese is 
present as the free metal ion. This could be 
predicted as manganese forms weak complexes and 
it cannot compete effectively with copper and zinc 
for the available amino acids. 
The success of histidine, cystine and cysteine 
in competing for the available metal ions is 
undoubtedly due to their ability to act as tridentate 
ligands, whereas most a-amino acids can form only 
bidentate chelates. Thus, the crystal structure of 
a mixed-ligand complex, Cu.His.Thr, shows the copper 
to be coordinated to the histidine through an 
imidazole nitrogen as well as the amino nitrogen 
303 
and a carboxyl oxygen. The strongest bonding 
appears to be through the nitrogen atoms. Similarly, 
in copper(II)-cystine complexes it is believed 
that interaction occurs between the metal ion and 
the -s-s- linkage. 192 In Cu.His.Cystine the 
copper is probably coordinated to the histidine in 
the same way as for Cu.His.Thr, and the bonding to 
cystine is probably .the same as in copper(II)-
cystine complexes. It is suggested that in t h e 
structure of Cu.His.Cystine two nitrogens of the 
histidine and a nitrogen and carboxyl oxygen of 
17 0 
cystine lie in a plane around the copper ion, the 
fifth and sixth coordination sites of which are 
occupied, less strongly, by the histidine 
carboxyl group and the -S-S- portion of cystine. 
Similarly, whereas protonation of most a-amino 
acids lets them function only as monodentate ligands, 
monoprotonation of histidine, cystine or cysteine 
leaves them able to act as bidentate chel~ting agents, 
with corresponding. gain in stability of their 
complexes. It is likely, for example, that in the 
species Cu.H.His.Cystine the proton is on the amino 
group of the cystine molecule at the end remote from 
the copper. 
Copper complexes are much more stable than those 
of zinc, so that the ratio of free copper(II) ion 
to free zinc(II) ion is very much less than the 
ratio of total copper to total zinc. Under the 
specified conditions, complex formation with copper(II) 
is virtually complete whereas about 8% of the zinc 
remains free. 
This approach is important to the study of 
metal ion-protein interactions, particularly as the 
concentrations of free metal ions are maintained at 
such low levels by the metal-buffering capacity of 
the free amino acids that are ordinarily present in 
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such solutions. 304 Evidence has recently been presented 
for an albumin-Cu(II)-amino acid complex, but there 
is insufficient information for these interactions 
to be interpreted quantitatively. 
The results are, in general, consistent with the 
findings of Neumann and Sass-Kortsak 8 but direct 
comparison is not possible because these workers used 
for their measurements similar order of concentration 
for albumin, copper(II) and individual amino acids. 
The distribution pattern of copper(II) in such a 
system would be expected to show quantitative 
differences from similar systems in which only traces 
of copper were present. 
6.2 The effect of adventitious trace metals. 
One of the advantages of the COMICS approach to 
metal complex equilibria is the ease with which it 
is possible to study the effects of extrinsic metal 
ions on a particular multi-metal - multi-ligand 
system. Taking the copper-zinc-manganese-amino 
acids system as a model for blood plasma, it is of 
interest to compute the equilibrium concentrations 
of metal ions and complex species when cations such 
Pb2+, N1· 2+, Cd2+, d C 2+ 1 t as an o are a so presen. 
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The concentration of the added metal ion was 
arbitrarily set at one of the levels l0- 3mM 
(which approximates to the concentration of 
exchangeable copper ion in plasma), l0-2mM, or 
O.lmM. 
The stability constants for all the metals with 
all the amino acids have not yet been determined 
so that the results at present are illustrative of 
possible applications, rather than fully 
quantitative. 
a) Lead(II) 
Stability constants for nine complexes of 
lead(II) with five amino acids are available at 
37°C and I= 0.15M (see Chapter V and Table 6.01). 
The possible hydrolysis of the lead(II) ion was 
allowed for by the inclusion of the appropriate 
constant (section 5.2). The equilibrium 
concentrations of metal complexes, free metal ions, 
and free amino acid anions were computed at pH 7.4 
for a solution of compositi9n described in section 6.1 
containing lead(II) ions also. Table 6.07 shows 
the effect of the presence of 0.01 and O.lmM lead(II) 
on the concentrations of those copper(II) and zinc(II) 
complexes which are present in appreciable amounts. 
1 
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The manganese(II) complexes are omitted because 
their concentrations are unaffected by the presence 
of lead. 
TABLE 6.07 
Effect of addition of (a) O.OlrnM, and (b) 
O.lrnM Pb(II) ions to a system containing initially 
only Cu(II), Zn(II), and Mn(II) ions. 
Complex Distribution % [MT] 
Initial ( a) (b) 
[Cu.Cystine.His] 48 48 50 
[Cu.H.Cystine.His] 37 37 38 
[Cu(His) 2 ] 13 13 10 
[Zn.His.Cys] 24 20 0.1 
[Zn.His]+ 21 25 32 
2- 16 9 [Zn (Cys) 2 ] 
zn2+ 9 11 20 
[Zn.H.His.Cystine] 6 7 9 
[Pb.Cys] 99 33 
[Pb.His]+ 0.2 19 
[PbOH] + 13 
Pb 2+ 0.2 27 
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The distribution of the amino acids among copper, 
zinc, and manganese is not significantly altered by 
-3 the presence of 10 mM lead(II) ions because at 
this level, there is sufficient excess cysteine to 
complex virtually all the lead to form Pb.Cys. 
For the same reason, this complex accounts for 99% 
of the lead(II) when the lead conce~tration is 
increased to O.OlrnM. However, as a result of the 
decrease in free cysteine when lead is present, 
zinc-cysteine complexes are partially dissociated, 
the change being greatest with [Zn(Cys) 2 ]
2
-. The 
decreased concentration ot [Zn.His.Cys] . is 
compensated in part by the increase in concentration 
of [Zn.His]+. These effects are even more pronounced 
when the solution is O.lmM in lead because virtually 
all the cysteine is present as Pb.Cys and the level 
of free cysteine is extremely low (2.5 x lo-12M). 
The complexes [Pb.His]+ and [PbOH]+ are now important 
and the free lead ion accounts for 27% of total metal 
ion concentration. 
These results indicate that lead competes 
successfully for cysteine and that as the lead 
concentration increases, so the concentration of 
free cysteine, or cysteine bound to zinc, decreases. 
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Histidine is effective as a chelating agent for 
lead only if there is insufficient cys teine to 
complex all the lead(II). 
b) Cadmium(II). 
By analogy with zinc, cadmium can be expected 
to form stable complexes with cysteine, cystine, and 
histidine. Unfortunately, stability constants for 
these species are not at present available, partly 
for experimental reasons involving the insolubility 
194 
of cadmium-cysteine and cadmium-cystine species 
(compare also the zinc-cystine complexes) . The 
insertion into the COMICS programme of the constants 
for cadmium with amino acids in which bonding is 
through the a-amino nitrogen and the carboxylate 
ion had little effect on the distribution of copper, 
zinc, and manganese among the amino acids. The free 
cadmium ion accounted for 94% of the total cadmium. 
Thus, the effects of cadmium toxicity (at least up 
to a level of O.lmM cadmium) are un likely to be 
produced by disturbances of the equilibria that 
have so far been studied in this work. 
c) Nickel(II). 
The nickel( II)-amino acid complexes considered 
in the COMICS calculation were summarised i n section 6.1 
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and these include the complexes of histidine, 
cysteine, and cystine. The subsequent inclus ion 
of the mixed-ligand complexes of nickel(II) with 
these amino acids may alter the distribution pattern 
discussed below. 
Table 6.08 shows the effect of the presence of 
0.01 and O.lmM nickel(II) on the concentrations of 
those copper(II) and zinc(II) complexes which are 
present in appreciable amounts. The concentrations 
of manganese complexes are unaffected by the 
presence of nickel(II). 
TABLE 6.08 
Effect of addition of (a) O.OlmM, and (b) 
O.lmM Ni(II) ions to a system containing initially 
only Cu(II), Zn(II), and Mn(II) ions. 
Complex Distribution 9--0 [MT] 
Initial (a) (b) 
[Cu.Cystine .His] 48 50 38 
[Cu.H.Cystine.His] 37 39 30 
[Cu(His) 2 ] 13 10 0.7 
[Zn.Cys.His] 24 20 1 
[Zn.His]+ 21 20 5 
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Table 6.08 continued. 
[Zn (Cys) 2 ] 
2- 16 17 4 
zn2+ 9 11 38 
[Zn.H.Cystine.His] 6 6 1 
[Zn(His) 2 ] 6 4 0.1 
[Zn.Gln] + 3 4 14 
[Ni(H:j.s) 2 ] 75 13 
[Ni.His]+ 18 43 
[Ni (Cys) 2 ] 6 13 
Ni 2+ 0" 1 3 
In a solution l0- 3mM nickel, 81% of the total 
nickel is pr~sent as Ni(His) 2 and the concentrations 
of copper(II) and zinc(II) complexes are not affected 
by the presence of nickel. The concentrations of the 
zinc-histidine complexes are slightly lower than 
normal in a O.OlmM nickel solution but when the 
nickel concentration in increased to O.lmM, the 
concentrations of both copper and zinc complexes 
containing hi~tidine are considerably lower than 
normal. The decreased concentration of the zinc-
histidine complexes is partially compensated by 
the increase in [Zn.Gln]+ and zn2+. 
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The toxicity of nickel salts is low 59 and these 
calculations indicate that only O.lmM nick~l has a 
large effect on the standard distribution of copper 
and zinc among the amino acids in this model for 
blood plasma. 
d) Cobalt(II). 
Refinement of this model will require the 
determination of the stability con$tants of the cobalt 
complexes of cysteine and cystine. Insertion of 
the stability constants for cobalt with eight amino 
acids (listed in section 6.1), shows that at a 
level of O.lmM cobalt, the concentrations of the 
complexes [Cu(His) 2 ], [Zn.Cys.His], [Zn.His]+, and 
[Zn(His) 2 ] are lower than normal, but that at cobalt 
levels of O.OlmM and l0- 3mM, the concentrations of 
these complexes are only marginally affected. The 
most important cobalt complex at each level is 
[Co.His]+. 
e) Mercury(II). 
No reliable stability constants were obtained 
for mercury(II) complexes and therefore no COMICS 
calculations could be carried out. Thiols form 
very stable complexes with mercury and presumably 
cysteine would chelate mercury preferential ly in 
the model for blood plasma. 
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6.3 The effect of chelating agents on systems 
containing adventitious metal ions. 
The use of metal-binding drug$ to remove unwanted 
metal ions from the body is well established. 87 
For example, D-penicillamine is the recommended 
treatment for lead poisoning. 112 D-penicillamine 
is also used extensively to remove copper from 
patients suffering from Wilson's disease. 106 Although 
zinc is excreted as a penicillamine complex, cqpper 
is not 87 and the mechanism by which D-penicillamine 
promotes loss of copper is not understood. Since 
cystine is one of the two amino acids which 
coordinates strongly to copper, penicillamine may 
be oxidised to dipenicillamine (3,3,3' ,3'-
tetramethylcystine) in the body before it can 
effectively coordinate to, and remove, copper. 
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From the COMICS calculations, the complex [Cu.Cystine.His] 
is by far the most important copper complex. By 
analogy, it is su9gested that copper may be excreted 
in the form of a copper-histidine-dipenicillamine 
complex. Another possibility is the excretion of an 
albumin-copper-dipenicillamine complex in view of the 
fact that evidence for an albumin-copper-amino acid 
304 
complex has recently been presented. 
However, the action of the chelating drugs is 
not always clearly understood and the COMICS 
calculations provide a new approach to this problem . 
D-penicillamine. 
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The stability constants of zinc(II)-D-penicillamine 
and of the mixed-ligand complexes of zinc-D-penicillamine-
L-histidine and zinc-D-penicillamine-L-cysteine were 
229 
available , and are summarised in Table 6.09. The 
stability constants of lead(II)-D-penici _lamine were 
determined in the present work. Refinement of this 
model will require the prior determination of mixed-
ligand complexes of lead(II) with pairs of the ligands 
cysteine, penicillamine, and histidine. 
TABLE 6. 09 
Stability constant values 229 for zinc(II)-
D-penicillamine complexes at 37 °C and I= 0 . 15M (KN0 3 ) 
Complex Overall stability 
constant, log f3 
[Zn. Pen] 9. 52 
[Zn (Pen) 2 ] 
2- 19.17 
[Zn . H(Pen) 2 ] 25.02 
[ Zn . H 2 (Pen ) 2 ] 30.42 
[Zn. His. Pen] 15.75 
Complex Overall stabili t y 
c onstant, log f3 
[Zn.H.His.Pen] 21 . 69 
[Zn.H.His(Pen) 2 ] 
2- 30.63 
[Zn.H 2 .His(Pen ) 2 ] 36 . 43 
[Zn.Cys.Pen] 1 8 .7 3 
[Zn.H.Cys.Pen] 25.14 
The stability constants of the penic ' llamine 
complexes were incorpo r ated into COMICS and the 
equilibrium concentrations of al l species were 
computed at pH 7 . 4 for a solution of standard 
composition which also contai ned lead and 
penicillamine. The lead concentrati ons taken 
-3 
were 10 mM, O.OlmM, and O.lmM and two 
concentrations of D-penicillamine were specified, 
namely 0 . 033mM (equivalent to the level of L-cysteine 
in blood plasma), and 0 . 33mM. Table 6 .1 0 shows a 
selection of these results. 
TABLE 6.10 
Effect of the addition of D-penicillamine to 
a system containing Pb(II), Cu(II), Zn (II), and 
Mn (II) ions. 
Complex 
Cu.Cystine.His] 
[Cu . H.Cystine.His] 
[Cu(His) 2 ] 
[Zn.His.Cys] 
[Zn . His]+ 
2-Zn(Cys)2] 
Distribution% [~] 
(a) 
49 
38 
11 
0.1 
35 
(b) 
47 
37 
15 
15 
12 
10 
(c) 
45 
35 
19 
0.3 
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Table 6 10 continued. 
Zn 2+ 18 4 
[Zn.H.His . Cystine] 9 3 
[ Zn . Cy s . Pen] 13 7 
[Zn.His.Pen] 12 2 
[Zn(Pen) 2 ] 
2- 9 85 
[Pb. Pen] 33 80 99 
[Pb. Cys] 33 20 1 
[Pb.His]+ 11 
[PbOH] + 7 
(a) [Pb 2+] - O.lmM, [D-Pen] - 0.033mM; 
(b) [Pb2+] 
-
O.OlmM, [D-Pen] - 0.033mM; 
( C) [Pb2+] - O.lmM, [D-Pen] - 0.33mM. 
Condition (a) represents the treatment of a high 
concentration of lead(II) by a relatively low 
concentration of D-penicillamine. The free lead 
concentration has been lowered (see Table 6.07) by 
partial chelation with D-penicillamine but the level 
of Pb.Cys remains unchanged as insufficient 
penicillamine is present. The concentrations of 
the copper and zinc complexes have not returned to 
normal. 
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Under the cond · tions represen ted by b . , 
penicillamine competes successfully with cysteine 
for lead and 80% of the total lead is present as 
PbePen ~ The concentration of Pb eCys is thus reduced, 
resulting in increased levels of [Zn.HiseCys] and 
2-(Zn(Cys 2 ] ~ The complexes [Zn.Cys sPen] and 
[ZnaHis ~Pen ] are present in significant 
concentrations. 
Condi ion c) represents the treatment of a 
high lead concentration by an equal ly high concentration 
of D-penicillamine . 99% of the total lead is present 
as [Pb PenJ and 85% of the zinc is present as 
[Zn Pe In this case, D-penicillamine is 
extremely efficient · n chelating not only the lead 
but also the zinc ~ These results are in agreement 
with the observed zinc depletion which occurs during 
penicillamine 87 herapy 
This picture may change s ignificantly once 
ons ants are available for zinc-cystine complexes 
N-(2-mercaptopropionyl)glycine forms stable complexes 
with lead and the stability constants of its complexes 
with lead II) and zinc II were substi uted in COMICS 
and the calcula ions described for D-penicillamine 
were repeated The results are summarised in Table 6.11 
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The manganese complexes are present in low concentrations 
ai:e are omitted~ 
TABLE 6 .11 
Effect of the addition of N-(2-merc aptopropionyl 
glycine(Mpg) to a system containing Pb(II), Cu (I I), 
Zn(II , and Mn(II) ions. 
Complex Distribution% [MT] 
(a) {b) (c) 
lCu ~Cystine ~His] 49 48 46 
[Cu~H.Cystine~His] 38 37 36 
[Cu(His) 2 J 11 14 16 
[Zn ~His .. Cys] 0" 1 21 13 
[Zn His + 35 21 12 
[Zn(Cys) 2 ] 
2- 12 6 
Zn 2+ 18 9 4 
lZn.H~His~Cystine 9 6 3 
[Zn .Mpg] 5 18 
[Zn Mpg) 2 ] 
2- 1 29 
[Pb. OH. Mpg] 32 42 83 
[Pb.Cys] 33 57 15 
[Pb.His] 11 0. 1 
[PbOH] + 7 0., 1 
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Table 6.11 continued. 
(a) [Pb 2+] ~ O.lmM, [Mpg] ~ 0.033mM; 
(b) [Pb 2+] ~ O.OlmM, [Mpg] ~ 0.033mM; 
(c) [Pb2+] ~ O.lmM, [Mpg] ~ 0.33mM. 
N-(2-mercaptopropionyl)glycine does not remove 
the effect of lead poisoning under conditions (a). 
However, almost normal distribution of zinc amongst 
the amino acids is obtained under conditions (b) and 
42% of the total lead is present as [Pb.OH.Mpg] 
Condition (c) represents the treatment of a high 
• 
lead concentration by an equally high N-(2-mercapto-
propionyl)glycine concentration. 83% of the total 
lead is coordinated by the chelating agent but 
only 47% of the zinc is present in the complexes 
2-[Zn.Mpg] and [Zn(Mpg) 2 ] . This contrasts with 
the situation with D-penicillamine (column (c) 
Table 6.10) where virtually all the zinc is bound 
to penicillamine. Thus, although N-(2-mercapto-
propionyl)glycine competes less effectively for lead 
than does D-penicillamine, it still removes lead 
from the system and has less effect on the zinc 
distribution among the amino acids. Thus, it is 
suggested that the zinc depletion observed during 
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penicillamine therapy could be considerably reduced 
if this ligand were used instead of penicillamine. 
Similar calculations were carried out to 
determine the effect of the addition of chelating 
drugs to systems containing cadmium. Both 
D-penicillamine and N-(2-mercaptopropionyl)glycine 
competed successfully with the amino acids for 
cadmium. These results may be deceptive because 
stability constant data for cadmium were available 
only with nitrogen and oxygen chelating ligands 
(see section 6.2). 
6.4 Future developments. 
The present calculations represent a first step 
towards the establishment of a model for metal complex 
equilibria in blood plasma. They are necessarily 
crude but will be pregressively refined by allowing 
for other metal ions and other ligands, including 
peptides as models for proteins, and also by the 
further study of mixed complex formation. 
COMICS at present only considers equilibria in 
a single phase but it should be possible to extend 
the programme to deal with a multi-phase system in 
which the relative volume of the phases is specified, 
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together with the distribution coefficient of species 
across phase boundaries. It is an approximation t o 
deal with dynamic equilibrium and the possibility 
of a species entering or leaving the syste m or 
undergoing chemical transformation (including the 
modification or the destruction of a ligand as the 
result of enzyme activity) has not yet been considered. 
Computer programmes exist for the study of multi-
enzyme and multi-phase systems (for example, 
HALTAFALL 21 ) and perhaps, in the future, these may 
be incorporated into COMICS to provide a multi-phase 
system as a model for an entire organism . 
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APPENDIX 
TABLES OF EXPERIMENTAL pH TITRATION DATA 
Full experimental data, in the form-· of computer 
outputs, are available from Dr D. D. Perrin, 
Department of Medical Chemistry, John Curtin School 
of Medical Research, Australian National University, 
Canberra. 
TABLE A.01 
Summary of pH titration data for pK values of 
-a 
amino acids. Initial concentration of amino acid 
(L) ' pH range, and number of reading (N) for each 
titration. 
10 3L pH range N 
(1) L-leucine 
5.0 3.7 - 9.8 15 
5.1 2.6 - 9.0 25 
5.2 2.6 - 8.9 22 
6.3 2.6 - 8 .. 9 26 
(2) L-isoleucine 
5.0 2.6 - 9.1 27 
6.5 5.9 - 11 . 0 25 
(3) L-ornithine hydrochloride 
2.8 5.3 - 11.0 31 
4.1 3.5 - 9.0 21 
4.2 4.2 - 10.8 30 
5.4 2.5 - 9.0 32 
6.8 3.5 - 9. 8 28 
Al 
10 3L pH range N 
(4) L-arginine 
2.5 2.2 - 9.1 24 
3.8 5.2 - 9.8 16 
5.0 7.0 - 9.8 17 
TABLE A.02 
S f H t 't t' d t f 2+ 'th 1 . urnmary o p i ra ion a a or M wi g ycine. 
Initial concentration of total metal ion (M), and 
amino acid (L), pH range, and number of readings (N) 
for each titration. 
2.4 
2.4 
2.4 
2.4 
2.4 
2.5 
2.5 
2.5 
10 3L pH 
(1) Cobalt(II) 
5.0 4.2 
10.0 4.4 
12.5 4.3 
(2) Nickel(II) 
10.0 4.3 
15.0 4.3 
(3) Cadmium(II) 
4.9 4.1 
9.9 4.3 
12.5 4.3 
TABLE A.03 
range 
- 8 . 8 
- 8 . 9 
- 7.7 
- 8.0 
- 8.0 
- 7.7 
- 9.0 
- 8 .. 8 
N 
19 
21 
15 
23 
24 
8 
16 
19 
S f . . d f 2+ . h 1 . urnmary o pH titration ata or M wit L- eucine. 
2.5 
2.5 
2.5 
(1) Manganese(II) 
5.3 
6.4 
7.6 
3.9 - 9.0 
4.0 - 9.0 
4.0 - 9.0 
12 
14 
16 
A2 
2.4 
2.4 
2.4 
2.4 
2.4 
2.4 
1.3 
2.6 
2.6 
2.6 
2.5 
2.5 
2.5 
2.5 
2.5 
2.5 
pH range 
(2) Cobalt(II) 
5.2 
6.5 
8.0 
3.7 - 8.9 
3.7 - 8.7 
3.8 - 8.6 
(3) Nickel(II) 
5.2 
6.5 
7.8 
4.1 - 7.3 
4.1 - 7.3 
3.8 - 7.2 
(4) Copper (II) 
2.6 
4.9 
6.1 
7.3 
(5) Zinc (II) 
5.1 
6.4 
7.6 
3.5 - 6.0 
3.3 - 5.4 
3.3 - 4.8 
3.3 - 4.6 
3.7 - 7.6 
3.7 - 7.8 
3.8 - 7.7 
(6) Cadmium(II) 
5.3 
6.6 
8.0 
TABLE A.04 
3.9 - 8 .5 
4.0 - 8.1 
4.0 - 8 . 0 
N 
20 
20 
20 
17 
18 
20 
12 
10 
12 
12 
16 
20 
21 
13 
10 
12 
A3 
S f . . d f 2+ . h . 1 . urrunary o pH titration ata or M wit L-iso eucine 
2.5 
2.5 
2.5 
2.4 
2.4 
2.4 
(1) Manganese(II) 
4.2 
5.6 
7.0 
3.8 - 8.8 
3.9 - 8.8 
4.0 - 8.9 
(2) Cobalt(II) 
4.2 
5.6 
7.0 
3.6 - 8.5 
3.7 - 8.8 
3.8 - 9.1 
6 
8 
12 
18 
24 
30 
A4 
10 3M 10 3L pH range N 
( 3) Nickel(II) 
2.4 3.9 3.6 - 8.6 18 
2.4 5.2 3.7 - 9.3 23 
2.4 6.5 3.7 - 9.2 25 
(4) Copper(II) 
2. 6 3.8 3.3 - 7.1 23 
2.6 5.1 3.2 - 9.9 32 
2.6 6.3 3.2 - 9.7 26 
(5) Zinc(II) 
2.5 3.9 3.6 - 7.6 13 
2.5 5.2 3.7 - 7.5 14 
2.5 6.5 3.7 - 7.7 18 
( 6) Cadmium (II) 
2.5 4.2 3.8 - 8.4 10 
2.5 5.2 3.9 - 8.5 13 
2.5 7.0 4.0 - 8.8 9 
TABLE A.OS 
Summary of pH titration data for M2+ with 
L-ornithine hydrochloride. 
(1) Manganese(II) 
2.5 4.2 3.5 - 8.7 12 
2.5 5.6 3.5 - 8.9 16 
2.5 7.0 3.6 - 8.8 18 
(2) Cobalt(II) 
2.4 4.2 3.5 - 8.6 18 
2.4 5.6 3.5 - 8.7 23 
2.4 7.1 3.5 - 9.1 29 
( 3) Nickel (II) 
2.4 4.2 3.5 - 8.9 25 
2.4 5.6 3.5 - 9.3 30 
2.4 7.1 3.5 - 8.9 29 
AS 
10 3M 10 3L pH range N 
(4) Copper (II) 
2.6 4.1 3.1 - 6.5 22 
2.6 5.4 3.1 - 9.7 39 
2.6 6.8 3.1 - 9.3 35 
( 5) Zinc(II) 
2.5 4.2 3.9 - 7.8 16 
2.5 5.6 3.5 - 8.0 19 
2.5 6.8 3.5 - 8.9 27 
( 6) Cadmium (II) 
2.5 4.1 3.5 - 8.6 17 
2.5 5.5 3.5 - 8.9 21 
2.5 6.8 3.6 - 9.0 25 
TABLE A.06 
Summary of pH titration data for 2+ 'th . . M wi L-arginine 
(1) Manganese(II) 
2.5 3.8 4.2 - 8.8 13 
2.5 5.2 3.0 - 8.8 22 
2.5 6.4 3.0 - 8.8 18 
( 2) Cabal t (II) 
2.4 3.8 3.2 - 8.5 22 
2.4 5.1 3.1 - 8.6 23 
2.4 6.4 3.0 - 8.5 25 
(3) Nickel(II) 
2.5 3.8 3.1 - 8.5 24 
2.5 5.0 5.1 - 8.9 25 
2.5 6.3 6.2 - 9.5 18 
(4) Copper (II) 
1.3 1.9 3.3 - 7.1 13 
2.6 5.0 3.4 - 8.9 24 
2.6 6.3 3.8 - 9.9 24 
2.4 
2.4 
2.4 
2.5 
2.5 
2.5 
10 3L pH 
( 5) Zinc(II) 
3.9 5.0 
5.2 3.0 
6.5 3.1 
( 6 ) Cadmium (II) 
3.9 6.7 
5.2 3.0 
6.5 3.2 
TABLE A.07 
range 
- 7.7 
- 7.9 
- 8.1 
- 8.4 
- 8.5 
- 8.6 
Representative data for pH titrations of 
L-methionine solutions containing (1) cadmium(II) 
ions and (2) lead(II) ions. Titres in ml. 
N 
14 
26 
23 
13 
22 
19 
A6 
(1) Initial conditions: [Cd2+] - 0.0025M; [HL] - 0.0076M; 
[HN0 3 ] - 0.0040M; volume - 50.22 ml.; titrant KOH - 0.9862M. 
Titre 
0.24 
0.25 
0.26 
0.27 
0.28 
0.29 
0.30 
0.32 
0.33 
0.34 
pH 
6.933 
7.060 
7.170 
7.269 
7.359 
7.444 
7.523 
7.674 
7.744 
7.813 
-n 
0.28 
0.35 
0.42 
0.49 
0.56 
0.63 
0.69 
0.82 
0.89 
0.95 
Titre 
0.35 
0.36 
0.37 
0.39 
0.41 
0.43 
0.45 
0.49 
0.52 
0.54 
pH 
7.881 
7.948 
8.013 
8.146 
8.275 
8.404 
8.536 
8.807 
9.027 
9.177 
n 
1.00 
1.07 
1.12 
1.23 
1.33 
1.43 
1.52 
1.68 
1.82 
1.97 
(2) Initial conditions: [Pb 2+] - 0. 0012M; [HL] - 0. 0032M; 
[HN0 3 ] - 0.0010M; volume - 50.22 ml.; titrant KOH - 0.9862M. 
Titre 
0.09 
0.10 
0.11 
0.12 
0.13 
0.14 
0.15 
pH 
7.117 
7.261 
7.404 
7.557 
7.724 
7.899 
8.061 
-
n 
0.59 
0.74 
0.88 
1.03 
1.16 
1.29 
1.42 
Titre 
0.16 
0.17 
0.18 
0.19 
0.20 
0.21 
0.22 
pH 
8.206 
8.341 
8.459 
8.569 
8.671 
8.764 
8.857 
-n 
1.55 
1.69 
1.84 
2.01 
2.20 
2.43 
2.71 
TABLE A.OB 
Summary of pH titration data for lead(II) hydrolysis 
and for M2+ with L-cysteine. 
10 3M 
1.0 
1.2 
5.0 
1.2 
1.2 
1.2 
1.2 
1.2 
(1) 
(2) 
pH range 
Lead(II) hydrolysis 
3.2 - 7.0 
3.1 - 6.7 
3.0 - 6.3 
Lead(II)-L-cysteine 
2.5 
3.1 
3.2 - 5.5 
3.2 - 5.3 
(3) Nickel(II)-L-cysteine 
1.8 
2.4 
3.2 
TABLE A.09 
4.5 - 6.6 
4.5 - 6.5 
4.9 - 6.3 
N 
10 
6 
12 
17 
17 
19 
24 
21 
Representative pH titration of solution containing 
D-penicillamine and lead(II) ions. Titres in ml. 
A7 
Initial conditions: [Pb 2+] = 0.0007M; [H 2L] = 0.0013M; 
[HN0 3 ] - 0.0006M; volume - 50.19 ml.; titrant KOH= 0.9862M 
-
Titre - Titre pH n pH n 
0.03 3.788 0.14 0.09 4.624 0.81 
0.04 3.916 0.23 0.10 5.028 0.93 
0.05 4.041 0.34 0.11 7.294 0.97 
0.06 4.163 0.45 0.12 7.926 0.99 
0.07 4.291 0.57 0.13 8.547 1.03 
0.08 4.433 0.69 
TABLE A.10 
Surmnary of pH titration data for cadmium(II)-
D-penicillamine. 
10 3M 
1.2 
1.2 
1.2 
10 3L 
2.5 
3.1 
3.7 
TABLE A.11 
pH range N 
4.6 - 7.6 20 
4.5 - 7.4 20 
4.5 - 7.4 21 
Surrunary of pH titration data for pK values of 
-a 
N-(2-mercaptopropionyl)glycine. 
1.2 
1.2 
2 . 5 
2.5 
3.7 
5.0 
pH range 
2.9 - 3.4 
3.3 - 8.9 
2.7 - 3.4 
3.1 - 4.0 
7.5 - 9.1 
2.8 - 3.4 
TABLE A.12 
N 
7 
7 
7 
10 
15 
8 
Representative data for pH titrations of 
N-(2-mercaptopropionyl)glycine solutions containing 
M2+. Titres in ml. 
(1) Zinc(II) 
Initial conditions: [Zn2+] - 0.0012M; [H 2L] - 0.0043M; 
[HN0 3 ] - 0. 0; volume= 50.22ml., titrant KOH - 0.9862M. 
-Titre pH n -Titre pH n 
0.19 4.254 0.06 0.33 6.460 1.73 
0.20 4.376 0.10 0.34 6.680 1.87 
0.21 4.516 0.14 0.35 6.916 2.01 
0.22 4.677 0.20 0.36 7.154 2.14 
0.23 4.846 0.29 0.37 7.382 2.25 
0.24 5.015 0.40 0.38 7.596 2.35 
A8 
A9 
Titre - Titre -pH n pH n 
0.25 5.183 0.53 0.39 7.798 2.44 
0.26 5.337 0.67 0.40 7.999 2 . 52 
0.27 5.488 0.81 0.41 8 . 199 2.60 
0.28 5.635 0.96 0.42 8 . 416 2.69 
0.29 5.782 1.11 0.43 8.676 2.83 
0.30 5.932 1.27 0.44 8.987 3 . 21 
0.31 6.094 1.42 0.45 9.312 4.49 
0.32 6.264 1.58 
(2) Cadmium (II) 
Initial conditions: [Cd2+] - 0.0012M; [H 2L] - 0.0041M; 
[HN03 ] - 0. 0; volume= 50.19 ml., titrant KOH - 0.9862M. 
- Titre -Titre pH n pH n 
0.13 3.732 0.11 0.30 5.549 1.49 
0.15 3.847 0.18 0.31 5.894 1.64 
0.17 3.963 0.27 0.32 6.256 1.79 
0.19 4.083 0.39 0.33 6.600 1.93 
0.21 4.212 0.54 0.34 6.800 2.08 
0.23 4.369 0.71 0.35 7.159 2.19 
0.25 4.561 0.90 0.36 7.404 2.32 
0.26 4.686 1.00 0.37 7.648 2.42 
0.27 4.834 1.11 0.38 7.903 2.52 
0.28 5.018 1.23 0.39 8.195 2.59 
0.29 5.253 1.36 0.40 8.560 2 . 63 
(3) Lead(II) 
Initial conditions: [Pb 2+] 
- 0.0012M; [H 2L] - 0.0066M; 
[HN0 3 ] - 0.0010M; volume - 50.20 ml.; titrant - 0.9862M. 
Titre - Titre pH -pH n n 
0.19 3.398 0.12 0 . 50 6.202 1 . 75 
0.22 3.512 0.15 0.55 7.400 2 . 20 
0.25 3.619 0.21 0.57 7.600 2.36 
0.28 3.732 0.29 0.58 7.739 2.37 
0.31 3.856 0.38 0.59 7.830 2.42 
0.34 3.978 0.51 0.61 7.999 2.54 
0.37 4.158 0.61 0.62 8.075 2 . 61 
0.40 4.374 0.75 0.63 8.148 2.70 
0.44 4.836 1.02 0 . 65 8.298 2 . 88 
0.46 5.219 1.22 
AlO 
TABLE A.13 
pH titration data for the determination of pK 
-a 
values of glutathione. Titres in ml. 
Initial conditions: [H 3L] - 0. 0020M; [HN0 3 ] - 0. 0; 
Volume - 50.22 ml.; titrant KOH= 0.9862M. 
Titre 
0.11 
0.12 
0.13 
0.14 
0.15 
0.16 
0.17 
0.18 
pH 
7.632 
7.940 
8.144 
8.303 
8.438 
8.558 
8.669 
8.773 
Titre 
0.19 
0.20 
0.21 
0.22 
0.23 
0.24 
0.25 
0.26 
pH 
8.876 
8.974 
9.073 
9.170 
9.270 
9.372 
9.477 
9.591 
Titre 
0.27 
0.28 
0.29 
0.30 
0.31 
0.32 
0.33 
pH 
9.708 
9.832 
9.960 
10.088 
10.202 
10.307 
10.400 
Initial conditions: [H 3L] - 0.0024M; [HN0 3 ] - 0.0; 
Volume - 50.22 ml.; titrant KOH= 0.9862M. 
Titre 
0.00 
0.02 
0.04 
0.06 
0.08 
0.09 
0.10 
0.11 
0.15 
pH 
3.246 
3.382 
3.530 
3.708 
3.937 
4.085 
4.273 
4.560 
7.943 
Titre 
0.16 
0.17 
0.18 
0.19 
0.21 
0.22 
0.23 
0.24 
0.25 
pH 
8.108 
8.245 
8.362 
8.467 
8.652 
8.737 
8.818 
8.900 
8.980 
Titre 
0.26 
0.27 
0.28 
0.29 
0.30 
0.32 
0.33 
0.34 
0.35 
pH 
9.059 
9.138 
9.218 
9.300 
9.388 
9.572 
9.672 
9. 7 76 
9.886 
Initial conditions: [H 3L] - 0.00363M; [HN0 3 ] - 0.0; 
Volume - 50.20 ml.; titrant KOH= 0.9862M. 
Titre 
0.00 
0.02 
0.04 
0.05 
0.07 
0.09 
0.11 
0.12 
pH 
3.165 
3.262 
3.363 
3.416 
3.535 
3.666 
3.813 
3.900 
Titre 
0.17 
0.21 
0.22 
0.23 
0.24 
0.25 
0.27 
0.29 
pH 
4.642 
7.689 
7.856 
7.989 
8.100 
8.194 
8.354 
8.494 
Titre 
0.39 
0.41 
0.43 
0.45 
0.47 
0.49 
0.50 
0.51 
pH 
9.060 
9.169 
9.282 
9.400 
9.522 
9.661 
9.732 
9.812 
All 
Titre pH Titre pH Titre pH 
0.13 3.995 0.31 8.616 0.52 9.898 
0.14 4.100 0.33 8.732 0.53 9.983 
0.15 4.231 0.35 8.844 0.54 10.072 
0.16 4.400 0.37 8.953 
Initial conditions: [H 3L] - 0.0048M; [HN0 3 ] - 0. 0; 
Volume - 50.22 ml.; titrant KOH= 0.9862M. 
Titre pH Titre pH Titre pH 
0. 00 · 3.117 0.21 4.348 0.41 8.608 
0.01 3.156 0.22 4.504 0.43 8.699 
0.02 3.196 0.23 4.732 0.45 8.782 
0.04 3.274 0.24 5.170 0.47 8.866 
0.06 3.359 0.29 7.830 0.50 8.990 
0.08 3.448 0.30 7.934 0.52 9.072 
0.10 3.543 0.31 8.024 0.54 9.154 
0.12 3.645 0.32 8.104 0.56 9.238 
0.14 3.759 0.33 8.176 0.58 9.326 
0.16 3.888 0.34 8.240 0.60 9.419 
0.18 4.038 0.35 8.300 0.62 9.516 
0.19 4.126 0.37 8.412 0.66 9.740 
0.20 4.227 0.39 8.513 0.70 10.010 
TABLE A.14 
pH titration data of glutathione solutions containing 
M2+. Titres in ml. 
(1) Zinc(II) 
Initial conditions: [Zn2+] - 0.0012M; [H3L] - 0.0025M; 
[HN0 3 ] - 0. 0; volume= 50.20 ml. titrant KOH - 0.9862M. 
Titre - Titre - Titre -pH n pH n pH n 
0.09 4.036 0.01 0.19 6.261 0.51 0.29 7.802 1.25 
0.10 4.202 0.01 0.20 6.366 0.59 0.30 8.038 1.29 
0.11 4.432 0.01 0.21 6.473 0.66 0.31 8.272 1.33 
0.12 4.798 0.01 0.22 6.584 0.74 0.32 8.482 1.37 
0.13 5.257 0.05 0.23 6.700 0.82 0.33 8.673 1.41 
0.14 5.567 0.12 0.24 6.827 0.90 0.34 8.842 1.46 
0.15 5.764 0.19 0.25 6.974 0.97 0.35 8.998 1.53 
0.16 5.912 0.27 0.26 7.144 1.05 0.36 9.139 1.62 
0.17 6.038 0.35 0.27 7.338 1.12 0.37 9.269 1.76 
0.18 6.153 0.43 0.28 7.566 1.19 0.38 9.394 1.95 
Al2 
Initial conditions: [Zn2+] - 0.0012M; [H 3L] - 0.0037M; 
[HN0 3 ] - 0.0; volume= 50.20 ml.; titrant KOH = 0.9862M. 
Titre - Titre Titre -pH n pH n pH n 
0.01 3.208 0.01 0.22 5.734 0.26 0.38 7.924 1.37 
0.02 3.256 0.01 0.23 5.857 0.34 0.39 8.080 1.39 
0.04 3.358 0.01 0.24 5.967 0.42 0.40 8.220 1.41 
0.06 3.468 0.01 0.25 6.071 0.50 0.42 8.463 1.44 
0.08 3.589 0.01 0.26 6.172 0.57 0.43 8.570 1.45 
0.10 3.722 0.01 0.27 6.274 0.65 0.44 8.668 1.47 
0.12 3.880 0.01 0.28 6.375 0.73 0.45 8.760 1.49 
0.13 3.969 0.01 0.29 6.485 0.81 0.46 8.848 1.52 
0.14 4.073 0.01 0.30 6.600 0.88 0.48 9.016 1.59 
0.15 4.194 0.01 0.31 6.730 0.96 0.50 9.177 1.70 
0.16 4.340 0.01 0.32 6.876 1.04 0.52 9.332 1.88 
0.17 4.530 0.01 0.33 7.035 1.11 0.54 9.489 2.16 
0.18 4.800 0.02 0.34 7.209 1.17 0.56 9.644 2.61 
0.19 5.133 0.06 0.35 7.396 1.24 0.57 9.720 2.93 
0.20 5.400 0.12 0.36 7.577 1.29 
0.21 5.592 0.19 0.37 7.756 1.33 
Initial conditions: [zn2+] 
-
0.0012M; [H 3L] - 0.0043M; 
[HN0 3 ] - 0. 0; volume= 50.19 ml.; titrant KOH - 0.9862M . 
Titre - Titre - Titre pH -pH n pH n n 
0.02 3.222 0.26 5.764 0.33 0.44 8.162 1.43 
0.04 3.310 0.27 5.873 0.41 0.45 8.274 1.44 
0.06 3.403 0.01 0.28 5.975 0.49 0.46 8.375 1.44 
0.08 3.503 0.01 0.29 6.073 0.56 0.47 8.468 1.45 
0.10 3.612 0.01 0.30 6.170 0.64 0.48 8.556 1.46 
0.12 3.733 0.01 0.31 6.271 0.72 0.49 8.637 1.47 
0.14 3.870 0.01 0.32 6.376 0.80 0.50 8.714 1.48 
0.16 4.033 0.01 0.33 6.490 0.87 0.51 8.794 1.49 
0.17 4.130 0.01 0.34 6.612 0.95 0.52 8.864 1.51 
0.18 4.244 0.01 0.35 6.742 1.03 0.54 9.000 1.56 
0.19 4.384 0.01 0.37 7.067 1.17 0.56 9.132 1.63 
0.20 4.560 0.01 0.38 7.242 1.23 0.58 9.264 1.73 
0.21 4.792 0.03 0.39 7.418 1.28 0.60 9.394 1.90 
0.22 5.076 0.06 0.40 7.593 1.33 0.62 9.524 2.15 
0.23 5.320 0.11 0.41 7.754 1.37 0.64 9.661 2.52 
0.24 5.501 0.18 0.42 7.902 1.39 0.66 9.800 3.11 
0.25 5.645 0.27 0.43 8.038 1.41 0.68 9.942 4.05 
Al3 
Initial c onditions: [Z n 2+ ] - 0.0015M; [H 3L] - 0.0074M; 
[HN0 3 ] - 0.0; volume = 50. 17 ml. ; titrant KOH - 0.9862M. 
-Titre pH n Ti t r e p H - Titre -n pH n 
0.10 3 . 337 0.01 0.3 8 5.0 6 0 0 .11 0.66 8.070 1.41 
0.12 3.400 0.01 0.40 5 . 3 30 0 .2 0 0.68 8.198 1.42 
0.14 3 . 464 0.0 1 0.41 5 .438 0 . 26 0.70 8.306 1.43 
0.16 3.530 0.01 0 . 42 5. 536 0 .32 0.73 8.455 1.43 
0.18 3.600 0. 01 0.46 5.878 0 . 5 7 0 .76 8.588 1.43 
0.20 3.674 0 . 02 0.48 6 . 0 46 0 .7 0 0.7 8 8.666 1 . 44 
0.22 3.754 0.01 0.50 6.235 0. 83 0 .8 0 8 .744 1.45 
0.24 3.838 0.02 0.52 6.460 0 . 95 0 . 84 8.890 1.48 
0.26 3.930 0.02 0.54 6 . 723 1. 0 7 0 .88 9.028 1 . 54 
0.28 4 . 035 0.02 0 . 56 7 . 00 1 1.18 0 .92 9.165 1.63 
0.30 4.156 0.02 0.58 7 . 281 1.27 0.96 9.302 1.76 
0.32 4.301 0.02 0.60 7.534 1.33 1.00 9.447 1. 9 6 
0.34 4.496 0.03 0.62 7 .7 42 1.3 8 
0.36 4.744 0.05 0 . 64 7. 920 1.4 0 
(2) Cadmium( II) 
Initial conditions: [Cd2+] - 0.00 12M ; [H 3L] - 0.0025M; 
[HN0 3 ] - 0. 0; volume= 50 . 19 ml. ; titrant KOH = 0.9862M. 
-Titre - -pH n Titre pH n Titre pH n 
0.02 3.364 0.01 0. 1 7 5. 1 8 4 0.36 0.29 8.020 1.19 
0.04 3.504 0.02 0. 1 8 5.32 7 0 .44 0.30 8.236 1.23 
0.06 3.672 0 . 02 0 .19 5 .492 0.51 0.31 8.444 1.26 
0.08 3.873 0.02 0 . 20 5.674 0.59 0.32 8.642 1.28 
0.09 3.9 92 0.02 0. 21 5.882 0.66 0.33 8.830 1.30 
0.10 4.124 0.03 0.22 6. 132 0.74 0.34 9.000 1.33 
0 . 11 4.282 0.05 0.23 6. 428 0.81 0.35 9.174 1.38 
0.12 4.459 0.07 0.24 6. 741 0.89 0.36 9.346 1.44 
0.13 4.630 0 .11 0 . 25 7 . 0 44 0.96 0.37 9.529 1.53 
0.14 4.782 0 . 16 0 .2 6 7.317 1.03 0.38 9.708 1.67 
0. 1 5 4 . 916 0 . 2 3 0 .27 7.566 1 . 09 0.39 9.887 1. 89 
0.16 5.046 0.29 0 .2 8 7.798 1.15 0.40 10.044 2.22 
Al4 
Initial conditions: [Cd2+] - 0. 0012M; [H 3L] - 0. 0031M; 
[HN0 3 ] - 0.0; volume= 50.19 ml.; titrant KOH= 0.9862M. 
Titre 
0.02 
0.04 
0.06 
0.10 
0.12 
0.13 
0.14 
0.15 
0.16 
0.17 
0.18 
pH 
3.293 
3.407 
3.534 
3.841 
4.038 
4.153 
4.283 
4.421 
4.561 
4.685 
4.800 
-n 
0.01 
0.02 
0.02 
0.03 
0.04 
0.05 
0.07 
0.09 
0.13 
0.18 
0.24 
Titre pH 
0.20 5.035 
0.22 5.305 
0.23 5.458 
0.24 5.635 
0.25 5.856 
0.26 6.118 
0.27 6.419 
0.28 6.722 
0.29 7.000 
0.30 7.245 
0.32 7.666 
-n 
0.36 
0.50 
0.58 
0.65 
0.73 
0.80 
0.88 
0.95 
1.02 
1.08 
1.20 
Titre 
0.34 
0.36 
0.38 
0.40 
0.42 
0.43 
0.44 
0.45 
0.47 
0.48 
0.49 
pH 
8.042 
8.385 
8.681 
8.937 
9.178 
9.300 
9.419 
9.542 
9.808 
9.943 
10.070 
-
n 
1.27 
1.31 
1.32 
1.33 
1.37 
1.39 
1.44 
1.50 
1.70 
1.88 
2.15 
Initial conditions: [Cd2+] - 0.0012M; [H 3L] - 0. 0049M; 
[HN0 3 ] - 0.0; volume= 50.19 ml.; titrant KOH - 0.9862M. 
Titre 
0.19 
0.20 
0.21 
0.22 
0.23 
0.24 
0.25 
0.26 
0.27 
0.28 
0.30 
0.32 
0.33 
0.34 
pH 
4.044 
4.114 
4.200 
4.284 
4.369 
4.456 
4.540 
4.622 
4.708 
4.800 
5.010 
5.293 
5.477 
5.700 
n 
0.05 
0.07 
0.08 
0.09 
0.12 
0.15 
0.19 
0.24 
0.29 
0~35 
0.47 
0.59 
0.66 
0.73 
Titre 
0.35 
0.36 
0.37 
0.41 
0.42 
0.43 
0.44 
0.45 
0.46 
0.47 
0.48 
0.49 
0.50 
0.52 
pH 
5.968 
6.258 
6.529 
7.325 
7.488 
7.634 
7.778 
7.911 
8.038 
8.153 
8.259 
8.356 
8.449 
8.614 
TABLE A.15 
-n 
0.80 
0.88 
0.95 
1.20 
1.24 
1.28 
1.31 
1.33 
1.34 
1.34 
1.33 
1.32 
1.30 
1.26 
Titre 
0.55 
0.56 
0.58 
0.60 
0.62 
0.64 
0.66 
0.68 
0.70 
0.72 
0.74 
0.76 
0.78 
0.80 
pH 
8.830 
8.896 
9.021 
9.144 
9.266 
9.388 
9.515 
9.651 
9.800 
9.960 
10.129 
10.296 
10.445 
10.570 
-
n 
1. 21 
1.19 
1.17 
1.15 
1.13 
1.12 
1.13 
1.14 
1.17 
1.24 
1.40 
1.69 
2.19 
2.96 
Summary of pH titration data for determination of 
stability constants of mixed-ligand complexes of nickel(II) 
10 3M l0 3L1 l0
3L2 pH range N 
(1) Nickel(II)-L-cysteine-glycine 
2.5 2.5 2.6 3.6 - 7.9 23 
2.5 3.1 2.6 3.6 - 8.4 30 
Al5 
10 3L 10 3L2 pH range N 
(2) Nickel(II)-L-cystine-glycine 
0. 1 0 .1 0.1 6.9 - 9.4 17 
(3) Nickel (II ) -L-cystine-L-leucine 
0.1 0.2 0.1 6.6 - 9.3 19 
